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Abstract 
This project has been part of an ongoing interest in metabolites with a cyclic tricarbonyl motif 1, 
usually enolised. Coleophomones A–C have a unique architecture with the cyclic tricarbonyl motif 
embedded in an 11-membered ring: A & B exist in ‘aldol’ equilibrium, B & C are geometric isomers, 
and D lacks the macrocycle.1,2 Antifungal & antibiotic activity, and inhibition of human heart chymase 
& bacterial cell-wall transglycosylase, has generated synthetic interest.  
 
Figure 1 
In an approach distinct from reported studies,3 we propose 4-carbonyl-substituted isoxazoles, from 
dipolar cycloaddition of nitrile oxides, as building blocks for the tricarbonyl framework. Our strategic 
disconnection to benzisoxazoles is exemplified in the Scheme 1. 
Scheme 1 
During this investigation precursors to the macrocycles of coleophomones A, B, C and analogues were 
developed. (Scheme 2).  
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Scheme 2 
En route to these precursors we have uncovered and probed a facile and highly unusual benzisoxazole 
to oxazole rearrangement (Scheme 3). 
 
Scheme 3 
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1.0 Introduction  
The initial aim of the work described herein was the synthesis of the coleophomone family of natural 
products and related compounds via an isoxazole route. 
This family of natural products is of interest as its member’s exhibit antibacterial, antifungal activity, 
and enzyme inhibition; as well as a synthetic challenge. There are four members of the coleophomone 
family: coleophomones A, B, C and D. 
History of the Coleophomone Natural Products 
The coleophomone family (Figure 1) of compounds was first reported in a Japanese patent made on 
behalf of the Shionogi Pharmaceutical Company.2 Coleophomones A 1, B 2 and C 3 were isolated from 
a fungal broth of Stachybotrys cylindrospora; Coleophomone D 4 was isolated one year later by the 
same company from a Stachybotrys parvispora Hughes broth as a mixture of isomers.1 The following 
year, a research group based at Merck published a paper describing the isolation of coleophomones A 
and B from a broth of Coleophoma sp.4 
  
Figure 1 
The coleophomones have been shown to inhibit bacterial cell wall transglycosylase and human heart 
chymase; transglycosylase catalyses the polymerisation of disaccharide-pentapeptide units to form 
uncrosslinked peptidoglycan, also known as murein.5 Murein is a building block for bacterial cell walls 
and so is necessary for survival and reproduction, and therefore if production is inhibited, cell death 
will occur.  
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Human heart chymase is responsible for the conversion of Angiotensin I to Angiotensin II, with the 
latter being linked to hypertension, which is considered to be a major risk factor for death and organ 
damage.6,7 It can be envisaged that the coleophomone family and their analogues could be used as a 
treatment for both bacterial infection and hypertension. 
Structure of the Coleophomones 
The coleophomones are a structurally intriguing group of compounds; every member of the group 
contains a highly reactive cyclic tri-carbonyl unit, multiple alkenes, as well as complex inter-connected 
ring systems; also A, B and C possess an 11 member macrocycle containing an ether oxygen. 
Coleophomones A and B are isomeric to each other and exist in equilibrium, rapidly interconverting 
through an aldol type reaction; B and C are geometric isomers with E and Z macrocycles respectively 
(Figure 2). 
 
Figure 2 
Colephomone D does not exhibit the macrocycle, instead a methoxy group is present on the aromatic 
ring, which also possesses opposite regiochemistry when compared to A, B and C. As it does not 
contain the macrocycle, D has more rotational freedom than the other members of the family, existing  
as a mixture of isomers (Scheme 1).2  
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Scheme 1. Coleophomone D as a mixture of isomers.  
Coleophomone D1 interconverts into D2 and D4 via a reversible aldol process, D4 and D2 can then 
convert into D3 or back into D1 via the same processes. D4 and D2 can also interconvert into the other 
via rotation. 
 
Retrosynthesis 
The aim of this project is to attempt the synthesis of the Coleophomone natural products and their 
analogues by masking the cyclic-tricarbonyl system as an isoxazole. Previous work on this project 
identified two separate approaches to accomplish this and the first is shown below (Scheme 2).8  
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Scheme 2 
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This approach proposed the cycoladdition of a nitrile oxide, prepared from aromatic oxime 16 where 
R2 represents a handle for forming the aldehyde at a later step, with enamine 14, derived from 
acetonedicarboxylate 17. Alkylations were to be carried out alpha to the isoxazole and at the phenolic 
position, installing the alkyl groups present in the desired natural product.  
Following this, the esters were to be converted into ketones and undergo aldol closure to generate the 
six-membered ring, thereby forming the tricyclic system found in the natural products. At this stage 
further elaborations were to be undertaken to furnish this core structure, yielding the required 
aldehyde. Finally the isoxazole would be cleaved and hydrolysed yielding either coleophomone D or a 
precursor, which would be closed using ring closing metathesis (RCM) or Wittig type chemistry to yield 
coleophomones A, B and C. 
However, using this approach, it was not possible to synthesise the desired methyl ketone required for 
aldol closure from test compound 18, and consequently, this approach was deemed ineffective 
(Scheme 3). 
 
Scheme 3 
At this juncture a second approach based on the work by Suzuki et. al. was identified (Scheme 4).9 
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Scheme 4 
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Similar to the last, this approach proposed the cycloaddition of aromatic precursor 15 to cyclic 
diketone 23 to yield fused benzisoxazole 12, albeit in fewer steps. Once this had been accomplished, 
this system would be further elaborated to yield the desired natural product.  
Using this approach, a previous researcher was able to successfully form fused benzisoxazole 24 
(Figure 3).8 
 
Figure 3 
At this point in the project, we wanted to determine whether it would possible to form the 11-
membered macrocycle with the isoxazole present. It would be synthetically advantageous if this were 
possible, however, fused bis-alkyl benzisoxazole 25 might be too strained to permit this (Scheme 5). 
 
Scheme 5 
As such, bis-alkyl benzisoxazole 26 represents the first synthetic target of this program, as we wished 
to use it as a test compound for RCM. Once we had determined whether it possible to form the 
macrocycle, we planned to then proceed to implement the rest of the functionality found in the 
coleophomones. 
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1.1 The Isoxazole Functionality  
One of the key points of our methodology is to mask the highly reactive tri-carbonyl system present in 
the coleophomones as an isoxazole (Figure 4). This will allow the introduction of additional 
functionality without being constrained by the reactivity of the tri-carbonyl group.  
 
Figure 4 
Therefore an understanding of isoxazole chemistry is required, as will now be described. 
Chemistry of Isoxazoles 
The isoxazole functionality was first proposed in 1888 by Claisen who suggested the name 
monoazole.10 They were first named isoxazole after a publication by Hantzsch, even though the 
isoxazole structure was not determined until 1946.11–13 The standard ways of labelling positions on an 
isoxazole ring is illustrated below (Figure 5).  
 
Figure 5 
Isoxazoles can undergo a variety of reactions as the ring contains a range of chemical properties. The 
ring itself shows some aromatic character with the nitrogen atom acting as an electron withdrawing 
group and the oxygen as electron donating.  
Electrophilic Reactions 
C4 is the most reactive position towards electrophilic substitution. Its reactivity is determined by the 
substituents at the adjacent positions, electron donating groups activate and conversely electron 
donating groups will deactivate position C4. Isoxazole will undergo a range of electrophilic substitution 
reactions (Scheme 6).14 
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Scheme 6 
Nucleophilic Reactions 
Nucleophilic substitution reactions typically occur at positions C3 and C5. However, if the nucleophile 
is a strong base, for example butyllithium and C3 is unsubstituted, then isoxazole ring opening will 
take place as the proton at C3 is acidic (Scheme 7). 
 
Scheme 7 
Side chains at C3 and C5 can be deprotonated with a strong base such as lithium diisopropyl amine 
(LDA) or butyllithium, with C5 substituents being considerably more reactive than those at C3 due to 
extended conjugation (Figure 6).15–17 
 
Figure 6 
Ring Cleavage 
The N-O bond of the isoxazole ring is relatively weak and can be cleaved to expose the corresponding 
enamino ketone and hydrolysis or diazotization can then be employed to reveal the 1,3-dicarbonyl 
functionality (Scheme 8).18,19 
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Scheme 8 
Ring cleavage is typically achieved via hydrogenation over a range of catalysts such as: palladium on 
charcoal, palladium oxide and Raney nickel.20–23  
Although these methods are reliable, one of the main disadvantages is that they will also reduce other 
sensitive functionality, such as olefins and some heterocycles. Consequently other cleavage methods 
have been developed; these include titanium trichloride and sodium in ethanol, samarium diiodide, 
molybdenum hexacarbonyl and as mentioned, de-protonation at the C3 position.24–26  
Ring cleavage via molybdenum hexacarbonyl is of interest to us as other reductive methods may affect 
the functionality present in the colephomones. Below  is the mechanism of this cleavage as proposed 
by Nitta et al. (Scheme 9).24  
 
Scheme 9 
Cleavage is initiated when the nitrogen lone pair coordinates to the metal atom. This prompts N-O 
bond cleavage to yield (β-oxo alkenyl)nitrene complex 44 and upon heating in the presence of water 
this decomposes to yield enamino ketone 40. 
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Preparation 
Isoxazole preparation is classified in five main categories, which are defined by their ring closure 
pattern (Figure 7). 
 
Figure 7 
These are: two (3+2), one (3+1+1) and two (4+1) processes, with the numbers in the brackets referring 
to the number of atoms in each component involved in the formation reaction.27  
The two (3+2) reactions can be further subdivided into two different types, the [CCC + NO] and the 
[CNO + CC] processes. The first process involves the oximation of 1,3-dicarbonyl compounds, whilst 
the second, is the 1,3-dipolar cycloaddition of a nitrile oxide to an alkene (Scheme 10).28,29  
 
Scheme 10 
The [CNO + CC] is the process relevant to this project. The CC portion is an enolate derived from the 
corresponding ketone and the CNO portion is a nitrile oxide, the formation of which will be discussed 
at length in the following section.30 
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Nitrile Oxides 
The use of nitrile oxides has been catalogued for a long time and their applications are still being 
studied today.31,32 Nitrile oxides are made up of three atoms and they adopt a linear shape due to the 
two formal π bonds between carbon and nitrogen (Figure 8). 
 
Figure 8 
Nitrile oxides are also sensitive to moisture and are therefore formed in situ in the majority of 
reactions. 
Formation 
There are several approaches to generating nitrile oxides, some examples being: dehydrohalogenation 
of C-halogenated oximes, dehydration of nitroalkenes, thermolysis of furoxans and oxidation of 
aldoximes. 
Dehydrohalogenation of C-halogenated Oximes 
This method was first introduced in 1894 by Werner and Buss.33 It comprises two steps, starting with 
an aldoxime. Aldoxime 55 can be C-halogenated with a variety of different halogenating agents to 
supply a ‘positive halogen’, examples being N-iodosuccinimide, N-chlorosuccinimide, t-butyl 
hypochlorite or chlorine which yields an α-halonitroso compound, that will tautomerise (as illustrated 
in scheme 5) to a hydroxyimoyl chloride 57 which will slowly decompose in air. The hydroxyimoyl 
chloride then undergoes dehydrohalogenation in situ to yield nitrile oxide 51, usually in the presence 
of a base such as pyridine, which acts as a dehydrohalogenating agent (Scheme 11). 
 
Scheme 11 
Dehydration of Nitroalkanes 
Hoshino and Mukaiyama introduced an effective one-step reaction for the formation of aromatic and 
aliphatic nitrile oxides from primary nitroalkanes.34 This protocol commonly utilises phenyl isocyanate 
60 and triethylamine as the dehydrating mixture, although, other reagent combinations have also 
been reported (Scheme 12).35 
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Scheme 12 
It is also possible to employ di-tert-butyl dicarbonate (Boc2O) instead of phenyl isocyanate, which 
yields the respective N- or O-tert-butoxycarbonyl (Boc) protected products. 
Thermoylsis of Furoxans 
Stable heterocyclic products known as furoxans 63 are formed by the dimerisation of nitrile oxides; 
this process can be reversed by the addition of heat (Scheme 13).36,37  
 
Scheme 13 
If the nitrile oxide is generated in the presence of dipolarophiles, cycloaddition will take place avoiding 
re-dimerisation. However, at high temperatures nitrile oxides will rearrange to form isocyanates 62 
which is a drawback of this method. 
Oxidation of Aldoximes 
Aldoximes can be oxidised to nitrile oxides with a variety of oxidising agents, for example, 
iodobenzene diacetate, lead tetraacetate, chlorobenzotriazole and metal oxides manganese dioxide or 
chromium(IV) oxide (Scheme 14).38–41 
 
Scheme 14 
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1.2 1,3- Dipolar Cycloadditions 
A cycloaddition is a  pericyclic reaction that is defined as: 
“A reaction in which two or more unsaturated molecules (or parts of the same molecule) combine with 
the formation of a cyclic adduct in which there is a net reduction of the bond multiplicity”42  
Pericyclic reactions are often used to assemble four-, five- and six-membered heterocyclic rings. The 
three simplest types of cycloaddition reaction are as follows: 1) the [2+2] cycloaddition, 2) the Diels-
Alder reaction, and 3) the 1,3-dipolar cycloaddition (Figure 9). 
 
Figure 9 
The [2+2] cycloaddition and Diels-Alder reactions are used to form four- and six-membered rings 
respectively, while the 1,3-dipolar cycloaddition, also known as the Huisgen Cycloaddition, is used to 
form five-membered rings, for example isoxazoles.43 
The 1,3-dipolar cycloaddition is related to the Diels-Alder reaction in that it is a [4π+2π] process; 
however, the 4π-electron component is a 1,3-dipole rather than a diene, and the 2π-electron 
component is a multiply-bonded two-atom section. The relationship of these two components can 
either be intra or inter-molecular and the mechanism proceeds through a 6π-electron aromatic 
transition state.  
The isoxazoles that will be synthesised in this project will be produced using a 1,3-dipolar 
cycloaddition, with a nitrile oxide acting as the 1,3-dipole and a cyclohexane 1,3-dione as the 
dipolarophile. 
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The 1,3-Dipole 
A 1,3-dipole is a molecule that has charge separated over three atoms, an example being carbonyl 
oxide (Scheme 15). 
 
Scheme 15 
There are two main resonance forms for the 1,3-dipole, one in which the carbon atom contains eight 
electrons in the outer shell 65 and one in which it contains six 66. As the latter would be unstable the 
1,3-dipole is traditionally displayed in the octet form. 
There are two primary types of 1,3-dipolar compounds. The first, type-1, has a 1,3-dipolar canonical 
form in which there is a double bond between atoms A and B in the sextet form and a triple bond in 
the octet form; the central atom B is in an sp-hybridized state (Figure 10).  
 
Figure 10 
This type of dipole is known as the propargyl-allenyl type and is linear; some examples of this type of 
dipole are shown below (Figure 11).44  
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Figure 11 
The second type is known as the allyl anion type and has a 1,3-dipolar canonical form which has a 
single bond between A and B in the sextet form, and a double bond between them in the octet form; 
the central atom is sp2- hybridized (Figure 12).  
 
Figure 12 
The structure of these dipoles is bent, and again, some examples are shown below (Figure 13). 
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Figure 13 
As stated, in this project, the dipole used is a nitrile oxide, which is type-1; this dipole contains both an 
electrophilic and a nucleophilic portion (Figure 14). 
 
Figure 14 
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The Dipolarophile 
Dipolarophiles are compounds that will react with dipoles, in this case a 1,3-dipole. Traditional 
examples of dipolarophiles are alkenes such as those used in the Diels-Alder reaction. However, there 
are many other examples as illustrated  below (Figure 15).45,46  
 
Figure 15 
In the case of this project, the dipolarophile is an alkene as part of an enolate.9 
Mechanism of 1,3-Dipolar Cycloaddition 
Two different mechanisms have been proposed for 1,3-dipolar cycloaddition. R. Huisgen47 proposed 
the concerted mechanism in 1968 and in the same year R. A. Firestone48 proposed a di-radical 
mechanism (Scheme 16).  
 
Scheme 16 
Later evidence was provided to suggest that the reaction follows the concerted mechanism.49 
The success of the reaction depends on two factors:  the reaction must be sterically favourable and a 
full π-orbital of one reactant must be able to favourably interact with an empty π* orbital of the other 
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reactant i.e. they must be of the same phase. The better these interactions, the lower the energy gap 
between the two orbitals and therefore, the greater the reactivity.  
This can be explained using FMO (Frontier Molecular Orbital) theory.50 The FMOs involved in this 
mechanism are the HOMO (Highest Occupied Molecular Orbital) and LUMO (Lowest Unoccupied 
Molecular Orbital) of the 1,3-dipole interacting with the LUMO and HOMO of the dipolarophile. If 
these molecular orbitals overlap correctly, then new bonds will be formed, yielding a new ring (Figure 
16).51 
 
Figure 16 
Based on direction of charge transfer in the above interactions it is possible to separate 1,3-dipolar 
cycloadditions into three distinct types: 1) Dipole-HOMO controlled reactions in which the charge 
moves from dipole to dipolarophile, 2) Dipole-LUMO controlled reactions where the charge moves 
from dipolarophile to dipole, or 3) where both control the reaction (Scheme 17). 
 
Scheme 178 
Type-1 reactions have the smallest energy gap between the HOMO of the 1,3-dipole and the LUMO of 
the dipolarophile; examples being reactions of ylides52 and other nucleophilic dipoles. Electron 
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withdrawing substituents on the dipolarophile, which lower the energy of the LUMO, or electron 
donating substituents on the dipole, which raise the energy of the HOMO, accelerate this type of 
reaction. 
Type-2 reactions are the opposite of type -1, the smallest energy separation being between the HOMO 
of the dipolarophile and the LUMO of the dipole; examples are reactions of ozone53 and other 
electrophilic 1,3-dipoles. 
Type-3 reactions have neither HOMO nor LUMO dominating the FMO interactions; this type of 
reaction is known as ambiphilic; an example being azides.54  
It is possible to form different stero- and regio-isomers during the 1,3-dipolar cycloaddition (Figure 
17); however, the selectivity usually favours one over the other i.e. it is not a 1:1 mixture of isomers. 
 
Figure 17 
Regioselectivity is determined both by the class of 1,3-dipolar cycloaddition taking place and by which 
molecules possess the dominant HOMO and LUMO. Stereochemistry is determined by the geometrical 
approach of the dipole and dipolarophile, with both exo and endo-transition states being possible. 
However, the configuration of the dipolarophile is usually retained which is evidence for a concerted 
mechanism.50 
Whilst stereochemical or regiochemical issues could have been a concern in this  synthesis; they were 
not, as the dipolarophile is planned to be a symmetrical six-membered ring, forming a fused isoxazole 
and no other products were observed by Suzuki et al.30 
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1.3 Alkene Metathesis 
As one of the key steps in this project will be the investigation of ring closing metathesis using Grubbs 
II catalyst, this process warrants some discussion. 
Olefin metathesis is a well-documented process that has been used in the synthesis of a range of 
natural products.55 It is defined as: 
 “A bimolecular process formally involving the exchange of a bond (or bonds) between similar 
interacting chemical species so that the bonding affiliations in the products are identical (or closely 
similar) to those in the reactants.”42 
There are three types of olefin metathesis: 1) ring-closing metathesis (RCM), 2) cross metathesis and 
3) ring-opening metathesis polymerisation (ROMP) (Figure 18). 
 
Figure 18 
Ring closing metathesis is a reaction in which two acyclic alkenes undergo a reaction that closes a ring 
and is promoted by a catalyst. Cross metathesis is the reaction between two different alkenes to yield 
a “dimerised” product connected by an alkene. Ring opening metathesis polymerisation is the 
opposite of RCM in that it opens a ring; however, the two units are then polymerised with other units.  
Origins of Metathesis 
The roots of metathesis can be traced back to the Nobel Prize winning work by Ziegler and Natta in the 
middle of the 20th century.56,57 This involved the synthesis of α-olefins using titanium tetrachloride and 
triethylaluminium catalysts (Scheme 18). 
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Scheme 18 
Calderon et. al. who were working at the Goodyear Tyre and Rubber company were the first to coin 
the term olefin metathesis in 1968. They found that it was possible to carry out the metathesis of 2-
pentene using a tungsten catalyst in conjunction with ethylaluminium dichloride (Scheme 19).58  
 
Scheme 19 
As the field of metathesis was starting to grow there was some debate as to the mechanism for this 
reaction.  Two potential mechanistic pathways were proposed,  the pairwise  and non-pairwise 
(Chauvin) mechanisms (Scheme  20).59,60 
 
Scheme  20 
These proposed mechanisms were investigated by Grubbs et. al. who made predictions on the ratio of 
products that should be observed for each pathway (Scheme 21).61 
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Scheme 21 
The experimentally observed results suggested that the non-pairwise mechanism was most likely. 
At approximately the same time as Grubbs initial investigations, the Tebbe reagent 119 was 
discovered by Tebbe and his group. This organometallic catalyst was able to switch isotopically 
labelled carbon atoms in methylenecyclohexane and isobutene (Scheme 22).62  
 
Scheme 22 
This laid the foundation for research by Grubbs and his group. Starting in the 1980s Grubbs and Evans 
began investigating Tebbe’s reagent; over the subsequent decades they would carry out research 
using tungsten, molybdenum and titanium as metathesis catalysts.63,64  
This work led to development of one of the most widely used olefin metathesis catalysts: Grubbs 
Catalyst. Grubbs chose ruthenium for his investigations as when compared to the above metals, it is 
the most reactive towards olefins but also more tolerant of functional groups and moisture.65 
Using this knowledge, Grubbs began the development of a metathesis catalyst that was not only 
active, but stable under standard atmospheric conditions and protic solvents. One of the first attempts 
at this was the use of ruthenium trichloride (Scheme  23).66 
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Scheme 23 
This catalyst was able to conduct ROMP reactions on 7-oxanorbomene derivatives in both wet and dry 
conditions; however, this catalyst, whilst stable, was not as active as Grubbs desired. Its reactivity was 
increased by adding groups that exhibited greater electron donating potential, such as 
triphenylphosphine.67–69  
Eventually this led to the development of Grubbs 1st generation catalyst 124; this catalyst showed both 
good reactivity and stability under atmospheric conditions (Figure 19).70 
 
Figure 19 
 Grubbs continued his work in this field with the aim of designing a catalyst that retained the same 
stability but exhibited even greater activity. As mentioned in the paragraph above, groups with greater 
electron donating potential placed at the axial position increased catalyst activity. In 1998 Hermann et. 
al.  reported that replacing the tricyclohexyl phosphine (PCy3) group with an N-heterocylic carbene 
displayed an increase in reactivity over the first generation catalyst (Figure 20).71 
 
Figure 20 
Grubbs screened a range of ligands of this type and this subsequently led to the synthesis of Grubbs 
2nd generation catalyst 126 (Figure 21).65 
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Figure 21 
Although this section has focused on Grubbs, it is important to note that there have been many other 
groups who have worked on metathesis and its catalysts, examples being Hoveyda and Schrock.72,73 In 
2005 Grubbs, Chauvin and Schrock shared the Noble prize for chemistry, for their work on metathesis. 
Ring Closing Metathesis  
The mechanism of ring closing metathesis comprises two main stages: 1) Catalyst initiation and 2) 
Catalyst Propagation, where the active complex promotes addition catalytic cycles (Scheme 24).74,75 
 
Scheme 24 
The first step is the binding of the catalyst to one of the olefins present in the substrate 127 to form a 
metallacyclobutane complex 129. This can either revert to the substrate 127 and catalyst 128 or 
alternatively an alkene 130 can be ejected and complex 131 is formed. This then goes on to form 
intermediate 132 before breaking down to yield the ring closed product 133 and metal complex 134. 
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Catalyst propagation then continues where the active complex 134 will go on to bind the un-cyclised 
substrate 127 and carry out the reaction in much the same fashion as in initiation. This cycle continues 
until all of the available substrate has been consumed. 
Regardless of the metal used this mechanism remains the same; however, there are differences, for 
example in a ruthenium-based catalyst such as Grubbs the olefin acts as an π-Lewis acid; conversely in 
a molybdenum catalyst the metal acts as the Lewis acid and the olefin as the base.  
It is important to note that this mechanism will give rise to both E and Z isomers of the double bond 
depending on which is the most energetically favourable. In the case of small strained ring systems, 
the cis-isomer is often favoured, as the system may be too strained to form the trans-isomer. 
However, in larger ring systems it is not uncommon to see a mixture of isomers. 
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1.4 Previous Synthesis 
As has been discussed, the coleophomone group of natural products possess a range of properties 
that make them attractive to the synthetic chemist. As a result, in the fifteen years since they were 
isolated they have received some attention from the chemistry community.   
The two major contributions have come from K.C. Nicolaouet al. in the form of a total synthesis paper 
for coleophomones B, C and D3 and from Suzuki et al. in the form of an investigation into apparent 
structural anomalies.9 There have also been some preliminary investigations carried out by Goldring et 
al., who have been working towards precursors for coleophomone A.76  
Nicolaou’s Total Synthesis  
Nicolaou was the first chemist to complete the total synthesis of colephomones B, C and D. His 
approach differs from ours in that while we intend to form the aryl cyclohexanedione unit using a 1,3-
dipolar cycoladdition of a nitrile oxide to a dipole, he builds both fragments separately and then 
combines them via base-mediated nucleophilic attack (Scheme 25). 
 
Scheme 25 
The Nicolaou group was able to form these fragments from commercially available starting materials 
(Scheme 26). 
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Scheme 26 
These fragments were then combined in the step that creates the C-C bond that we plan to form in 
the 1,3-dipolar cycloaddition we intend to use, this is C-acylation of a 1,3-dicarbonyl compound 
(Scheme 27). 
 
Scheme 27 
With the successful formation of this core structure, Nicolaou was then able proceed and concentrate 
on the next challenge, forming the 11-membered macrocycle. At this point in the synthesis precursor 
138 is able to interconvert between several tautomers, which were isolated via protection with 
diazomethane. Following this the 11-membered macrocycle was formed using RCM and the resulting 
macrocycles were furnished with the remaining functionality present in the natural products (Scheme 
28). 
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Scheme 28 
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Using this methodology, Nicolaou et al. were able to successfully form coleophomones B and C. 
However, contrary to the findings by the Merck isolation team, they were unable to convert B to A 
under a range of conditions. Due to this a de novo approach towards forming this member of the 
coleophomone family was required (Scheme 29). 
 
Scheme 29 
Whilst it was possible to generate spirocyclic system 155, it was not possible to close the ring using a 
wide range of ring closing metathesis conditions. This was believed to be due to the inherent strain of 
the spirocycle, and unfortunately current metathesis reagents were not powerful enough to overcome 
this. The synthesis of coleophomone A was therefore unsuccessful. 
Nicolaou also attempted the synthesis of coleophomone D. As it lacks the macrocycle found in A, B 
and C the synthesis of D was more accessible when compared to the others. Once again the initial 
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approach is to furnish both cyclic fragments before combining them in base-mediated nucleophilic 
attack (Scheme 30). 
 
Scheme 30 
This approach differs from the previous in that the initial steps in the formation of fragment one were 
radical bromination followed by acetolysis under acidic conditions to yield the corresponding acylated 
aldehyde 158. Following this the desired nitrile group was introduced using diethyl aluminium cyanide, 
However, this yielded a mixture of de-acylated products 159 and 160. The desired product, 160, was 
carried through and oxidised to yield the desired acetyl cyanide 161.  
Once again, these two fragments were combined to yield the furnished core of coleophomone D. 
However, as there is no macrocycle to form, the remaining steps were relatively straightforward 
(Scheme 31). 
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Scheme 31 
In conclusion, Nicolaou et al. were able to complete the total synthesis of coleophomones  B, C and D; 
however, it was not possible for him to form coleophomone A, and to date, this remains a synthetic 
challenge.  
Suzuki’s Comparison  
Suzuki et al. noted that there was an unusual difference between the biosynthetically expected 
structure 163 and that which was reported in the literature 162 (Figure 22).9 
 
Figure 22 
In order to resolve this discrepancy, Suzuki et al. conducted the synthesis of both the expected and 
aberrant isomers of a derivative of the natural product. However, unlike the synthesis Nicolaou 
performed, this required the tri-carbonyl system to be masked in order to prevent any potential 
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tautomeric inter-conversion. They began with the biosynthetically expected isomers, masking the 
reactive tricarbonyl system as an isoxazole (Scheme 32). 
 
Scheme 32 
One notable point of this synthesis is that hexamethylphosphoramide (HMPA) was required to achieve 
the desired bis-prenyl 171 in good ratios. In the absence of HMPA regioisomer 172 was obtained 
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almost exclusively. With biosynthetically expected aminal 174 obtained, the next challenge was to 
repeat this process for the aberrant version, using aryl bromide 175 as a starting point (Scheme 33).77 
 
Scheme 33 
This sequence was much the same as the previous with only two notable exceptions. Firstly the 
cycloaddition was carried out under a different set of conditions; illustrating how sensitive this 
reaction is. Secondly, the ratio of bis-prenyl regioisomers is slightly lower in this case.  
 
35 
 
The 1H and 13C data for both of these compounds were compared to those which were reported by the 
Merck isolation group, confirming that this unusual structure is indeed correct.  
Suzuki et. al. postulated several mechanisms by which aberrant structure 178 could have been 
formed. The first is that specific oxidative enzymes that introduce hydroxyl functionality at that 
position. 
The second is structural inter-conversion via a pseudo-symmetrical enol which could form under 
acidic, basic or photochemical conditions (Scheme 34).78,79  
 
Scheme 34 
The third suggested mechanism for inter-conversion is via a trans-annular C-hydride shift (Scheme 
35).80 
 
Scheme 35 
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However, in this case, these processes are only speculative at this point and they do not explain why 
only one isomer is observed. 
Goldring’s Investigation 
Goldring et al.  have begun tentative investigations towards forming Colephomone A via a spiro-fused 
indanone route (Scheme 36).81 
 
Scheme 36 
This approach differs from Nicolaou and  Suzuki in that it builds the fused six-five membered ring 
system first before going on to add the spiro ring via a [4 + 2] cycloaddition reaction. To date Goldring 
et al.  have only been able to demonstrate the synthetic utility of this methodology, they have not 
synthesised the natural product (Scheme 37). 
 
Scheme 37 
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It can be seen how this methodology could be applied to the synthesis of coleophomone A in the 
future, as this compound still represents an unresolved synthetic challenge.  
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2.0 Progression towards the Coleophomone 
Natural Products 
The aim of the project was to develop a synthetic route to the coleophomone natural products and 
their analogues via an isoxazole route.  
One of the first challenges the natural products present is the formation of the core bi-cyclic tri-
carbonyl system. As discussed in chapter one, our synthetic approach intended to accomplish this by 
performing a 1,3-dipolar cycloaddition to generate a benzisoxazole. Once this had been accomplished 
the next challenge would be to form the distinctive macrocycle (Scheme 1) .30  
 
Scheme 1 
As discussed earlier, we would aim to alkylate our benzisoxazole twice, once O and once on C before 
employing RCM to form the macrocycle. However, we were unsure whether it would be possible to 
generate the 11-membered ring due to the rigidity of the fused isoxazole system and as such bis-
alkenyl benzisoxazole 7 was the first synthetic objective following isoxazole formation. 
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2.1 Functionalized Imidoyl Chlorides 
Mono-Ortho Imidoyl Chlorides 
The first step in the synthetic plan is the formation of an aryl imidoyl chloride from which we could 
generate the nitrile oxide dipole. Although we believed that we would be able to successfully O-
alkylate a phenolic aryl ring; we also pursued the precursors for metal mediated cross coupling, as this 
represented an alternative approach to analogues (Scheme 2)  
 
Scheme 2 
While bromo-substituted benzisoxazole 4 in C-C cross-coupling would not give the desired C-O linkage 
present in the natural product, it would still present a viable route to analogues of coleophomones, 
furthermore C-O coupling can be envisaged.  
With the initial targets identified; we proceeded to synthesise the chosen imidoyl chlorides from  their 
corresponding oximes (Scheme 3). The oximes were available commercially for salicaldehyde and 
prepared by standard methods for 2-bromobenzaldehyde (hydroxylamine hydrochloride and sodium 
acetate). C-Chlorination was achieved in good yield using N-chlorosuccinimide and pyridine in 
chloroform at 40°C. 
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Scheme 3 
This demonstrates the ability of this methodology to synthesise the known ortho-functionalized 
benzimidoyl chlorides in excellent yields.30 
Bis-Ortho Substituted Imiodyl Chlorides 
While initially the focus was to be building the macrocycle using mono-functionalized imiodyl 
chlorides; the coleophomones A, B and C will require bis-ortho substituted aryl imidoyl chlorides 
(Scheme 4). 
 
Scheme 4 
Bis-ortho substituted benzisoxazole 16 was chosen as the building block, as its functionality should 
prove versatile enough to allow the introduction of the desired aldehyde in a number of ways (Scheme 
5). 
 
Scheme 5 
Initially the following route was planned, deprotonation of an aminal followed by substitution from an 
electrophilic source of bromine (Scheme 6).77 
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Scheme 6 
As 2-benzyloxybenzaldehyde 24 was commercially available it was chosen as the starting point in this 
synthesis (Scheme 7). The aminal 25 was easily prepared in good yield. 
 
Scheme 7 
Although it had been reported as possible to deprotonate at the desired ortho-position with two or 
more molar equivalents of base, no bromination was observed.77 To determine if the benzyl protecting 
group was being deprotonated the reaction was repeated with a methoxy substituent ortho to the 
imidazolidine ring 28 (Scheme 8).  
 
Scheme 8 
Again no bromination was observed; it is believed that this reaction may have failed due to 
deprotonation occurring at the tertiary carbon on the imidazolidine ring or anion quench occurring via 
a benzyne intermediate.  
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With this failure a new approach was required. It was possible to find a commercially available 
compound with the required bromine substituent in place, namely 2-bromo-6-fluorobenzaldehyde; 
however, the required protected phenolic group would have to be introduced via nucleophilic 
aromatic substitution (Scheme 9). This reaction proceeded, but only in low yield (23%). 
 
Scheme 9 
Although oxime formation was attempted, the 1H NMR spectra indicated what was was believed to be 
complex mixture of starting material and product, which we were unable to assign completely. This 
avenue of investigation was not explored further, as it was not possible to increase the yield of the 
first SNAr step. 
As the previous attempts were not acceptable a new tactic was required; this came in the form of the 
Reimer-Tiemann reaction. Using this reaction it should be possible to achieve formylation via 
electrophilic substitution with dichlorocarbene.  Scheme 10 illustrates the prototype reaction.82 
 
Scheme 10 
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We applied this approach to commercial 3-bromophenol. A benefit of this approach is that protection 
of the hydroxyl group was not required (Scheme 11). The Reimer-Tiemann protocol afforded 2-bromo-
6-hydroxbenzaldehyde in moderate yield. 
 
Scheme 11 
Although other isomers are observed in the crude mixture, the desired phenol 44 was the major 
component. 
With the successful formation of phenol 44 in reasonable yields it was possible to progress with the 
synthetic strategy (Scheme 12). 
 
Scheme 12 
The synthesis of oxime 45 and imiodyl choride 46 proceeded well by our established procedures, with 
good yields being obtained at both stages. The success of this methodology put us in a position to 
synthesise precursors to coleophomones A, B and C as required. 
Ortho,meta-Imidoyl Chlorides 
As mentioned, coleophomone D has a different substitution pattern to A, B and C and as such, it 
requires a different imidoyl chloride precursor.  Fortunately the desired substitution pattern was 
available in the form of ortho-vanillin (Scheme 13). 
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Scheme 13 
It was hoped that the phenol functionality would provide a synthetic handle to install the desired 
aldehyde at a later date. As ortho-vanillin is commercially available in large quantities it made an 
appropriate starting point (Scheme 14). 
 
Scheme 14 
It was possible to synthesise the corresponding oxime and imidoyl chloride in excellent yields from o-
vanillin and as such, a precursor for coleophomone D was readily available. 
Additional examples 
Over the course of this project it has been necessary to synthesize several imidoyl chlorides to provide 
additional examples for a publication (Figure 1) as will be reported later in this thesis. This was 
completed from commercial aldehydes via the oxime, or from commercial oxime in one case. 
 
Figure 1 
Although they are not related exactly to the coleophomones, they could be used to provide analogues 
if required. 
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2.2 Benzisoxazole Formation  
The next stage in the synthetic route was the formation of the core masked triacarbonyl system 
present in the coleophomones. This was accomplished as discussed earlier in this thesis (Scheme 32, 
Chapter 1), using a dipolar cycloaddition onto the enolate of a cyclohexane-1,3-dione (Scheme 15).  
 
Scheme 15 
Two equivalents of sodium were dissolved in propan-2-ol to form isopropoxide, this was added slowly 
to a mixture of dione and imidoyl chloride in propan-2-ol. It was necessary to conduct this at a lower 
temperature otherwise significantly lower yields were observed, we postulate this could be due to 
degradation of the nitrile oxide fromed in situ. A reasonable mechanism for this reaction is outlined in 
(Scheme 16).30 
 
Scheme 16 
A series of functionalized benzisoxazoles were synthesised from the corresponding imidoyl chlorides 
using a range of commercially available cyclohexane-1,3-diones (Figure 2); unsubstituted, 5-methyl 
(corresponding to the coleophomone substitution pattern) and 5,5-dimethyl. 
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Figure 2 
Figure 2: Note that benzisoxazole 61 was formed using an optimised procedure, the other examples 
remain to be optimised. It should be noted that compounds 61 and 68 have been described in existing 
literature.30 
There are some notable examples in this series, non-methylated- and dimethyl-benzisoxazoles 61 and 
62  represent possible analogues of the coleophomones. Bromobenzisoxazole 69 is of interest as it 
represents the 1,2,3-substitution pattern found in coleophomones A,B and C. Other important 
examples are fluoro- and bromo-benzisoxazoles 66, 67, 68 and 69, as these open up the possibility of 
nucleophilic aromatic substitution (SNAr) and metal-mediated cross coupling studies, respectively. 
Finally methoxy-phenol 63 is significant as it represents the necessary precursor for coleophomone D. 
The exact constitution of phenolic benzisoxazole 61 was established via single crystal X-ray 
crystallography (Figure 3). 
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Figure 3.  X-Ray crystal structure of 3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61. 
This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
 
This ensured we had the desired product following this reaction, an issue which will become apparent 
later in this thesis. It is also worth noting the intramolecular hydrogen-bond from the phenol to the 
isoxazole N-atom, it could be hypothesised that this decreases the acidity of the phenol. 
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2.3 Aromatic O and C-Alkylation 
O-Alkylation 
Following the success of the benzisoxazole formation, the next objective was O-alkylation of the 
phenolic ring.  Benzisoxazole 61 was chosen as a test compound as the corresponding unsubstituted 
cyclohexane-1,3-dione (£34.00/100g Sigma-Alrdich as of 28/10/14) is considerably cheaper than the 
mono-methyl version (£83.60/5g Sigma-Aldrich as of 28/10/14) present in the natural products (Figure 
4). 
 
Figure 4 
As mentioned previously, several routes for alkylation had been identified. The most direct, base 
mediated alkylation was attempted first (Scheme 17). 
 
Scheme 17 
Initially it was believed that this had been successful and yield optimization investigations were carried 
out (Table 1). 
Electrophile Base Additive Yield 
1.1 mol equiv. allyl bromide 1.1 mol equiv. K2CO3 None 42% 
1.1 mol equiv. allyl bromide 1.1 mol equiv. K2CO3 0.2 mol equiv. KI 52% 
1.1 mol equiv. allyl bromide 1.1 mol equiv. Cs2CO3 0.2 mol equiv. KI 75% 
Table 1. n.b. All reactions were carried out in refluxing THF with 1 mMol of substate. 
It is believed that the yield increase between potassium and caesium carbonate can be attributed to 
the improved solubility of the latter in organic solvents.83,84  
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However, whilst optimisation was successful, we later discovered that allyl benzisoxazole 70 was not 
the product of this reaction. In fact a very interesting rearrangement had taken place, yielding O-allyl 
benzoxazole 72 (Scheme 18). 
 
Scheme 18 
This rearrangement is extremely interesting as it represented something unreported which could 
potentially be explored. In the interests of continuity this rearrangement will be discussed at length 
towards the end of this thesis. In summary, the rearragenment was observed under a range of basic 
conditions. 
As a method was still required for O-alkylation research into this area continued in a search for a non-
basic protocol. We felt Mitsunobu chemistry was more appropriate when compared to a Chan-Lam-
Evans style coupling, as we had been developing  it in parallel to the base mediated method (Scheme 
19).85,86  
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 Scheme 19 
Initially attempts were made using 3-buten-1-ol, as the original aim of the Mitsunobu method was to 
introduce chains longer than allyl, and using diisopropyl azodicarboxylate (Scheme 20). 
 
Scheme 20 
However, following purification via column chromatography, it was found that what was believed to 
be the isolated fraction for O-alkyl benzisoxazole 77 contained both the desired product and di-acyl 
hydrazine by product 78 (Figure 5). 
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Figure 5 
Further attempts were made to isolate the desired product from the mixture; however, it was not 
possible to achieve this via column chromatography on silica.  
Initally it was hoped that separation would be possible using a different azodicarboxylate (Table 2). 
Reagent Outcome 
Diisopropyl azodicarboxylate Reaction successful. Di-acylhydrazine present. 
Diethyl azodicarboxylate Reaction successful. Di-acylhydrazine present. 
Di-tert-butyl azodicarboxylate Reaction successful. Di-acylhydrazine present. 
Dibenzyl azodicarboxylate Reaction successful. Di-acylhydrazine present. 
Table 2. n.b. All reactions were carried out in THF with 2.5 mMol of substate. 
Unfortunately these attempts were also unsuccessful, and we suggest the co-elution might be due to 
hydrogen bonding between O-butenyl benzisoxazole 77 and the acyl-hydrazine by-product. 
 
Evidence suggested that it should be possible to cleave di-tert-butoxycarbonyl hydrazine 79 using 
trifluoroacetic acid, yielding CO2, hydrazine as a salt and 2-methylpropene.
87 Although this was 
successful, a further, unexpected reaction took place to afford a mixture of the desired O-butenyl 
ketone and its hydrazone (Scheme 21). 
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Scheme 21 
This was unexpected as hydrazine should be relatively unreactive as a salt.  While it should be possible 
to convert hydrazone 80 back to benzisoxazole ketone 77, this was undesirable as it would add an 
unnecessary step to the synthetic route. 
 
Finally dimorpholine azodicarboxamide (DMDC) 81 was used as a coupling agent, in the hope that  the 
hydrazine by-product would be separable, as its functionality is significantly different to the 
oxycarbonyl coupling agents that had been employed previously (Figure  6) .88 
 
Figure 6 
Whilst DMDC is commercially available, it is not cheap (£72.80/5g Sigma-Aldrich as of 19/07/14) and 
as we would be using it on a relatively large scale this presented a problem. Fortunately it proved to 
be readily synthesised on multi-gram scale via condensation reaction between DEAD and morpholine 
at room temperature (Scheme 22).89 
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Scheme 22 
With the successful synthesis of the coupling agent, it was possible to attempt the coupling itself 
(Scheme 23). 
 
Scheme 23 
This new method proved to be very successful for O-allylation and but-3-enylation, as the 
corresponding carbohydrazide crystallized out from THF at room temperature.  
Subsequently investigations of different conditions were carried out in an effort to obtain optimal 
yields, using O-allylation as test reaction. 
The first of these was testing an alternative tributylphosphine to triphenylphosphine,  as it may be 
more reactive and easier to separate the oxide by-product (Scheme 24). 
 
Scheme 24 
However, after 18 hours the reaction showed no signs of reaching completion and was discarded. 
To determine the effect of temperature, the coupling was repeated at a higher temperature (Scheme 
25). 
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Scheme 25 
Formation of allyl benzisoxazole 70 was not observed, this suggests at higher temperatures DMDC or a 
related intermediate degrades before the coupling can take place.  
The next attempt at optimization involved using 1.5 molar equivalents of alcohol/DMDC/triphenyl 
phosphine, compared to the 2.5 molar equivalents that had been used in previous attempts (Scheme 
26). 
 
Scheme 26 
Once again, the reaction showed no sign of going to completion after 18 hours and was discarded. 
Finally the reaction was reattempted using the same conditions, but with an hour at 0°C pre-workup; 
the aim of this was to freeze out any excess carbohydrazide or DMDC (Scheme 27). 
 
Scheme 27 
An increase in yield was observed, although it is unknown if this increase in yield was due to increased 
familiarity with the reaction or to product being retained upon the stationary phase. 
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With optimal conditions for coupling established, a range of O-alkenyl benzisoxazoles were prepared 
(Table 3). 
Compound  Alkenyl Chain Length Yield (%) 
70 Allyl 99 
77 But-3-enyl 83 
82 Pent-4-enyl 74 
83 Hex-5-enyl 94 
Table 3. n.b. These yields refer to reactions done on varying scales, however, the molar ratio of 
reactants remained the same, as did the solvent. 
We were also able to successfully apply this methodology to O-allylation of the mono-methyl 
substituted isoxazole 4 as this yielded O-allyl precursor 84 which is closer to the natural products 
(Scheme 28). 
 
Scheme 28 
In order to confirm no rearrangement had taken place, the exact constitution of O-butenyl 
benzisoxazole 77 was confirmed via single crystal X-ray crystallography (Figure 7). 
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Figure 7. X-Ray crystal structure of 3-(2-(But-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-
one 77. This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
These results indicate that the methodology developed for O-alkylation is a success and it should be 
possible to introduce any chain length desired, within reason. 
Alternative Method for O-Alkylation 
While a highly successful method for O-alkylation was developed; it is worth noting another method 
was attempted. This method involved the use of an alkenyl trichloroacetimidate, as it was believed an 
acid based method would avoid rearrangement taking place (Scheme 29).90 Thus O-allyl 
trichloroacetimidate 86 was prepared from trichloroacetonitrile and allyl alcohol using a known 
procedure.90 
 
Scheme 29 
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The 1H NMR spectrum for the formation of allyl benzisoxazole 70 using this approach suggested that 
some allylation had taken place; however, it was not possible to be certain. Although interesting, with 
the success of other methods, this investigation was discontinued. 
Aryl Ring C-Alkylation 
As mentioned previously, one of the original methods proposed for benzisoxazole alkyation was via 
metal-mediated cross coupling to a 2-bromophenyl derivative.91 Whilst this would not result in the 
desired O-C linkage, it would still allow for analogues of the coleophomones to be synthesised. Some 
success was achieved before the development of an O-alkylation method was completed. 
The initial investigation took place using phenylboronic acid, as this is cheaper than the alkyl 
alternatives and it is still easy to recognise coupling product by 1H NMR spectroscopy (Scheme 30). 
This was successful using tetrakis(triphenylphosphine)palladium as catalyst. 
 
Scheme 30 
With this success, further coupling attempts were made using alkyl substituents (Table 4) with the 
same catalyst. 
Boronic Acid Catalyst Base Outcome 
Allylboronic acid 
pinacol ester 
Pd[PPh3]4 Na2CO3 No 
reaction 
Allylboronic acid 
pinacol ester 
Pd[PPh3]4 CsF No 
reaction 
Vinylboronic acid 
pinacol ester 
Pd[PPh3]4 Na2CO3 No 
reaction 
Vinylboronic acid 
pinacol ester 
Pd[PPh3]4 CsF No 
reaction 
Table 4. n.b. All reactions were carried out with 1 mMol of substrate, 0.1 mMol of catalyst, 3 mMol of 
boronic acid and 2 mMol at reflux in DME. 
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It is unknown why couplings with allyl or vinylboronic acid failed while the phenyl version was 
successful.  Once again, with the success of O-alkylation, our research focus was shifted away from this 
area. 
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2.4 Cyclohexanone Alkylation 
Having put one alkyl chain in place, the next objective was to introduce a second alkyl chain, this time 
on the cyclohexanone ring, either alpha to the carbonyl or to the isoxazole for the natural products; or 
directly attached at the carbonyl carbon for analogues (Figure 8). 
 
Figure 8 
α-Carbonyl Alkylation 
Traditional alkylation methods for this position involve forming the corresponding enolate using a non-
nucleophilic base such as lithium bis(trimethylsilyl)amide (LiHMDS) or lithium diisopropylamide (LDA) 
and quenching the anion with an electrophile, in this case allyl bromide. When this reaction was 
attempted using lithium bis(trimethylsilyl)amide (LiHMDS) and allyl bromide at low temperature it did 
not provide any C-allyl isoxazole 88 (Scheme31). 92 
 
Scheme 31 
As this reaction was unsuccessful, we initated studies to determine why. One possibility is that the 
cyclohexanone ring was less acidic than expected. To determine if this was the case, the 
deprotonation was carried out as before, however, this time the anion was quenched with a source of 
deuterons (Scheme 32). 
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Scheme 32 
The recovered ketone proved to be tetra-duterated, at both positions alpha to the carbonyl and at 
both positions alpha to the isoxazole. This result suggested that the cyclohexanone ring is acidic 
enough to readily undergo deprotonation. As only one mole equivalent of LiHMDS was used, further 
deuteration was either due to keto-enol tautomerism on quenching or as a result of methoxide 
formation, which is significantly less basic than LiHMDS (pKa of 15.54 and 30.00≈ respectively).93,94 
The previous reaction also indicated that there are two sites of deprotonation on the ring. As each site 
is different, the initial, kinetic deprotonation in Scheme 39 may have formed an anion that was non-
nucleophilic. However, if the anion of benzisoxazole 70 was allowed to warm to room temperature, 
equilibrium between the two reigoisomers may occur, and the thermodynamic anion might be more 
nucleophilic.  
To test this hypothesis, deprotonation was attempted again, but this time the reaction mixture was 
warmed to 0°C. This was maintained for an hour and then electrophile was added, the mixture was 
allowed to slowly warm to room temperature (Scheme 33), when evidence for C-allyl product was 
observed in the 1H NMR spectra. 
 
Scheme 33 
Initially we believed that we had been successful in achieving mono-alkylation and as such applied this 
methodology to the longer chain analogues (Table 5). 
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Compound 
Number 
O-Alkenyl Chain 
Length 
Yield 
(%) 
88 Allyl 56 
90 Butenyl 28 
91 Pentenyl 42 
92 Hexenyl 24 
Table 5. n.b. All yields are based on what was assumed to be mono-alkylation alpha to the carbonyl.  
However on scale up the mass spectra suggested the presence of di- and tri-alkylated products, it was 
not possible at this juncture to determine the ratio of alkylated products. This suggests that at -78°C 
the kinetic anion is unreactive, but that at 0°C both the kinetic and the thermodynamic anion were 
reactive  (Scheme 34). 
 
Scheme 34 
We postulated that the “benzylic” isoxazole alpha-anion may be the theromdyamic product as the 
negative charge is delocalised over a greater number of atoms when compared to the ketone enolate. 
Our suspicions of over-alkylation were confirmed when we repeated the experiment with excess base 
and halide (Scheme 35). 
 
Scheme 35 
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A controlled temperature study would have been ideal in this situation to try and pinpoint the 
boundary between reactivity and over-alkylation; unfortunately we lacked the appropriate cooling 
bath equipment to perform this, and an alternative was required.  
Initially we attempted inverse addition (adding the anion to the electrophile) in the hope that this 
would help control alkylation, but unfortunately it did not. 
We then attempted form the di-anion in the hope that a second, presumably more reactive anion 
would react selectively (Scheme 36). 
 
Scheme 36 
Over-alkylation was once again observed, and this time an [M+H] peak for what may be a tetra-
allylated benzisoxazole was identified in the mass spectrum. 
Our next attempt aimed at alkylating under conditions where only the desired mono-alkyl isomer 
could form; the first step in this was the synthesis of triisopropylsilyl (TIPS) enol ether 95, which 
proceeded in good yield (Scheme 37). 
 
Scheme 37 
This reaction is interesting because it suggests that at -78°C some amount of the desired enolate must 
be formed otherwise no reaction would occur. As to why alkylation does not occur at this 
temperature, either the temperature is too low for the enolate to be reactive or only trace amounts of 
it are being formed. Silyl enol ether formation can be explained under these conditions as firstly a 
silicon oxygen bond is highly favoured, with bond energies of 452 kJ/mol, and secondly if the ketone 
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and enolate are equilibrating, then trapping the enolate drives the equilibrium towards the desired 
anion. 95,96 
With the successful formation of enol ether 95 in good yields, the next stage was to reform the 
carbonyl group in the presence of an electrophile (Scheme 38) by the use of fluoride anion.97 
 
Scheme 38 
One driving force of this reaction is the formation of an Si-F bond which has a bond energy of 565 
kJ/mol.95 This also reforms the enolate of the carbonyl group, which drives nucleophilic attack from 
the enolate double bond towards the electrophile (Scheme 39). 
 
Scheme 39 
The results from this reaction were inconclusive. Trace amounts of bis-allyl benzisoxazole 88 were 
identified via LC-MS, however, isolation was not possible. The remaining mass balance consisted of 
allyl benzisoxazole 70. This suggested that de-protection had taken place; however, the anion had 
been quenched by an unknown source or was simply unreactive towards the electrophile. The latter 
theory is supported by our previous observations. 
Our next attempts focused on acylating the carbon alpha to the ketone in the hope that this would 
promote deprotonation at this site by increasing its acidity (Scheme 40). 
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Scheme 40 
We estimated that this would lower the pKa of the position by approximately 12 log units, as 
cylohexanone and ethyl acetoacetate have a pKa’s of 26.45 and 14.20 respectively (DMSO); and these 
serve as reasonable model systems (Scheme 41).98,99 
 
Scheme 41 
It was hoped that this reaction would yield the mono-acylated product; however, di-acylated O-allyl 
benzisoxazole 98 was isolated in poor yields (based on starting ketone) with no evidence of the mono-
acyl product. 
We believe this to be because once a single acylation has occurred, the acidity of the alpha-carbon is 
increased so much that after proton exchange occurs and it is acylated a second time in preference to 
starting ketone 70.  Attempts were made to either limit acylation or increase the yield of di-acylation 
(Table 6). 
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Reagents Addition Method Temperature Outcome 
EtCO2Cl 1 mol. equiv., 
LiHMDS 1.1 mol. 
equiv.,  
Standard -78->0°C 19% Diacylated product 
EtCO2Cl 1 mol. equiv., 
LiHMDS 1.1 mol. 
equiv.,  
Standard -78°C 25% Diacylated product 
EtCO2Cl 1 mol. equiv., 
LiHMDS 1.1 mol. 
equiv.,  
Inverse -78°C 20% Diacylated product 
EtCO2Cl 2 mol. equiv., 
LiHMDS 2 mol. equiv.,  
Drop wise addition 
of base to mixture of 
benzisoxazole and 
electrophile 
0°C Inseparable mixture of 
acylated isomers 
Table 6. n.b. All reactions were carried out in refluxing THF with 1 mMol of substate in THF. 
After several attempts we were unable to generate the desired mono-acylation and moved on to 
alternative methods. 
The next tactic focused on converting the ketone to a non-acidic functionality with the intention of 
limiting the available sites of deprotonation to the “benzylic” position (Scheme  42). 
 
Scheme 42 
This first attempts using this approach involved silyl enol ether 95 as the ether greatly reduces the 
acidity alpha to the ketone (Scheme 43). 
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Scheme 43 
This yielded de-protected O-allyl benzisoxazole 70 and a small quantity of enol ether 95. This result did 
not come as a great surprise, as it is possible to cleave silyl enol ethers using sources of small cationic 
metals, for instance methyl lithium.92 
Whilst attempting to synthesise coleophomone D we synthesised and isolated bis-triflated enol ether 
101 (Figure 9). 
 
Figure 9 
The synthesis of this compound will be discussed in greater detail in the section that relates to 
coleophomone D. However, as the ketone in this compound is masked we attempted de-protonation 
and alkylation. The 1H NMR spectra suggested that the isolated product might be phenol 102, 
however, it was not possible to confirm this (Scheme 44). 
 
Scheme 44 
Elimination of the sulfinate accompanied by loss of H+ as the ketone reforms is a pathway that may 
possibly explain this result.(Scheme 45). 
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Scheme 45 
As these functionalities appeared to be incompatible with this approach we attempted to form the 
enamine of cyclohexanone 106 (Scheme 46). 
 
Scheme 46 
Unfortunately this was unsuccessful; we believe this failed due to steric interactions with the 
neighbouring aromatic ring. This was unexpected as we were able to successfully form TIPS enol ether 
95 in good yields. We believe enol ether formation was successful for two reason: firstly the longer 
and less constrained O-Si linkage gives the TIPS group more steric freedom compared to the 
pyrrolidine ring; and secondly, the bond that is formed between silicon and oxygen is more 
thermodynamically favoured than that of carbon and nitrogen (452 vs 305 kJ/mol).95 
Following a related approach we then endeavoured to convert ketone 70 into acetal 107  (Scheme 47). 
 
Scheme 47 
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Whilst this was successful, it was noted that the 1H NMR spectra indicated there was approximately 
10% of the ketone remaining, and this was not separable via column chromatography. However, it was 
possible to test whether alkylation at the desired location was possible (Scheme 48). 
 
Scheme 48 
Mass spectra displayed an [M+H] ion corresponding to the desired mono-alkyl product. But 
unfortunately, the mixture of alkylation products and starting materials was again, inseparable via 
column chromatography. It was essential that acetal formation be driven to completion in order for 
this route to be viable so a number of protocol variations were studied. 
However, testing this formation with a range of conditions (Table 7) indicated that it was very difficult 
to drive acetal formation to completion. This could possibly be attributed to the same steric concerns 
that we encountered with enamine formation. 
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Table 7.  n.b. All expriments were heated to reflux. 
Reagents  Drying 
method 
Time Outcome 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
4 mol. equiv., 10 mol. % p-TSA, Toluene. 
Dean-Stark 
conditions 
1 Day Mixture of ketone and 
desired acetal, 
predominantly acetal. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
4 mol. equiv., 10 mol. % p-TSA, Toluene. 
Dean-Stark 
conditions 
2 Days Mixture of ketone and 
desired acetal, 
predominantly acetal. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % p-TSA, Toluene. 
Dean-Stark 
conditions 
1 Day Mixture of ketone and 
desired acetal, 
predominantly acetal. 
Benzisoxazole 1 mol. equiv., 2,2-
dimethylpropane-1,3-diol 10 mol. equiv., 10 
mol. % p-TSA, Toluene. 
Dean-Stark 
conditions 
1 Day No reaction. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % p-TSA, Toluene. 
10 mass % 
molecular 
sieves 
1 Day Mixture of ketone and 
desired acetal, 
predominantly acetal. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % p-TSA, Toluene. 
10 mass % 
powdered 
molecular 
sieves 
1 Day No reaction. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % BF3 Etherate, 
Toluene. 
10 mass % 
molecular 
sieves 
1 Day Mixture of ketone and 
desired acetal, 
predominantly ketone. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % p-TSA, Toluene. 
1 mass 
equiv. 
Ca2SO4 
1 Day No reaction. 
Benzisoxazole 1 mol. equiv., methanol 10 
mol. equiv., 10 mol. % p-TSA, Toluene. 
1 mass 
equiv. 
Ca2SO4 
 1 Day No reaction. 
Benzisoxazole 1 mol. equiv., Ethylene glycol 
10 mol. equiv., 10 mol. % p-TSA, Benzene. 
Dean-Stark 
conditions 
1 Day Mixture of ketone and 
desired acetal, 
predominantly acetal. 
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Another approach to masking the ketone as a non-acidic functionality was required; and as such the 
next logical step was to attempt the reduction of the ketone to the corresponding alcohol (Scheme 
49). 
 
Scheme 49 
This reduction was attempted with both sodium borohydride and lithium aluminium hydride in 
parallel, with the former giving almost quantitative conversion.  
With this success, the next step was to test to see if it would be possible to form a di-anion (alkoxide 
and carbanion) and alkylate directly, without the need for a protective group (Scheme 50). 
 
Scheme 50 
Following this reaction two products were isolated, the minor (approx. 10% based on starting material 
mass) showed signs of alkylation, though it was not definitive. The second larger fraction (approx. 50% 
based on starting material mass) displayed what appeared to be dimeric features i.e. what appeared 
to be a doubling of the intergrals in both the 1H and 13C NMR spectra; however, it was not possible to 
identify this compound. 
Given this result, the next step was to attempt to protect the alcohol and then re-attempt C-alkylation. 
We envisaged protection might be problematic due to steric and reactivity issues, so a range of 
protective groups were screened (Table 8). 
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Electrophile Base/Acid Temperature 
(°C) 
Outcome 
TES-Cl 1.1 
mol. equiv. 
Imidazole 2 mol. 
equiv. 
0 No Reaction 
TES-Cl 1.1 
mol. equiv. 
NaH 1.1 mol. equiv. 
Imidazole 1 mol. 
equiv. 
0 No Reaction 
TIPS-OTf 
1.1 mol. 
equiv. 
NaH 1.1 mol. equiv. 0 Trace amounts of protected product 
TMS-Cl 1.1 
mol. Equiv. 
NaH 1.1 mol. equiv. 
Imidazole 1 mol. 
equiv. 
0 Some conversion via TLC, however 
we were unable to isolate product, 
believed to have hydrolysed on base 
wash 
TMSCH2N2 BF4H 0 Trace amounts of protected product 
MEM-Cl 1.1 
mol. equiv. 
NaH 1.1 mol. equiv. 0 No Reaction 
MeI 1.1 
mol. equiv. 
Cs2CO3 66 No Reaction 
MeI 1.1 
mol. equiv. 
NaH 66 Significant amounts of protected 
product 
Table 8. n.b. All reactions were carried out using 1 mMol of substate in either DCM or THF. 
From these results, it can be seen that the alcohol is relatively unreactive towards electrophiles. 
However, we believe that de-protonation is occurring with sodium hydride, as a colour change is 
observed upon addition. This supports our initial hypothesis that the anion produced is unreactive due 
to poor nucleophilicity or steric effects. 
Our next approach would involve trying to chelate a lithium cation alpha to the ketone, which should 
stabilize the anion at this location and therefore reduce or prevent equilibrium (Scheme 51).100 
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Scheme 51 
If it was possible to successfully form hydrazone 109 then having the anion and an additional 
heroteroatom in close proximity should help to chelate the lithium and therefore stabilise the lithio-
enamine at this location. Attempts were therefore made to convert O-allyl isoxazole 70 into the 
corresponding hydrazone 110 (Scheme 52). 
 
Scheme 52 
Initially there were some problems obtaining full conversion, as N,N-dimethylhydrazine is volatile and 
it was presumed that it was being lost from the reaction mixture via evaporation, however, this was 
remedied by improving the cooling efficiency of the reflux condenser.  This methodology was then 
applied to the longer chain O-alkenyl benzisoxazoles  (Table 9). 
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Compound 
Number 
O-Alkenyl Chain 
Length (R) 
Yield 
(%) 
110 Allyl 68 
111 Butenyl 74 
112 Pentenyl 60 
113 Hexenyl 69 
Table 9. n.b. Yields refer to reactions done on varying scales, however, the molar ratio of reactants, 
solvent and temperature remained the same throughout. 
We were able to successfully form all of the desired O-alkenyl hydrazones so we progressed to the 
next stage of this approach, using strong base deprotonation and allyl bromide as electrophile 
(Scheme 53). 
 
Scheme 53 
This reaction was regiochemically extremely successfully, as there was no sign of alkylation alpha to 
the isoxazole or alkylation occurring more than once, however, the yield was moderate. Unfortunately 
due to time constraints it was not possible to optimise this reaction so it was applied directly to the 
extended chain O-alkenyl derivatives to achieve mono-C-alkylation in each case (Table 10). 
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Compound 
Number 
O-Alkenyl 
Chain Length 
(R) 
Yield (%) 
114 Allyl 34 
115 Butenyl 45 
116 Pentenyl 49 
117 Hexenyl 63 
Table 10. n.b. Yields refer to reactions done on varying scales, however, the molar ratio of reactants, 
solvent and temperature remained the same throughout. 
In each case the remaining mass balance was starting hydrazone and unidentifiable highly polar 
material. The increase for yield in the longer chains can be attributed to increased familiarity with the 
reaction, as the initial C-allyl benzisoxazole was only prepared once. 
It should also be noted that on scale up, unless the reaction was kept below -65°C then signs of 
multiple alkylation presented. This suggests that using this methodology we are on the boundary of 
being able to control alkylation. 
Whilst a hydrazone is an isostere of a carbonyl group, and therefore could be considered a cyclic 
tricarbonyl analogue, we would prefer to be able to unmask it at a later date. The two most well 
documented approaches to hydrazone to ketone conversion are via ozonolysis or quaternization with 
an alkyl halide followed by hydrolysis (Scheme 54).100 
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Scheme 54 
Unfortunately while ozone is the most straightforward method it is also incompatible with alkenes as 
it will convert them to the corresponding tri-oxolane (Scheme 55). 
 
Scheme 55 
Therefore the quaternization approach, while not as efficient, was the method attempted for 
hydrazone removal using the O-butenyl derivative (Scheme 56). Only a very low yield of the ketone 
was recovered. 
 
 
Scheme 56 
It should be noted that due to time constraints this experiment was only conducted once and on a 
very small scale (ca. 20mg). That would suggest this result is not an accurate representation of the 
potential yield.  
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Even so we were able to produce a sample of bis-alkyl ketone 90’ which we were able to analyse 
further. When we compared the 1H NMR spectra of this bis-alkylated ketone 90’ with the polyalkyl 
mixtures produced earlier we noted significant differences. One example is that the CH multiplet of 
bis-alkenyl ketone 90’ comes at 3.23-3.34 ppm, however, the one observed in earlier mixtures appears 
as part of a larger multiplet at approximately 2.40-2.50 ppm (Figure 10). 
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Figure 10. (top) bis-alkyl benzisoxazole 90’ derived from hydrazone 115 and (bottom) bis-alkyl 
benzisoxazole 90 derived from ketone 70 (with small amounts of poly-alkyl material present). 
These differences suggest that our initial hypothesis about the isoxazole “benzylic” anion being 
thermodynamically more stable was correct and that any C-allylation that took place was most likely 
occuring alpha to the isoxazole first (Scheme 57). 
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Scheme 57 
However, alkylation attempts on the hydrazone series of compounds presumably took place alpha to 
the hydrazone for reasons of chelation as mentioned previously in this chapter. 
We attempted to unequivocally prove this by growing a single crystal of bis-allyl hydrazone 114 for X-
ray crystallography; however, we were met with a surprise, with the isolated crystal revealing an 
unexpected benzpyrazole 129 (Figure 11). 
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Figure 11. X-Ray crystal structure of 5-Allyl-3-(2-(allyloxy)phenyl)-1-(dimethylamino)-6,7-dihydro-1H-
indazol-4(5H)-one 129. This crystal structure was solved by Dr Mark Elsegood of Loughborough 
University. 
Initially we were worried that we had mis-assigned our previous spectra and this was our major 
product rather than a ketone hydrazone. However, upon comparison of the 1H NMR spectra of the 
single crystal and that of the bulk material, we found they were significantly different (Figure 12). 
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Figure 12. (top) bis-alkyl hydrazone  114 and  (bottom) bis-alkyl pyrazole 129. 
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Also the crystal of pyrazole 129 exhibits an intense infra-red stretch at 1666 cm-1, however, the bulk of 
the bis-allyl hydrazone material does not. These two pieces of information lead us to believe the 
sample submitted for X-ray examination is a result of selective crystallization of a by-product that 
forms at the hydrazone generation stage via the following mechanism (Scheme 58). 
 
Scheme 58 
It can be seen that nucleophilic attack at the isoxazole C-O carbon results in the ring opening of the 
isoxazole with an oxime acting as the leaving group. Following this the nitrogen lone pair of the 
hydrazine attacks the neighbouring oxime nitrogen and eliminates water. Aromatization occurs with 
the loss of a proton, forming the observed pyrazole. 
We believe that the bulk of our bis-allyl material is hydrazone and not pyrazole based on this 
information. Unfortunately due to this and time constraints we were not able to grow a crystal of this 
material and as such, cannot unequivocally determine the regiochemistry of hydrazone allylation. 
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Carbonyl Addition 
Whilst direct alkylation of the carbonyl carbon does not result in the natural product, it could still lead 
to analogues that may exhibit pharmacological activity (Scheme 59). 
 
Scheme 59 
Initial alkylation attempts were made using allylmagnesium bromide (Scheme 60). 
 
Scheme 60 
These attempts produced a 1:1 mixture of what appeared to be the desired bis-allyl benzisoxazole 130 
and an unknown by-product; the ratio of products was calculated from the integration of the 1H NMR 
spectra. In an effort to restrict addition to one site, the molar equivalents of Grignard reagent were 
reduced (Scheme 61). 
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Scheme 61 
Whilst reducing the molar equivalents of Grignard reagent stopped by-product formation, the yield 
was low and optimization would be required if this route is going to be viable. 
Grignard addition was also attempted on butenyl benzisoxazole 77 to determine if by-product 
formation was a unique feature of allyl benzisoxazole 70 (Scheme 62). 
 
Scheme 62 
Unexpectedly, by-product formation was not observed in this reaction; currently this cannot be 
explained. However, as a good yield was obtained, this presents a possible route to analogues of the 
coleophomones.  
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2.5 Isoxazole Ring Cleavage 
Before investigations into RCM began, it was important to determine if it was possible to cleave the 
isoxazole ring in the presence of an alkene. 
As mentioned previously, there are various methods for isoxazole cleavage, with the cleanest usually 
being hydrogenation. Unfortunately this was not a possibility using traditional catalysts, as it would 
reduce both the isoxazole and any alkenes present. 
However, it was proposed that the selective cleavage of an isoxazole in the presence of an alkene via 
hydrogenation might be possible with Lindlar’s catalyst. The reason for this is that while Lindar’s 
catalyst will reduce an alkyne to the corresponding cis-alkene; it will not reduce an alkene to an alkane 
(Scheme 63).101 
 
Scheme 63 
Allyl benzisoxazole 70 was chosen as a test compound to determine if selective reduction was possible 
(Scheme 64). After 24 hours there was no evidence to suggest that hydrogenation had taken place and 
we concluded this was a not a productive approach. 
 
Scheme 64 
With the unsuccessful attempt at hydrogenation, the next step was to test ring cleavage using 
molybdenum hexacarbonyl, which has been used previously in the Jones group and which selectively 
cleaves N-O bonds (Scheme 65).102 
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Scheme 65 
This method proved to be very successful, cleaving both butenyl 77 and allyl benzisoxazoles 70 in 
excellent yields. 
 As cleavage was successful, it was important to determine in which tautomeric form these 
compounds exist, as there is the possibility of both enamino ketone 137 and imino enol 138 being 
present (Scheme 66). 
 
Scheme 66 
15N HMBC NMR spectroscopy was used to determine which form was predominant. The spectra 
indicated that the central nitrogen is bonded to two protons, both of which are in separate 
environments. This suggests that enamino ketone 137 is the exclusive form.  It is believed that 
enamino-ketone 137 is the predominant form due to stabilization from hydrogen bonding between 
the enamine and ketone (Scheme 67) 
 
Scheme 67 
This hydrogen bond forms a six membered ring, which would significantly lower the energy of this 
conformation; this hypothesis was further reinforced by single crystal X-ray structural determination 
(Figure 13). 
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Figure 13.  X-Ray crystal structure of 2-((2-(Allyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione 
135. This crystal structure was solved by Dr Mark Elsegood of Loughborough University.  
 It is also important to note that only one hydrogen bond is observed, there is no evidence to suggest a 
second is formed between the ethereal oxygen and the second enamine proton. This is probably due 
to the energy required to bring the aromatic ring into the plane and that ethereal oxygen is a poor 
hydrogen bond acceptor.103 
Following this success, ring cleavage was attempted on a sample of bis-allyl benzisoxazole believed to 
comprise mono-allyl and various over alkylation products (Scheme 68). 
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Scheme 68 
The yields above were based on isolated material as each derivative has a distinct retention time on 
silica. Not only did this confirm that it was possible to cleave bis-alkyl benzisoxazole 125, it also 
confirmed our earlier hypothesis that over-alkylation was occurring in a ratio of approximately 3:2 
mono to bis-alkylation.  The successful formation of bis-allyl enaminoketone 139 opened a route 
towards an 11-membered macrocyclic system. 
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2.6 Ring Closing Metathesis 
With the successful formation of bis-allkyl benzisoxazoles we began to test RCM conditions. Although 
these tests were to be carried out on mixtures of multiple alkylation products, it still allowed us to 
probe what was possible while we developed methods to control alkylation.  
Initial RCM tests were conducted on the mixture contained mostly bis-allyl benzisoxazole 125 as this 
would generate the 11-membered macrocycle present in the natural products. Although performing 
RCM on this analogue will produce a mixture of chiral E/Z diastereoisomers, this was not regarded as a 
problem at the time as we only wanted to determine if RCM was possible (Scheme 69). 
 
Scheme 69 
With this in mind an investigation of RCM conditions was carried out (Scheme 70). 
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Scheme 70 
Unfortunately no signs of ring closed benzisoxazole 147 were observed after 24 hour. Ring closure was 
reattempted at a higher temperature to determine if the reaction required more energy to form the 
macrocycle (Scheme 71). 
 
Scheme 71 
Once again, no evidence was observed to suggest that ring closing had taken place and the reaction 
was stopped. In both cases, approximately 60% of starting material was recovered, as well as a large 
amount of unknown baseline material. These are believed to be related to the catalyst and products of 
cross metathesis. 
As it seemed that we would not be able to form the 11-membered ring, we moved and tried to form 
12-membered macrocycle 148 (Scheme 72). 
 
Scheme 72 
Although it was not possible to fully assign the spectra of macrocycle 148, we believed we had enough 
evidence to attempt to optimize the catalyst loading (Table 11). 
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Catalyst Loading 
(Mol. %) 
Approximate yield 
(%) 
20 30 
10 60 
5 50 
2.5 40 
Table 11.  n.b. All attempts at optimisation were carried out on the same batch of starting material to 
ensure that even though it was a mixture, the optimisation results were as accurate as possible. 
It can be seen that too much catalyst harms the reaction, possibly due to cross metathesis processes 
dominating. Ten percent catalyst loading appears to be optimum for ring closing, and as such, this was 
applied to the longer chain benzisoxazoles (Table 12). 
Ring 
size 
Yield (%) Compound 
Number 
11 No RCM 
observed 
147 
12 60 148 
13 47 149 
14 Trace n/a 
Table 12. n.b. All attempts were carried out on a mixture. 
Twelve and thirteen members appears to be the optimal macrocycle size, at eleven, the ring is too 
strained to close and at fourteen we believe cross metathesis processes start to dominate, yielding a 
mixture of oligomers. 
Whilst RCM was successful, it was not possible to determine the stereochemistry of the macrocycle 
formed: we could not determine if it was E or Z, or what the ratio of the two isomers were, nor could 
was it possible to fully assign the 1H or 13C NMR spectra obtained. 
As mentioned, at the point we were testing the mixtures, we were trying to control alkylation. Once 
this had been achieved we subjected the newly formed bis-alkyl hydrazones to RCM conditions. 
Initially we tested RCM on bis-allyl hydrazone 114 (Scheme 73). 
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Scheme 73 
We were not surprised to find that this attempt at RCM was unsuccessful, as the ketone analogue had 
also failed. We proceeded to move on to the longer chain analogues using the same conditions as 
previous RCM attempts. Due to time constraints it was not possible to try with O-hexenyl hydrazone 
117 which would yield the fourteen-membered macrocycle (Table 13). 
Ring size Outcome 
11 No RCM observed 
12 No RCM observed 
13 No RCM observed 
Table 13. n.b. All reactions were carried out on 1 mMol of substate. 
We were extremely surprised to find that RCM did not take place on these compounds and believe 
there could be two main factors contributing to this. The first is sterics, the extended length of the 
N,N-dimethyl group could be blocking the ends of the alkenes coming together in a complex (Figure 
14). 
 
Figure 14 
The second cause for the failure of RCM could be attributed to the basic nature of the hydrazone 
functionality (Figure 15 ).104,105 
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Figure 15 
Basic amines are able to coordinate to the ruthenium of Grubbs II forming a stable intermediate which 
is deactivated towards RCM (Figure 16).106,107 
  
Figure 16 
Although currently this has only been reported on primary amines, it is possible a similar mechanism 
could be taking place in the case of our hydrazone. 
We believe it is a combination of these two factors that make the hydrazone series of compounds 
unreactive under RCM conditions. 
Given the unreactive nature of the hydrazine class of compounds to RCM conditions we went forward 
and attempted RCM on bis-alkyl ketone 90’ derived from the corresponding hydrazone. This attempt 
was made using the standard conditions we had developed for RCM (10% Grubbs II catalyst at 40°C) 
(Scheme 74). 
 
 
93 
 
 
Scheme 74 
As the reaction was performed on a very small scale, the results were inconclusive. High resolution 
mass spectrometry (HRMS) did not display an [M+X] ion under 5.00ppm which was consistent with the 
desired product, however, it did display a peak at 573, which is consistent with a dimer of the desired 
product plus a proton. 1H NMR spectroscopy of the purified mixture displayed some features that may 
be consistent with a macrocycle. Due to time constraints it was not possible to clarify this result 
further. 
As it was not possible to form the eleven-membered macrocycle with the isoxazole in place, we 
investigated if it were possible on ring opened bis-allyl enamino ketone 139 (Scheme 75). 
 
Scheme 75 
This attempt at RCM proved to be successful, yielding the desired 11-membered macrocycle. 1H NMR 
spectroscopy suggests that the configuration of the macrocycle is cis. This is based on the J coupling 
constant value of the two alkenyl protons (Figure 17) 
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Figure 17. Observed and predicted 1H NMR  500 MHz spectra of macrocylic enamino ketone 155 at 
40°C. This spectra was generated by Dr Mark Edgar of Loughborough University. 
In terms of alkene J values, 6-10 and 12-18 Hz correspond to cis- and trans-disubstituted alkenes 
respectively, and as such, this is strong evidence for the presence of a cis configuration.108  
It is also interesting to note that RCM went ahead despite the presence of an amine; we believe this is 
due to the fact that nitrogen lone pair less available in this system, as it is tied up in the enamino-
ketone conjugation, a vinylogous amide. 
The success of ring closing metathesis on this system supports our hypothesis that the isoxazole ring 
adds too much rigidity to the system and as such, ring closing metathesis cannot take place, however, 
once this rigidity is removed, metathesis is possible. 
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2.7 Benzisoxazole to Oxazole Rearrangement 
Previously in this thesis it was noted that an interesting rearrangement had been observed (Scheme 
76).  
 
Scheme 76 
This rearrangement was originally discovered when it was found that it was not possible to O-alkylate 
phenolic benzisoxazole 61 with an alkyl chain longer than allyl, via base mediated alkylation (Scheme 
77). 
 
Scheme 77 
The 1H NMR spectra indicated that neither desired but-3-enyl benzisoxazole 77 nor starting material 
were isolated, and a new, unknown compound was being formed.  
 As mentioned previously, the Mitsunobu based alkylation method had been developed to overcome 
the problem of O-alkylating with alkenyl halides. In an effort to compare O-allylation yields, the two 
methods were performed in tandem. 
 It was at this point it was noted that the 1H NMR spectra for the two O-allyl compounds were 
significantly different (Figure 18). 
 
96 
 
 Figure  18. (top) O-allyl benzoxazole  71 and  (bottom) O-allyl isoxazole 70. 
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Although the differences may appear obvious in retrospect; both the spectra in figure 18, could also 
be interpreted as corresponding to allyl benzisoxazole 70 if no evidence to the contrary was 
presented. 
At this point it was known that two different compounds were being obtained from a process that, on 
paper, should have resulted in the same compound; due to this efforts were made to determine the 
absolute structure of both. 
Searches into this area suggested a rearrangement with this class of compounds had been observed 
elsewhere, albeit under different conditions (Scheme 78).109 
  
Scheme 78 
The above reaction is an example of an example of a Boulton-Katritzky type rearrangement (Scheme 
79).110 
 
Scheme 79 
As a result of this, it was initially proposed that the isoxazole ring was simply being transposed, and 
then base mediated alkylation of enol 163 was taking place (Scheme 80). 
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Scheme 80 
To help determine if this was indeed the case, benzisoxazole 61 was heated in the presence of base 
but no alkylating agent (Scheme 81). 
 
Scheme 81 
This reaction proved to be very successful, generating what was at that stage believed to be ring 
transposed benzisoxazole 163 in very good yields. The 1H NMR spectrum of phenolic benzisoxazole 61 
was compared against that of the presumed ring transposed product 163, and they proved to be 
different.  
However, as the isoxazole ring formation itself requires base, it was important to prove that phenolic 
benzisoxazole 61 was indeed being generated and not some, as yet, unknown product (Scheme 82). 
 
Scheme 82 
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As mentioned earlier, it was possible to prove the exact constitution of phenolic benzisoxazole 61 via 
single crystal X-ray crystallography (Figure 19). 
 
Figure 19. X-Ray crystal structure of 3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61. 
This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
We hypothesise that the formation of fused phenolic benzisoxazole 61 is successful for the following 
reasons: although two equivalents of base are used, the first is used to form nitrile oxide from the 
imidoyl chloride 14 which is believed be the fastest process.  While the second equivalent of 
isopropoxide could in principle deprotonate phenolic benzisoxazole 61, the excess 1,3-
cyclohexanedione is more acidic (pKa of approximately 14.8 vs 10.3 respectively) and therefore the 
second equivalent of dione acts as a buffer.111,112 
Following this, it was then necessary to prove that the Mitsunobu procedure had indeed formed allyl 
benzisoxazole 70. This was achieved using a specialized type of 13C NMR spectroscopy: Incredible 
Natural Abundance Double Quantum Transfer Experiment (INADEQUATE). The INADEQUATE spectra 
successfully displayed the 13C-13C 1-bond couplings within allyl benzisoxazole 70, therefore allowing 
the exact structure of the carbon skeleton to be determined. Using this in conjunction with other data 
that had been gathered, it was possible to prove that allyl benzisoxazole 70 had been successfully 
synthesised using the Mitsunobu method (Figure 20). 
 
Figure 20 
 
100 
 
As these investigations had been taking place, attempts were made to grow crystals of what was 
believed to be ring transposed dimethyl benzisoxazole 164 (Figure 21).  
 
Figure 21 
These attempts proved to be successful and it was possible to determine the exact structure by X-ray 
crystallography (Figure 22). 
 
 
Figure 22. X-Ray crystal structure of 2-(2-Hydroxyphenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]oxazol-
4(5H)-one  166. This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
However, we were surprised to find that what was believed to be an isoxazole ring transposition was 
in fact benzisoxazole to benzoxazole rearrangement (Scheme 83). 
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Scheme 83 
To help confirm if this was also the case in the allylation reaction, 1H Nuclear Overhauser Effect 
Spectroscopy (NOESY) was performed on what was believed up to this point to be ring transposed allyl 
enol ether 168 (Figure 22). 
 
Figure 22 
1H NOESY spectroscopy is used to detect through space interactions between protons. As a result it 
should be possible to detect if the allyl chain was on either the aromatic or cyclohexanone ring by 
looking for NOESY interactions with the corresponding aromatic or aliphatic protons.  
The 1H NOESY spectra indicated there were interactions between the CH2 of the allyl chain and the CH 
of the aromatic ring, which strongly suggests that oxazole formation under these conditions, followed 
O-alkylation (Scheme 84). No interaction of this CH with the cyclohexanedione moiety was observed, 
which would have been expected for allyl enol ether 169. 
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Scheme 84 
In an effort to gain additional information, the reaction for formation of benzoxazole 167 was carefully 
monitored by LC-MS to determine if any intermediates were forming (Scheme 85). 
 
Scheme 85 
This investigation indicated that a more polar intermediate with the same molecular weight ([M+H] = 
230) as benzisoxazole 61 was forming, before being converting to benzoxazole 167. 
An attempt was made to isolate and purify this intermediate by preparative reverse phase high 
performance liquid chromatography (HPLC). This attempt proved successful and it was possible to 
obtain a small quantity of the unknown intermediate. The 1H and 13C NMR spectra suggested the 
cyclohexanedione ring had become symmetrical and was demonstrating delocalisation. These were 
two key pieces of information. 
Literature indicates that it is possible to generate an oxazole from an azirine and that it is possible to 
form an azirine from an isoxazole under thermolysis conditions (200°C).113,114 If it is postulated that the 
observed oxazole formation is taking place via a similar route, then azirine formation is most likely 
occurring via another pathway, as our rearrangement takes place at 66°C. 
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Further research suggested that one possible route to azirines at lower temperatures is the Neber 
rearrangement (Scheme 86).115 
 
Scheme 86 
We conducted a control experiment to determine if the free phenol was essential to the transposition 
process (Scheme 87). 
 
Scheme 87 
This result suggests that the phenol is necessary for the rearrangement to take place and as such we 
can reason that it must be involved in a key step. 
Based on  the above pieces of information it is believed that two sequential rearrangement reactions 
are taking place; firstly a Boulton-Katritzky type reaction  followed by a Neber rearrangement with a 
phenolate anion serving as the leaving group to form azirine 176 (Scheme 88). The azirine could be in 
equilibrium with a nitrile ylide intermediate that can ring close to an oxazole via an electrocyclic 
process. 
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 Scheme 88 
This mechanism meets the criteria of what is precedented in the literature, as well as helping us to 
understand why azirine formation is occurring at lower temperatures, and why the reaction only 
appears to take place with the free phenol.  
While the NMR spectral data gathered correspond to either of the possible intermediates (azirine or 
nitrile ylide), infrared (IR) spectral data display a carbonyl shift at a much lower than expected 
adsorption band, 1595 cm-1; the expected ketone carbonyl shift is 1680-1750 cm-1.108 This suggests 
that the C=O bond is much weaker than usual; this could be explained by the presence of an anionic 
carbon α to both of the ketones, as in intermediate 178. An anionic carbon at this location would be 
delocalised to stabilize the negative charge (Scheme 89). 
 
Scheme 89 
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This stabilization would result in a much weaker than normal carbonyl bond, which in turn would 
significantly lower the observed ketone carbonyl adsorption band in the spectrum. The fact that ylide 
178 is doubly stabilized by both carbonyls would also increase the likelihood of being able to isolate it. 
In addition the positive end of the dipole is stabilised by the attached phenolic unit. 
Unfortunately it was not possible to grow a single crystal of the intermediate isolated  during the non-
methyl benzisoxazole 61 to benzoxazole 167 rearrangement. A second sample of intermediate was 
isolated from the rearrangement of dimethyl benzisoxazole 62 to oxazole 166. However attempts to 
grow a single crystal from this intermediate failed and it is believed that it collapsed under 
crystallization conditions as the structure obtained was that of dimethyl benzoxazole 166 (Figure 23). 
 
Figure 23 
Another feature of this mechanism is that only catalytic amounts of base would be required for it to 
take place; this theory was put to the test (Scheme 90). Reducing the base to 10% level still resulted in 
ring transformation. 
 
Scheme 90 
This success lends credence to our proposed mechanism. We then went on to determine if the 
rearrangement would occur under a range of basic conditions (Table 14). 
 
106 
 
Base Solvent Yield (%)b 
Cs2CO3 THF 87 
K2CO3 THF 84 
Na2CO3 THF 5 
Et3N THF 0 
DMAP THF 0 
DBU THF 83 
LDA THF 37 
Cs2CO3 Toluene 97 
NaOiPr iPrOH 85 
Cs2CO3 EtOH-H2O 87 (for 7a) 
none H2O 8 
Cs2CO3 H2O 91 (for 7a) 
Table 14. a Isoxazole 61 (2.18 mmol), Base (4.37 mmol), reaction time 4 h, solvent under reflux; b 
Isolated yields refers to oxazole 167 unless otherwise stated. All entries in this table were generated 
by Romain Marty, a summer project student. 
 
We found that the best yields are obtained using caesium and potassium carbonate; sodium 
carbonate provided a much lower yield, possibly due to its poor solubility in THF. We also found that 
the reaction does not appear to proceed with triethylamine (Et3N) or (4-dimethyaminopyridine 
(DMAP), however, it will proceed with 1,8-diazabicycloundec-7-ene (DBU) and to a lesser extent with 
LDA.  
 
We also observed that under nucleophilic conditions (i.e. Cs2CO3 in aqueous ethanol) amide 180 was 
obtained (Scheme 91). 
 
 
Scheme  91 
 
This is believed to a product of nucleophilic ring opening (Scheme 92). 
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Scheme 92 
The basic aqueous medium attacks the oxazoles ring, presumably by attack at C-5, the ring then opens 
to yield amide anion 184, which undergoes protonation to yield enol 180. The structure of enol 180 
was confirmed by crystallography (Figure 24). 
 
Figure 24. X-Ray crystal structure of 2-Hydroxy-N-(2-hydroxy-6-oxocyclohex-1-en-1-yl)benzamide 180. 
This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
We hypothesised that it might be possible to trap the proposed nitrile ylide intermediate with an 
appropriate nucleophile (Scheme 93). 
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Scheme 93 
This was attempted using ethanethiol (Scheme 94). 
 
Scheme 94 
Instead a thioimidate being formed, thio-ether 186 was isolated, again, presumed to be a product of 
ring opening. This result was confirmed via X-ray crystallography (Figure 25). 
 
Figure 25. X-Ray crystal structure of N-(2-(ethylthio)-6-oxocyclohex-1-en-1-yl)-2-hydroxybenzamide 
186. This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
There are some interesting differences between the two crystal structures. Enol 180 possess a 
network of hydrogen bonds linking the two rings together, whilst thioether 186 does not. We believe 
there to be two reasons for this, firstly the greater steric bulk of the thioether chain. Secondly and 
more importantly, sulfur is a poor hydrogen bond acceptor when compared to oxygen.103 
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Thioether formation suggests the initiation of ring opening favours the carbon of the cyclohexanone 
ring (oxazole C-5) rather than at the carbon alpha to the phenol (oxazole C-2) (Figure 26). 
 
Figure 26 
If this was not the case, a mixture of thioether 186 and thioimidate 188 would be observed (Figure 27). 
  
  Figure 27 
This is unexpected as one would expect the carbon atom attached to the aromatic ring to be 
reasonably electropositive as it is between two electronegative heteroatoms. However, the electron 
donating ability of the phenol ring, as well as the extended resonance of the anion that is formed on 
the cyclohexanone ring may explain this why ring opening is initiated at that position. No further 
attempts were made at trapping the unknown intermediate as we believed that similar results would 
be observed. 
To discount the possibility of the oxazoles being formed by retro-1,3-dipolar cycloaddition from the 
isoxazoles and recombination via a different connectivity, a cross-over experiment was planned 
(Scheme 95). This required two isoxazoles with both their aromatic and cyclohexyl rings being 
different. 
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Scheme 95 
If our mechanism is correct, mixed oxazole 193 should not be observed. The cross-over experiment 
was attempted using di-methyl and nitro isoxazoles 62 and 64 (Scheme 96). 
 
Scheme 96 
No evidence of any cross-over was observed. This result suggests that the molecule is not splitting in 
two during the rearrangement, and supports our proposed mechanism 
We hypothesised that if a linear intermediate was being generated, then when a benzisoxazole 
asymmetrically substituted in the cyclohexane ring is subjected to rearrangement conditions a mixture 
should be obtained (Scheme 97).  
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Scheme 97 
As a suitable asymmetric di-ketone was commercially available in 4-4-dimethylcyclohexane-1,3-dione 
197, we synthesised and isolated the resultant isoxazoles (Scheme 98). A separable 1:2 mixture of 
isoxazole cycloadducts was obtained. 
 
Scheme 98 
It was possible to grow a single crystal of the major product to confirm the identity of each fraction of 
the reaction (Figure 28). 
 
Figure 28. X-Ray crystal structure of 3-(2-Hydroxyphenyl)-5,5-dimethyl-6,7-dihydrobenzo[d]isoxazol-
4(5H)-one 194. This crystal structure was solved by Dr Mark Elsegood of Loughborough University. 
This result is not unsurprising, as the major product is most likely slightly more favoured during the 
ring closure process as a result of steric factors. 
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The major isomer was subjected to rearrangement conditions (Scheme 99). 
 
Scheme 99 
The rearrangement was successful, yielding a mixture of benzoxazoles. This result supports our 
hypothesis that a linear intermediate is formed, as a mixture of isomers is obtained. The ratio of 
isomers currently cannot be assigned, as it was not possible to separate the mixture. 
Recently more evidence to support our mechanism has come to light in a paper published by Nunes et 
al.116 In this paper they state that they have been able to spectroscopically observe anti-nitrile ylide 
201 which rotated and closed on upon higher energy irradiation during the photo-catalysed isoxazole 
to oxazole rearrangement illustrated below (Scheme 100). 
 
Scheme 100 
This group were able to isolate and observe both the azirine and nitrile ylide via infrared (IR) 
spectroscopy. The results published in this paper strongly support our proposed mechanism as the 
only difference is the method by which the azirine is formed.  
To conclude we have demonstrated that this rearrangement takes place on a range electron 
rich/neutral and deficient aromatic benzisoxazoles (Figure 29). 
 
113 
 
 
Figure 29 
Benzoxazole Chemistry 
As we did not identify the rearrangement straight away, some investigations were carried out 
unknowingly on allyl benzoxazole 72, under the assumption that it was an isoxazole. These results 
could now be correctly interpreted as below. 
Carbonyl Addition 
Allyl benzoxazole 71 is similar to allyl benzisoxazole 70 in that it seems relatively unreactive towards 
electrophiles after being subjected to LDA under standard conditions (Scheme 101). 
 
Scheme 101 
This reaction was not repeated with the new conditions illustrated previously in this thesis and as a 
result, enolate formation and C-alkylation may be possible. 
However, when subject to an allyl Grignard reagent, benzoxazole 71 reacted readily (Scheme 102). 
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Scheme 102 
Initial attempts at low temperature afforded only moderate yields of tertiary alcohol 208. With some 
optimization it was possible to further increase the yield to 66% with warming to 50°C (Scheme 103). 
 
Scheme 103 
it was also possible to introduce a longer alkyl chain using the same methodology  to produce a pent-
4-enyl adduct (Scheme 104). 
 
Scheme 104 
We also determined it was possible to reduce the cyclohexenone ring of the oxazole in a similar 
fashion to that of the isoxazole with sodium borohydride affording secondary alcohol 210 in good yield 
(Scheme 105). 
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Scheme 105 
Ring Closing Metathesis 
Some ring closing metathesis investigations were carried out on the above substrates. While they do 
not possess the same motif as the natural products, they still served as a suitable series of compounds 
for testing RCM conditions; as steric constraints should be reasonably similar between the two classes 
of compounds (Scheme 106). 
 
Scheme 106 
Ring closing was tested on the diallyl material at a series of different temperatures (Table 15) and 
using Grubbs 2nd generation catalyst (Grubbs II). 
Solvent Temperature Duration Outcome 
Dry DCM 40°C 5 Days 80% of starting material recovered. 
Dry Toluene 60°C 5 Days 33% of starting material recovered. 
Dry Toluene 70°C 3 Days Unknown compound isolated 
Dry Toluene 80°C 5 Days Unknown compound isolated 
Dry Toluene 100°C 3 Days Unknown compound isolated 
 
Table 15. All reactions were carried out on a 37mg (1.18 mM) scale with regards to starting oxazole 
208 and 20% catalyst loading in 10mL of dry solvent.  Unless otherwise stated, the remaining mass 
balance was unidentifiable baseline material. 
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None of the above attempts produced a ring closed substrate, however, there appeared to be signs 
that de-allylation may have taken place. To investigate this, the reaction was repeated on a larger 
(0.50g) scale to determine if this was the case (Scheme 107). 
 
 
Scheme 107 
The reaction was monitored by LC-MS until [M+H] for the starting material was no longer present. No 
[M+H] peak was observed for the ring closed product, however, a strong  peak   was observed at 271, 
which correlates to [M+H] for de-allylated benzoxazole 212. This is also consistent with 1H NMR 
spectra obtained from this reaction; these spectra lacked peaks that are indicative of the O-allyl 
functionality. Evidence that Grubbs II catalyst is capable of deallylating hetero atoms has been 
presented by other groups (Scheme 108).117,118 
 
Scheme 108 
Synthetic Utility 
We have also demonstrated that this rearrangement possesses synthetic utility. A class of pyrimidine 
containing fused benzoxazoles has been described in patents filed by Udea et al. (Figure 30).119 
 
Figure 30 
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We have demonstrated that it is possible to access these structures in just one step from our 
rearranged benzoxazole via an Ullmann-type coupling (Scheme 109).120 
 
Scheme 109 
With this success we have demonstrated that it is possible to access this class of herbicides in just four 
steps with an overall yield of 38%, with the potential for further optimisation available (Scheme 110). 
 
 
Scheme 110 
 
 
 
 
 
118 
 
2.8 Progress towards Coleophomone D 
As mentioned, one of the objectives of this project has been the synthesis of coleophomone D 217 
(Figure 31) 
 
Figure 31 
Earlier in this thesis it was illustrated how we have been able to successfully synthesise a potential 
precursor for coleophomone D from o-vanillin (Figure 32). 
 
Figure 32 
With this precursor in hand, the next step was to determine how we were going install the aldehyde 
functionality present in the natural product. Previously we have had some success with metal 
mediated cross coupling chemistry on this class of compounds, and were hopeful we might apply it 
here (Scheme 111). 
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Scheme 111 
So going forwards, our first step would be to convert the phenol 63 to the triflate precursor in order to 
activate it towards metal mediated cross coupling. Following this we would couple it with vinylboronic 
acid or potassium cyanide, then cleave the alkene or perform a low temperature diisobutylaluminium 
hydride (DIBAL) reduction of the nitrile to yield the desired aldehyde.121 As phenolic benzisoxazole 61 
was readily available, we used it as a test compound (Scheme 112). 
 
Scheme 112 
Triflation was very successful, however, it should be noted if multiple equivalents of base and 
anhydride are used, a mixture of mono- and bis-triflated benzisoxazoles 220 and 101 was observed 
(Scheme 113). 
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Scheme 113 
This result is interesting because again, it suggests that not only is the carbon alpha to the carbonyl 
reasonably acidic, but the enolate oxygen at least, is reactive towards electrophiles. 
With the successful formation of triflated benzisoxazole 220, the next stage was to attempt cyanation 
(Scheme 114). 
 
Scheme 114 
This result was very interesting, as we did not isolate any of the desired cross-coupling product, nor 
was starting material returned; what we did isolate was an amorphous unidentified product with 
dimeric features in the 1H NMR spectra i.e. unexplained doubling of the integrals in the 1H NMR 
spectrra. Upon subjecting this product to crystallization procedures, small crystals of triflated 
benzoxazole 221 were obtained identified by X-ray structure determination (Figure 33). 
 
121 
 
 
Figure 33. X-Ray crystal structure of 2-(4-Oxo-4,5,6,7-tetrahydrobenzo[d]oxazol-2-yl)phenyl 
trifluoromethanesulfonate 221. This crystal structure was solved by Dr Mark Elsegood of 
Loughborough University. 
In order to confirm this result, benzoxazole 167, available from the rearrangement studies was 
triflated (Scheme 115). 
 
Scheme 115 
This yielded both the desired triflated benzoxazole 221 and a small amount of electrophilic addition 
product, bis-triflated benzoxazole 222. Single crystal X-ray crystallography has confirmed that the 
triflated oxazoles obtained from both reactions are the same. However, the 1H NMR spectra of the 
bulk material from the cyanation reaction does not match that of triflated benzoxazole 221. 
Initially we hypothesized that this trfilated benzoxazole was a product of rearrangement during 
triflation, as this takes place under basic conditions. However, there is no evidence of this product in 
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the 1H or 13C NMR spectra of triflated benzisoxazole 220. Another key fact is that the study of the 
rearrangement in various bases indicated that the rearrangement does not occur with (4-(4-
dimethylamino)pyridine (DMAP) in refluxing THF, so we can speculate that the  same is true at 0°C 
with pyridine. 
If these data are accurate, then it suggests that the rearrangement is either happening during the 
cyanation reaction or upon subjection of the amorphous product to crystallization conditions. 
Currently we are unable to explain how this could occur as it is inconsistent with our proposed 
mechanism of rearrangement. 
Following this result, alternative cyanation conditions, suggested by our industrial collaborator, were 
attempted (Scheme 116). 
 
Scheme 116 
This attempt failed, but unlike the previous attempt starting material was retained; there was no 
indication that any rearrangement had taken place. We also attempted to couple triflated 
benzisoxazole 220 with vinylboronic acid pinacol ester (Scheme 117). This attempt failed and again 
starting material was retained. 
 
Scheme 117 
As mentioned, previously, it has been possible to couple bromobenzisoxazole 68 with phenylboronic 
acid (Scheme 118). 
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Scheme 118 
It should also be possible to carry out this reaction on triflated benzisoxazole 220 and this was 
attempted to help determine if the triflate group was incompatible with fused isoxazole functionality 
(Scheme 119). 
 
Scheme 119 
This reaction did not yield the desired product; however, it did yield an unknown compound, with 
spectral features similar to that displayed by the unknown compound isolated from the initial cynation 
attempts. 
These results seem to indicate that there is a problem with our triflate functionality in the presence of 
palladium-tetrakis(triphenylphosphine). 
Due to time constraints we were not able to investigate these results any further and we are presently 
unable to interpret our experimental observations. 
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3.0 Conclusions and Future Research  
This chapter of the thesis will discuss the overall conclusions drawn from each research area of this 
PhD, as well as any future avenues of investigation that are available. 
Coleophomones A, B and C 
The main objective of this project was to generate macrocyclic structures relating to the 
coleophomone natural products via an isoxazole route. This aim has been achieved in three ways: 
firstly we have demonstrated that it is possible to synthesize 12-13 membered macrocycles with the 
isoxazole in place, from commercially available starting materials in 5 steps with an overall yield of 
approximately 13% (Scheme 1). 
 
Scheme 1 
Secondly we have made significant progress towards generating these macrocycles via a regio-
chemically pure route using hydrazone methodology (Scheme 2) 
 
Scheme 2 
Finally we have demonstrated that if the isoxazole is cleaved then it is possible to generate the 11-
membered macrocycle necessary for the natural products over 6 steps in approximately 4% yield 
(Scheme 3). 
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Scheme 3 
This 11-membered ring is of special interest as it represents a scaffold towards the natural products 
themselves, and as such, we hope to publish its synthesis. 
Many avenues remain open for the continuation of this project. The first is the optimization and 
continued study of hydrazone route towards regio-chemically pure macrocyclic structures in good 
yields (Scheme 4). 
 
Scheme 4 
Once this has been successfully undertaken then these structures could be further furnished with 
additional functionality in an effort to afford analogues that are closer to the natural products. 
Coleophomone D 
Reasonable progress has been made towards the total synthesis of colephomone D. Efforts towards a 
core benzisoxazole skeleton for the total synthesis of coleophomone D have met with some problems 
(Figure 1). 
 
Figure 1 
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Initially it was believed that it would be possible to use o-vanillin as a starting point, then convert the 
phenol to a triflate and employ metal medicated cross coupling to introduce a route to the perquisite 
aldehyde functionality. However, due to an as yet unknown reaction this has been unsuccessful and as 
such a new route towards this core structure would be essential for any future investigations.  
A potential route for this would be via a Meyers type directed lithiation of m-anisaldehyde (Scheme 
5).122 
 
Scheme 5 
If this were to be successful, then the aldehyde can either be introduced via the originally planned 
metal mediated cross coupling; or the aldehyde could be formed directly via metal halogen exchanged 
followed by a quench with dimethyl formamide. 
It should also be noted that allylation investigations carried out in efforts towards the synthesis of 
coleophomones A, B and C, also apply to D; once initial hurdles have been crossed, it should be 
possible to readily alkylate the core structure of coleophomone D.  
If this were to be successful then established chemistry could be used to furnish the rest of the core 
structure with the desired functionality, yielding coleophomone D within a few steps. 
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Benzisoxazole to Oxazole Rearrangement 
This novel and unexpected rearrangement has proved to be an unexpected, but never the less very 
interesting diversion from the core aims of the PhD project. Initial investigations into probing the exact 
nature of this rearrangement have been carried out and accepted for publication in Chemical 
Communications. Finally, due to this rearrangement it has been possible to readily access a known, 
biologically active product in 4 steps with a total yield of 38% (Scheme 6). 
 
Scheme 6 
Future investigations would aim to test the rearrangement with a broader range of examples (scheme 
7). 
 
Scheme 7 
Another possible route of investigation would be to try and determine the nature of the unknown 
reaction that is taking place when we attempted to couple triflate 14 with potassium cyanide (Scheme 
8). 
 
Scheme 8 
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If these two routes proved to be successful they would could the basis for future publications in this 
area. 
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4.0 Experimental 
Compound numbers in this chapter refence to compound numbers in Chapter 2. 
General 
Commercially available reagents and solvents were used throughout without further purification, 
except tetrahydrofuran distilled (THF) (benzophenone/Na) and N-Chlorosuccinimide which was freshly 
purified by recrystallization from boiling toluene, in accordance to the literature procedure.123 Light 
petroleum refers to the fraction with bp 40-60°C. Thin layer chromatography was carried out on Merck 
Kieselgel 60 GF254 aluminium foil backed plates. The plates were visualized under UV light. Flash 
column chromatography was carried out using Merck Kieselgel 60 H silica or Matrix silica 60, with the 
eluent specified. IR spectra were recorded using a Perkin Elmer FTIR Spectrometer (Paragon 100) as 
neat, or solutions using dichloromethane as solvent or using attenuated total reflectance for solids. 1H, 
19F, 15N and 13C NMR spectra were recorded using a Bruker 400 MHz NMR spectrometer (1H 400, 19F 
376, 100 MHz 13C frequencies respectively), Bruker 500 MHz NMR spectrometer (1H 500, 15N 50, 13C 
125 MHz frequencies respectively),  a Bruker 600 MHz NMR spectrometer (1H 600, 13C 150 MHz 
frequencies respectively) or a JEOL 400 MHz NMR machine (1H 400, 19F 376 , 13C 100 MHz frequencies 
respectively); chemical shifts are quoted in ppm and coupling constants, J, are quoted in Hz; d-
Chloroform was used throughout unless otherwise stated. In the 13C spectra, signals corresponding to 
C, CH, CH2 or CH3 groups, as assigned from either DEPT or HSQC, are noted. Quaternary carbons were 
assigned using a combination of NMR techniques including COSY, HSQC and HMBC, unless otherwise 
stated. Spectra were calibrated to residual solvent peaks.  High resolution mass spectra were recorded 
on a Thermofisher Exactive (Orbi) high resolution mass spectrometer. Melting points were recorded 
on a Stuart Scientific apparatus and are uncorrected. LCMS were recorded using an Agilent 
Technologies spectrometer, model G1956B, using a 50 x 2mm Gemini C18 3µm column running at 1.00 
mL/minute with acetonitirle:formic acid (99.9:0.1 v/v) as eluent. Unless otherwise stated all air 
sensitive reactions were carried out under an atmosphere of nitrogen.  
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General Procedure for Oxime formation 
Sodium acetate (4 mMol) was added to a solution of hydroxylamine hydrochloride (2 mMol) and 
aromatic aldehyde (1 mMol) in ethanol (10 mL) and water (5 mL). The reaction mixture was heated to 
reflux for 30 minutes and then allowed to cool to room temperature. Following this the reaction 
mixture was stored in a refrigerator overnight, after which it was filtered to yield the desired oxime. If 
the oxime did not crystallise out, then the mixture was acidified, and washed with DCM(3 x 10 mL). 
The organic extracts were washed once with saturated sodium chloride solution (30 mL), dried over 
magnesium sulfate and concentrated under reduced pressure to yield the desired oxime. 
2-Bromobenzaldehyde oxime 12 124 
 
Colourless needles (83%), M.p. 98-100°C lit. 102°C124; HRMS(EI+) C7H6BrNONa requires 221.9530 
[M+Na] found 221.9523 -3.1538 ppm; νmax (ATR)/cm
-1 945 (NO), 3248 (OH); δH (400MHz; CDCl3) 7.22-
7.26 (m, H, Ar CH), 7.23-7.34 (m, H, Ar CH) 7.58 (dd, J=1.20, 7.60 Hz, H, Ar CH), 7.81 (dd, J=1.60, 7.60 
Hz, Ar CH), 8.37 (broad s, H, NOH), 8.55 (s, H, CH); δC (100MHz; CDCl3) 123.9 (Ar C), 127.5 (Ar CH), 
127.6 (Ar CH),  131.3 (Ar CH), 131.3 (Ar C), 133.2 (Ar C), 149.9 (C). 
2-Bromo-6-hydroxybenzaldehyde oxime 45 
 
Beige solid (77%) M.p. 149-151°C; MS(EI+) C7H6NO2
79BrNa requires 237.9480 [M+Na] found 237.9470 -
4.2026 ppm; νmax (ATR)/cm
-1 974 (N-O), 3391 (OH); δH (400MHz; CDCl3) 6.83 (dd, J=2.00 Hz, 8.40 Hz, H, 
Ar CH), 7.03 (d, J=2.00 Hz, H, Ar CH), 7.64 (d, J=8.40 Hz, H, Ar CH), 8.20 (broad s, H, OH), 10.25 (broad s, 
H, OH), 11.29 (s, H, CH); δC (100MHz; CDCl3) 115.7 (Ar CH), 118.9 (Ar CH), 122.5 (C), 123.0 (C), 127.9 (Ar 
CH), 146.5 (C), 159.2 (C=NOH). 
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2-Hydroxy-3-methoxybenzaldehyde oxime 48125 
 
Beige solid (85%), M.p 122-124°C lit. 123°C; HRMS(EI+) C7H6N2O4Na requires 190.0480 [M+Na] found 
190.0475 -2.6309 ppm; νmax (ATR)/cm
-1 3367 (OH); δH (400MHz; CDCl3) 3.90 (s, 3H, OCH3), 6.82 (dd, 
J=7.60, 2.00 Hz, H, Ar CH), 6.86 (t, J=7.60, H, Ar CH), 6.91 (dd, J=7.60, 2.00, H, Ar CH), 8.23 (broad s, H, 
OH), 8.23 (s, H, CH), 9.94 (broad s, H, OH); δC (100MHz; CDCl3) 56.2 (OCH3), 113.3 (Ar CH), 116.7 (C), 
119.6 (Ar CH), 122.3 (Ar CH), 146.9 (C), 148.2 (C), 152.7 (Ar CH). 
 
2-Hydroxy-4-nitrobenzaldehyde oxime 51 
 
Pale yellow solid (93%), decomposes 210-212°C; HRMS(EI+) C7H6N2O4Na requires 205.0225 [M+Na] 
found 205.0218 -3.4143 ppm; νmax (ATR)/cm
-1 949 (NO), 1336 (NO), 1620 (C=N), 3290 (OH); δH 
(400MHz; d6-DMSO) 7.15 (d, J=8.80 Hz, H, Ar CH), 8.10 (dd, J=8.80, 3.00, H, Ar CH), 8.33 (s, H, CH), 8.41 
(d, J=3.00 Hz, H, Ar CH), 11.70 (broad s, 2H, 2 x OH); δC (100MHz; d6-DMSO) 116.6 (Ar CH), 119.4 (Ar C), 
122.2 (Ar CH),  125.6 (Ar CH), 139.6 (Ar C), 144.0 (Ar CH), 161.6 (C). 
2-Fluoro-6-hydroxybenzaldehyde oxime 53 
 
Brown solid (90%), M.p. 114-116°C; HRMS(EI+) C7H7 FNO requires 156.0455 [M+H] found 156.0454 -
1.0700 ppm; νmax (ATR)/cm
-1 970 (NO), 1628 (C=N), 3374 (OH); δH (400MHz; d6-DMSO) 6.87 (td, J=8.00, 
4.80 Hz, H, Ar CH), 7.19-7.25 (m, H, Ar CH), 7.32 (d, J=6.80 Hz, H, Ar CH), 8.38 (s, H, CH), 10.31 (broad s, 
H, OH) 11.58 (broad s, H, OH); δC (100MHz; d6-DMSO) 117.4 (d, J=18.0 Hz C-F, Ar CH), 120.2 (d, J=7.00 
(C-F), Ar CH), 121.9 (d, J=4.00 C-F, Ar C), 124.0 (d, J=3.00 Hz C-F, Ar CH), 144.5 (d, J=14.0 Hz C-F, Ar C), 
147.8 (d, J=4.00 Hz C-F, Ar CH), 151.5 (d, J=239 Hz, Ar C-F). 
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General Procedure for imidoyl chloride formation 
Oxime (2 mMol) and freshly purified N-chlorosuccinimide (2.2 mMol) were dissolved in chloroform (20 
ml), followed by addition of anhydrous pyridine (0.2 mMol). The reaction mixture was heated to 40°C 
and stirred for 18 hours under an atmosphere of nitrogen unless otherwise stated. The reaction 
mixture was allowed to cool to room temperature and the washed with water (2 x 20 mL) and with 
brine (20 mL). The organic extracts were then dried over sodium sulfate, filtered and concentrated 
under reduced pressure to yield the crude imidoyl chloride which was used with no further 
purification. 
Note: This series of imidoyl chloride are not stable, even when stored under an atmosphere of 
nitrogen and should be used within 2 days.  
2-Hydroxyphenylhydroximdoyl chloride 1430 
 
Orange solid 99%; νmax (ATR)/cm
-1 651 (C-Cl), 941 (NO), 3293 (OH); δH (400MHz; CDCl3) 6.96-7.02 (m, 
2H, 2 x Ar CH), 7.33-7.37 (m, H, Ar CH), 7.81-7.83 (dd, J=1.59, 8.00 Hz, H, Ar CH), 8.40 (broad, H, NOH), 
10.07 (s, H, Ar OH); δC (100MHz; CDCl3) 115.7 (C) 117.1 (Ar CH), 119.8 (Ar CH), 129.4 (Ar CH), 132.3 (Ar 
CH) 156.4 (C), 171.4 (C). This compound was not of sufficient purity to obtain an accurate melting 
point and was unstable to mass spectrometry conditions. The spectra reported above are in 
agreement with the literature data.30 
2-Bromo-N-hydroxybenzimidoyl chloride 15126 
 
Yellow oil (94%); νmax (neat)/cm
-1 757 (C-Cl), 937 (NO), 3338 (OH); δH (400MHz; CDCl3) 7.26-7.30 (m, H, 
Ar CH), 7.33-7.35 (m, H, Ar CH), 7.42-7.44 (m, H, Ar CH), 7.60-7.62 (dd, J=1.20,  8.00 Hz, H, Ar CH), 9.40 
(broad, H, NOH); δC (100MHz; CDCl3) 122.2 (C), 127.5 (Ar CH), 131.2 (Ar CH), 131.6 (Ar CH), 133.5 (Ar 
CH), 135.6 (C), 172.0 (C). This compound was not of sufficient purity to obtain an accurate melting 
point and was unstable to mass spectrometry conditions. The data reported above is in good 
agreement with the literature data.126 
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2-Bromo-N,6-dihydroxybenzimidoyl chloride 46 
 
Beige solid (62%); δH (400MHz; CDCl3) 6.85-6.87 (dd, J=2.40, 8.40 Hz, H, Ar CH), 7.10-7.11 (d, J=2.40 Hz, 
H, Ar CH), 7.33-7.57 (d, J=8.40 Hz, H, Ar CH), 11.50 (broad s, H, Ar OH), 12.31 (s, H, NOH). This 
compound was not of sufficient purity to obtain an accurate melting point and was unstable to mass 
spectrometry conditions.  
 
 
N,2-Dihydroxy-3-methoxybenzimidoyl chloride 49 
 
Reaction time: 3.5 days. Brown solid 83% m.p. 143-146°C; νmax (DCM)/cm
-1 3691 (OH); δH (400MHz; 
CDCl3) 3.91 (s, 3H, OCH3), 6.83-6.93 (m, 2H, 2 x Ar CH), 7.41 (d, J=7.20 Hz, H, Ar CH), 7.99 (broad s, H, 
NOH), 10.05 (broad, H, OH); δC (100MHz; CDCl3) 56.2 (OCH3), 114.1 (Ar CH), 116.1 (C), 119.3 (Ar CH), 
121.0 (Ar CH), 142.2 (C), 146.5 (C), 158.2 (C). This compound was not of sufficient purity to obtain an 
accurate melting point and was unstable to mass spectrometry conditions. 
2,4-Dichloro-N,6-dihydroxybenzimidoyl chloride 50 
 
Brown solid (88%), δH (400MHz; d6-DMSO) 7.56 (d, J=2.56 Hz, H, Ar CH), 7.77 (d, J=2.56 Hz, H, Ar CH), 
10.80 (broad s, H, OH), 12.96 (broad s, H, OH); δC (100MHz; d6-DMSO) 120.9 (C), 122.3 (C), 123.1 (C), 
127.4 (Ar CH), 130.9 (Ar CH), 134.6 (C), 150.5 (C). This compound was not of sufficient purity to obtain 
an accurate melting point and was unstable to mass spectrometry conditions. 
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N,2-Dihydroxy-4-nitrobenzimidoyl chloride 52 
 
Yellow solid 96%; (400MHz; d6-DMSO) 7.18 (d, J=8.00 Hz, H, Ar CH), 8.24-8.30 (m, 2H, 2 x Ar CH), 11.72 
(broad s, H, OH), 12.64 (broad s, H, OH); δC (100MHz; d6-DMSO) 117.6 (Ar CH), 120.9 (C), 126.5 (Ar CH), 
127.7 (Ar CH), 132.7 (C), 139.7 (C), 162.2 (C). This compound was not of sufficient purity to obtain an 
accurate melting point and was unstable to mass spectrometry conditions. 
 
2-Fluoro-N,6-dihydroxybenzimidoyl chloride 54 
 
Brown solid 81%; νmax (DCM)/cm
-1 3691 (OH); δH (400MHz; CDCl3) 6.76-6.79 (m, H, Ar CH), 7.08-7.15 
(m, H, Ar CH), 7.19-7.24 (m, H, Ar CH). This compound was not of sufficient purity to obtain an 
accurate melting point and was unstable to mass spectrometry conditions. This compound 
decomposed rapidly and should be used immediately. 
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2-(2-(Benzyloxy)phenyl)-1,3-dimethylimidazolidine 25 
 
2-(Benzyloxy)benzaldehyde (3.00 g, 2.26 ml, 14.2 mMol) and N,N’-dimethylethylenediamine (1.48 g, 
1.79 ml, 16.8 mMol) in ethanol (100 ml) was stirred at room temperature for 12 hours. Magnesium 
sulfate (4.50 g) was added, and the resulting mixture was stirred for a further 15 min. The reaction 
mixture was filtered and washed with diethyl ether and the solvent was removed under reduced 
pressure to yield the product 2-(2-(benzyloxy)phenyl)-1,3-dimethylimidazolidine 25 (2.90 g, 70 %) as a 
yellow solid.  
M.p 84-86°C; MS(EI+)  C18H23ON2 requires 283.1810 [M+H] found 283.1800 -3.5313 ppm; νmax 
(ATR)/cm-1 2946 (CH); δH (400MHz; CDCl3) 2.21 (s, 6H, 2 x CH3), 2.57-2.60 (m, 2H, 2 x CH), 3.35-3.37 (m, 
2H, 2 x CH), 4.14 (s, H, NCHN), 5.08 (s, 2H, ArOCH2), 6.94 (dd, J=0.80, 8.40 Hz, H, Ar CH), 7.03 (t, J=7.60 
Hz, H, Ar CH), 7.22-7.25 (m, H, Ar CH), 7.32-7.45 (m, 5H, 5 x Ar CH), 7.72 (dd, J=1.56, 7.60 Hz, H, Ar CH); 
δC (100MHz; CDCl3) 39.8 (2 x NCH3), 53.5 (2 x NCH2), 70.2 (ArOCH2), 82.8 (NCHN), 111.8  (Ar CH), 121.5 
(Ar CH), 127.2 (2 x Ar CH), 127.8 (Ar CH), 128.1 (Ar C), 128.5 (2 x Ar CH), 128.9 (Ar CH), 129.5 (Ar CH), 
137.3 (Ar C), 158.0 (Ar CO). 
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2-(2-Methoxyphenyl)-1,3-dimethylimidazolidine 28 77 
 
2-Methoxybenzaldehyde (3.00 g, 22.0 mMol) and N,N’-dimethylethylenediamine (2.33 g, 26.4 mMol) 
in ethanol (100 ml) was stirred at room temperature overnight. Magnesium sulfate (4.50 g) was 
added, and the resulting mixture was stirred for a further 15 min. The reaction mixture was filtered 
and washed with diethyl ether and the solvent was removed under reduced pressure to yield the 
product 2-(2-methoxyphenyl)-1,3-dimethylimidazolidine 28 (3.28 g, 95%) as a yellow solid.  
Mp: 46-48°C lit. 41-42°C77; C12H18ON2Na requires 229.1317 [M+Na] found 229.1308 -3.9279; νmax 
(ATR)/cm-1 2939 (CH); δH (400MHz; CDCl3) 2.20 (s, 6H, 2 x CH3), 2.59-2.63 (m, 2H, 2 x CH), 3.33-3.46 (m, 
2H, 2 x CH), 3.82 (s, 3H, OCH3), 4.06 (s, H, NCHN), 6.87-6.89 (s, 2H, OCH2), 6.88 (dd, J=0.80, 8.40 Hz, H, 
Ar CH), 7.01 (dd, J=0.80, 8.00 Hz, H, Ar CH), 7.24-7.27 (m, H, Ar CH), 7.67 (dd, J=2.00, 7.60 Hz, H, Ar 
CH); δC (100MHz; CDCl3) 39.7 (2 x NCH3), 53.5 (2 x NCH2), 55.5 (ArOCH3), 82.8 (NCHN), 110.4  (Ar CH), 
121.1 (Ar CH), 127.6 (Ar C), 128.9 (Ar CH), 129.3 (Ar CH), 158.9 (Ar CO). The 1H and 13C data reported 
above are in good agreement with those reported in the literature.77 
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2-(Benzyloxy)-6-bromobenzaldehyde 26127 
 
Benzyl alcohol (0.160 g, 0.160 ml, 1.65 mMol) was added to a suspension of sodium hydride (0.660 g 
1.65 mMol) in anhydrous DMF (25 mL) and allowed to stir for 15 min. 2-Bromo-6-fluorobenzaldehyde 
30 (0.300 g, 1.47 mMol) was added and the reaction mixture was left to stir under an atmosphere of 
nitrogen for 4 hours. Following this the reaction mixture was diluted with water (25 mL) and extracted 
with diethyl ether (3 x 25 mL). The combined organic extracts were then washed with water (2 x 25 
mL) and brine (1 x 25 mL), dried over sodium sulfate and concentrated under reduced pressure. The 
crude product was purified by flash column chromatography using light petroleum:ethyl acetate 
(97.5:2.5 v/v) to yield 2-(benzyloxy)-6-bromobenzaldehyde 26 as a yellow solid (0.10 g, 23%).  
Mp: 56-60°C lit. 54-56°C128; MS(EI+) C14H11O2
79BrNa; requires 312.9840 [M+Na] found 312.9830 -
3.1951 ppm; νmax (ATR)/cm
-1 1688 (C=O), 2880 (CH); δH (400MHz; CDCl3) 5.18 (s, 2H, OCH2), 6.99 (dd, 
J=1.60, 8.00 Hz, H, Ar CH), 7.23-7.45 (m, 9H, 9 x Ar CH), 10.48 (s, H, CHO); δC (100MHz; CDCl3) 70.9 
(OCH2), 115.5 (Ar C), 124.0 (Ar CH), 124.3(Ar CH), 126.9 (Ar CH), 127.1 ( 2 x Ar CH), 128.0 (Ar CH), 128.7 
(2 x Ar CH), 161.2 (Ar CO), 190.1 (Ar CHO). The data reported above is in agreement with that reported 
in the literature.128 
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2-Bromo-6-hydroxybenzaldehyde  44128 
 
 
3-Bromophenol (5.50 g, 3.43 ml, 32.0 mMol) was added to a solution of sodium hydroxide (10.24 g, 
256 mMol) in water (200 ml) and heated to 75°C. Chloroform (11.45 g, 7.70 mL, 96.0 mMol) was 
added drop wise over 45 minutes. The mixture was heated at 75°C until signs of chloroform reflux 
were no longer observed. The orange-brown suspension was then cooled to 0°C and acidified with 2M 
hydrochloric acid. The reaction mixture was then extracted with ethyl acetate (3 x 100 mL) and the 
combined organic extracts were washed with water (2 x 100 mL) and brine (1 x 100 mL), dried with 
sodium sulfate and concentrated under reduced pressure. The crude product was then purified by 
flash column chromatography using light petroleum:ethyl acetate (92.5:7.5 v/v) as eluent to yield 2-
bromo-6-hydroxybenzaldehyde 44 as a brown solid (3.57 g, 56%).  
M.p. 49-51°C lit. 50-52°C129; νmax (ATR)/cm
-1 1645 (C=O), 3081 (OH); MS(EI+) C7H5O2
79BrNa; requires 
222.9371 [M+Na] found 222.9360 -4.9341 ppm; δH (400MHz; CDCl3) 6.92-6.95 (dd, J=2.40, 8.80 Hz, H, 
Ar CH), 7.11-7.12 (d, J=2.40 Hz, H, Ar CH), 7.74-7.77 (d, J=8.80 Hz, H, Ar CH), 10.03 (s, H, CHO), 11.10 
(broad s, H, Ar OH); δC (100MHz; CDCl3) 115.6 (Ar CH), 119.8 (Ar CH), 125.0 (Ar C), 127.8(Ar C), 131.9 
(Ar CH), 163.6 (Ar OH), 189.7 (Ar CHO). The data reported above is in agreement with that reported in 
the literature. 128 
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General Procedure for Benzisoxazole formation 
Sodium isopropoxide (2 mMol) was added to a solution of dione  (2 mMol)  in isopropyl alcohol (10 
mL) at room temperature and left to stir for 10 minutes. Afterwards this solution was added very 
slowly to a solution of benzimidoyl chloride (1mMol) in isopropyl alcohol (10 mL) at 0°C and left to stir 
for 4 hours at room temperature under an atmosphere of nitrogen. Following this, the reaction 
mixture was concentrated under reduced pressure. The crude mixture was then dissolved in either 
ethyl acetate or dichloromethane (20 mL) and washed twice with water (20 mL) and once with 
saturated sodium chloride solution (20 mL), dried over magnesium sulfate and concentrated under 
reduced pressure to yield crude benzisoxazole. This was used without purification, recrystallized from 
a mixture of ethyl acetate and light petroleum or purified via column chromatography using light 
petroleum: ethyl acetate (1:1 v/v) as a eluent. 
3-(2-Bromophenyl)-6-methyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 4 
 
Brown solid (28%) Mp 68-71°C; HRMS(EI+) C14H12NO2
79BrNa; requires 327.9950 [M+Na], found 
313.9782 -3.6586 ppm; νmax (ATR)/cm
-1 1682 (C=O), 2962 (C-H); δH (400MHz; CDCl3) 1.14-1.16 (d, 
J=6.40 Hz, 3H, CH3), 2.23-2.28 (m, 1H, CH), 2.49-2.54 (m, 2H, 2 x CH), 2.62-2.69 (dd, J=10.00, 17.60 Hz, 
1H, CHH), 3.09-3.15 (dd, J=4.80, 17.60Hz, 1H, CH2), 7.24-7.33 (m, 3H, 3 x Ar H), 7.59-7.61 (m, 1H, Ar H); 
δC (100MHz; CDCl3) 28.4 (CH3), 35.5 (CH), 37.0 (CH2), 52.5 (CH2), 114.4 (C), 123.4 (Ar C), 127.2 (Ar CH), 
129.1 (Ar C), 131.2 (Ar CH), 131.3 (Ar CH), 133.0 (Ar CH), 159.2 (C), 180.5 (C), 190.0 (C). 
3-(2-Hydroxyphenyl)-6-methyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 5 
 
Pale yellow solid (83%) M.p. 121-122°C; HRMS(EI+) C14H13NO3Na; requires 266.0793 [M+Na] found 
266.0782, -4.1341 ppm; νmax (ATR)/cm
-1 1689 (C=O), 3078 (OH); δH (400MHz; CDCl3) 1.24-1.26 (d, 
J=6.80 Hz, 3H, CH3), 2.38-2.42 (m, H, CH), 2.45-2.59 (m, H, CH), 2.70-2.76 (m, 2H, CH2), 3.20-3.26 (dd, 
J=5.12, 17.20Hz, H, CH), 6.99-7.08 (m, 2H, 2 x Ar CH), 7.35-7.41 (m, H, Ar CH,) 8.62-8.65 (dd, J=2.00, 
8.00 Hz, H, Ar CH), 9.49 (s, H, Ar OH); δC (100MHz; CDCl3) 20.7 (CH3), 29.9 (CH), 31.1 (CH2), 47.4 (CH2), 
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112.8 (C), 114.6 (C), 116.8 (Ar CH), 117.5  (Ar CH), 119.8 (Ar CH), 131.9 (Ar CH), 132.5 (Ar CH), 156.6 
(C), 159.5 (C), 181.5 (C), 191.7 (C). 
3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 6130 
 
Pale yellow solid (94%), M.p. 108-110°C lit. 107-110°C30; HRMS(EI+) C13H11NO3Na; requires 252.0637 
[M+Na] found 252.0623, -5.5541 ppm; νmax (ATR)/cm
-1 1679 (C=O), 3136 (OH); δH (400MHz; CDCl3) 2.28 
(dt, J=6.40, 12.40 Hz, 2H, CH2), 2.67 (t, J=6.40 Hz, 2H, OCCH2), 3.10 (t, 2H, J=12.40 Hz, O=CCH2), 7.01-
7.08 (m, 2H, 2 x Ar CH), 7.36-7.41 (m, H, Ar CH,) 8.60 (dd, J=1.60, 8.00 Hz, H, Ar CH); δC (100MHz; 
CDCl3) 21.6 (CH2), 23.4 (CH2), 39 (CH2), 112.9 (C), 114.8 (C), 117.5 (Ar CH), 119.9 (Ar CH), 131.9 (Ar CH), 
132.5 (Ar CH), 156.6 (C), 159.5 (C), 181.6 (C), 192.2 (C). The data reported above is in good agreement 
with the literature data.30 
3-(2-Hydroxyphenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 62 
 
Clear crystals (78%) M.p. 111-113°C; HRMS(EI+) C15H15NO3Na requires 280.0950 [M+Na]found 
280.0946, -1.0711 ppm; νmax (ATR)/cm
-1 1685 (C=O), 3103 (OH); δH (400MHz; CDCl3) 1.25 (s, 6H, 2 x 
CH3), 2.58 (s, 2H, OCCH2), 2.98 (s, 2H, O=CCH2), 7.04-7.12 (m, 2H, 2 x Ar CH), 7.39-7.43 (m, H, Ar CH,) 
8.67-8.69 (dd, J=1.60, 8.00 Hz, H, Ar CH); δC (100MHz; CDCl3) 28.1 (2 x CH3), 34.8 (C), 36.9 (CH2), 53.5 
(CH2), 112.8 (C), 113.8 (C), 117.5 (Ar CH), 119.8 (Ar CH), 131.9 (Ar CH), 132.5 (Ar CH), 156.7 (C), 159.5 
(C), 181.1 (C), 191.5 (C). 
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3-(2-Hydroxy-3-methoxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one  63 
 
Beige solid (50%) M.p. 112-114°C; HRMS(EI+) C14H13NO4Na requires 282.0742 [M+Na] found 282.0732 
-3.5452 ppm; νmax (DCM)/cm
-1 1692 (C=O), 3521 (OH); δH (400MHz; CDCl3) 2.29-2.32 (m, 2H,  CH2), 2.66 
(t, J=6.0 Hz, 2H, OCCH2), 3.13 (t, J=6.4 Hz ,2H, O=CCH2), 3.95 (s, 3H, OCH3), 6.99-7.03 (m, 2H, 2 x Ar CH) 
7.88 (d, J=6.00, H, Ar CH), 8.55 (broad s, H, Ar OH); δC (100MHz; CDCl3) 21.7 (CH2), 23.3 (CH2), 38.7 
(CH2), 56.1 (OCH3), 113.6 (C), 113.8 (Ar CH), 114.97 (C), 119.6 (Ar CH), 123.2 (Ar CH), 145.9 (C), 148.2 
(C), 158.6 (C), 181.6 (C), 192.2 (C). 
3-(2-Hydroxy-4-nitrophenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 64 
 
Pale yellow solid (23%) M.p. 159-161°C; HRMS(EI+) C13H11N2O5 requires 275.0668 [M+H], found 
275.0659 -3.2719 pmm; νmax (DCM)/cm
-1 1342 (NO2), 1691 (C=O), 3689 (OH); δH (400MHz; CDCl3) 2.33-
2.40 (m, 2H,  CH2), 2.77 (t, J=6.0 Hz, 2H, OCCH2), 3.19 (t, J=6.4 Hz ,2H, O=CCH2), 7.17 (d, J=8.80 Hz, H, Ar 
CH), 8.30 (dd, J=2.80, 8.80 Hz, H,  Ar CH,) 10.01 (d, J=2.80 Hz, H, Ar CH), 10.50 (broad s, H, Ar OH); δC 
(100MHz; CDCl3) 21.6 (CH2) 23.3 (CH2), 38.8 (CH2), 112.6 (C), 113.5 (C), 118.1 (Ar CH), 127.8 (Ar CH), 
128.9 (Ar CH), 139.8 (C), 158.7 (C), 162.1 (C), 182.1 (C), 192.8 (C).  
3-(3,5-Dichloro-2-hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 65 
 
Brown solid (19%) decomposes 133-135°C; νmax (DCM)/cm
-1 1692 (C=O), 3690 (OH); δH (400MHz; d6-
DMSO) 2.16-2.19 (m, 2H, CH2), 2.47-2.52 (m, 2H, OCCH2), 3.14 (t, J=6.00 Hz ,2H, O=CCH2), 7.41 (d, 
J=2.40 Hz, H, Ar CH), 7.71 (d, J=2.40, Ar CH,) 10.08 (broad s, H, Ar OH); δC (100MHz; CDCl3) 21.6 (CH2), 
23.4 (CH2), 38.9 (CH2), 114.7 (C), 115.8 (C), 123.1 (C), 124.6 (Ar CH), 130.0 (Ar CH), 132.4 (Ar CH), 151.4 
(C), 158.3 (C), 182.1 (C), 192.4 (C). This compound did not ionize under the mass spectrometery 
conditions. 
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3-(2-Fluoro-6-hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one  66 
 
White crystals (47%) M.p. 133-135°C; HRMS(EI+) C13H11NO3F  requires 248.0723 [M+H], found 
248.0716 -2.8218 ppm; νmax (DCM)/cm
-1 1692 (C=O),  3690(OH); δH (400MHz; CDCl3) 2.32 (quin, J=6.40 
Hz, 2H,  CH2), 2.70 (t, J=6.40 Hz, 2H, OCCH2), 3.15 (t, J=6.40 Hz ,2H, O=CCH2), 6.85 (td, J= 8.40, 5.20 Hz, 
H, Ar CH), 7.21-7.26 (m, Ar CH,) 8.39 (dt, J=8.00, 1.6 Hz, H, Ar CH), 9.49 (broad s, H, Ar OH); δC 
(100MHz; CDCl3) 21.6 (CH2), 23.3 (CH2), 38.9 (CH2), 114.9 (C), 115.3 (d, J=3 Hz C-F, Ar C), 118.7 (d, J=18 
Hz C-F, Ar CH), 119.6 (d, J=7 Hz C-F, Ar CH), 126.9 (d, J= 4Hz C-F, Ar CH), 145.2 (d, J=13 Hz C-F, Ar C), 
152.1 (d, J=240 Hz C-F, Ar CF), 158.1 (d, J=3 Hz C-F, Ar C) 181.9 (C), 192.4 (C).  
3-(2-Bromophenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 67 
 
Orange solid (36%) Mp 177-179°C; HRMS(EI+) C15H14NO2
79BrNa; requires 342.0105 [M+Na], found 
313.9782 -2.9239 ppm; νmax (ATR)/cm
-1 1606 (C=O), 2956 (C-H); δH (400MHz; CDCl3) 1.20 (s, 6H, 2 x 
CH3), 2.43 (s, 2H, CH2), 2.95 (s, 2H, CH2), 7.34-7.42 (m, 3H, 3 x Ar-H), 7.68-7.70 (dd, J=0.80, 7.60 Hz, 1H, 
Ar H); δC (100MHz; CDCl3) 28.4 (2x CH3), 31.4 (C), 37.0 (CH2), 52.5 (O=CCH2) 114.4 (C), 123.4 (C), 127.2 
(Ar CH), 129.1 (Ar C), 131.1 (Ar CH), 131.3 (Ar CH), 133.0 (Ar CH), 159.2 (C), 180.5 (C), 190.8(C). 
3-(2-Bromophenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 6830 
 
Brown solid (68%) Mp 78-82°C lit. 99°C30; HRMS(EI+) C13H10NO2
79BrNa; requires 313.9793 [M+Na], 
found 313.9782 -3.5034 ppm; νmax (ATR)/cm
-1 1684 (C=O), 2984 (C-H); δH (400MHz; CDCl3) 2.29-2.31 
(quintet, J=6.00 Hz, 2H, CH2), 2.53-2.57 (m, 2H, OCCH2), 3.08-3.12 (t, J=6.00 Hz, 2H, O=CCH2), 7.32-7.41 
(m, 3H, 3 x Ar-H), 7.67 (m, 1H, Ar H); δC (100MHz; CDCl3) 20.8 (CH3), 22.2 (CH2), 23.1 (CH2), 38.1 (CH2), 
115.3 (C), 123.3 (C), 129.1 (Ar C), 131.2 (Ar CH), 131.2 (Ar CH), 133.0 (Ar CH), 159.3 (C), 180.1 (C), 
191.3(C). The 1H and 13C spectra are in good agreement with literature data.30 
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3-(2-Bromo-6-hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 69 
 
Orange solid (16%) sublimes 157°C; MS(EI+) found 329.9726 [M+Na], C13H10NO3
79BrNa; requires 
329.9736 [M+Na]; νmax (ATR)/cm
-1 1672 (C=O), 2957 (C-H) and 3216 (OH); δH (400MHz; d6-DMSO) 2.15-
2.18 (m, 2H,  CH2), 2.45-2.50 (m, 2H, OCCH2), 3.10-3.14 (m, 2H, O=CCH2), 6.85-6.89 (dd, J=2.40, 8.00 
Hz, 1H, Ar-H), 7.13 (d, J=2.40 Hz, 1H, Ar H), 7.26-7.29 (d, J=8.00 Hz, 1H, Ar H); δC (100MHz; d6-DMSO) 
21.7 (CH2), 22.6 (CH2), 37.6 (O=CCH2), 114.5 (C), 119.1 (Ar C), 119.3 (Ar CH), 122.9 (Ar CH), 132.2 (Ar 
CH), 158.6  (C), 159.5 (C), 181.9 (C), 191.6 (C).  
3-(2-Hydroxyphenyl)-5,5-dimethyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 194 
 
Brown solid (57% as a mix of two isomers). Note the following data is for the above isomer only. 96-
97°C; HRMS(EI+) C15H16NO3 requires 258.1130 [M+H] found 258.1120 -3.8743 ppm; νmax (DCM)/cm
-1 
1683 (C=O), 3275 (OH); δH (400MHz; CDCl3) 1.27 (s, 6H, 2 x CH3), 2.13 (t, J=6.40 Hz, 2H, CH2), 3.12 (t, 
J=6.40 Hz, 2H, CH2), 7.03-7.10 (m, 2H, 2 x Ar CH), 7.38-7.40 (m, 2H, Ar CH), 8.55 (dd, J=8.00 1.60 Hz, H, 
Ar CH), 9.45 (broad s, H, OH); δC (100MHz; CDCl3) 20.50 (CH2), 24.2 (2 x CH3), 35.1 (CH2), 43.4 (C), 113.1 
(C), 113.2 (C), 117.6 (Ar CH), 119.8 (Ar CH), 131.9 (Ar CH), 132.5 (Ar CH), 156.4 (C), 160.0 (C), 180.3 (C), 
197.6 (C). 
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Optimised procedure for 2-(2-(prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 71 
 
3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61 (5.00 mMol), 3-bromoprop-1-ene 
(5.50 mMol) and freshly purified potassium iodide (1 mMol) were dissolved in dry THF (50 ml). To this, 
caesium carbonate (5.50 mMol) was added and the solution was heated to reflux for 18 hours. 
Following this, the reaction mixture was cooled to room temperature and quenched with 1M aqueous 
hydrochloric acid (25 mL). The reaction mixture was then extracted with DCM (3 x 25 mL) and the 
combind organic extracts were washed with 1M sodium hydroxide (2 x 75 mL) and brine (1 x 75 mL). 
This was then dried over magnesium sulfate, filtered and evaporated to dryness under reduced 
pressure to yield 2-(2-(Allyloxy)phenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 71 as a white solid (75%) 
which could be used without further purification. 
M.p 132-133°C; C15H15NO3Na; HRMS(EI+) requires 292.0950 [M+Na] found 292.0938 -4.1083 ppm; νmax 
(ATR)/cm-1 1681 (C=O); δH (400MHz; CDCl3) 2.26-2.34 (m, 2H, CH2) 2.64 (t, J=7.20 Hz, 2H, CH2), 3.06 (t, 
J=6.40 Hz, 2H, CH2), 4.67-4.69 (m, 2H, OCH2) 5.03-5.34 (dd, J=10.40, 1.60 Hz, H, cis-gem. CH2), 5.54-
5.60 (dd, J=17.20, 1.60 Hz, H, trans-gem. CH2), 6.04-6.13 (m, H, alkene CH), 6.94-7.11 (m, H, Ar CH), 
7.38-7.45 (m, H, Ar CH), 7.83 (dd, J=8.00, 1.60 Hz, H, Ar CH), 8.08 (dd, J=7.60, 1.60 Hz, H, Ar CH); δC 
(100MHz; CDCl3) 22.4 (2 x CH2), 38.0 (CH2), 69.4 (OCH2), 113.4 (Ar CH), 116.1 (C), 117.2 (gem. CH2), 
121.0 (Ar CH), 131.2 (Ar CH), 132.4 (Ar CH), 132.7 (alkene CH), 134.9 (C), 156.8 (C), 160.8(C), 163.0 (C), 
191.7 (C=O). 
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Un-optimised general procedure for one pot isoxazole to O-allyl benzoxazole transformation 
Hydroxyphenyl benzisoxazole (1.00 mMol) and 3-bromoprop-1-ene (1.10 mMol) were dissolved in dry 
THF (50 ml). To this, potassium carbonate (1.10 mMol) was added and the solution was heated to 
reflux for 18 hours. Following this, the reaction mixture was cooled to room temperature and 
quenched with 1M aqueous hydrochloric acid (25 mL). The reaction mixture was then extracted with 
DCM (3 x 25 mL) and the combined organic extracts were washed with 1M sodium hydroxide (2 x 75 
mL) and brine (1 x 75 mL). This was then dried over magnesium sulfate, filtered and evaporated to 
dryness under reduced pressure to yield the desired O-allyl benzoxazole which could be used without 
further purification. 
2-(2-(Prop-2-enyloxy)phenyl)-6-methyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one 156 
 
White solid (40%), m.p. 109-111°C; HRMS C17H17O3NNa requires 306.1106 [M+Na] found 306.1095 -
3.5935 ppm;  νmax (ATR)/cm
-1) 1679 (C=O); δH (400MHz; CDCl3) 1.24 (d, J=6.40 Hz, 3H, CH3), 2.41 (dd, J= 
16.00, 11.20 Hz, H, CH), 2.55-2.77 (m, 3H, 3 x CH), 3.12 (dd, J=16.80, 4.40 Hz, 1 H, CH), 4.68 (d, J=4.80 
Hz, 2H, OCH2),  5.33 (dd, J=10.10, 1.60Hz, 2H, cis-gem. CH2), 5.58 (dd, J=17.20, 1.60 Hz, H, trans-gem. 
CH2), 6.05-6.14 (m, H, alkene CH), 7.01-7.07 (m, 2H, 2 x Ar CH), 7.41-7.46 (m, H, Ar CH), 8.07 (dd, 
J=8.00, 2.00 Hz, H, Ar CH); δC (100MHz; CDCl3) 21.1 (CH3), 30.3 (CH2), 30.8 (CH), 46.3 (CH2), 69.3 
(OCH2), 113.3  (Ar CH), 116.0 (C), 117.2 (CH), 120.9 (Ar CH), 131.1 (Ar CH), 132.4 (Ar CH), 132.7 (Alkene 
CH), 134.7 (C), 156.8 (C), 161.4 (C), 163.7 (C), 191.3 (C=O). 
2-(2-(Prop-2-enyloxy)phenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one 157 
 
White solid (63%), M.p. 64-66°C;  νmax (ATR)/cm
-1) 1694 (C=O); HRMS C18H20O3NNa requires 298.1443 
[M+H] found 298.1438 -1.6770 ppm; δH (400MHz; CDCl3) 1.16 (s, 6H, 2 x CH3), 2.45 (s, 2H, CH2), 2.86 (s, 
2H, CH2), 4.60-4.68 (m, 2H, OCH2), 5.27 (dd, J=10.80, 1.60 Hz, H, gem. CH2), 5.54 (dd, J=15.60 Hz, 1.60 
Hz, H, gem. CH2), 6.00-6.07 (m, H, alkene CH), 6.95-7.01 (m, 2H, 2 x Ar CH), 7.35-7.39 (m, H, Ar CH), 
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8.04 (dd, J=8.00, 2.00 Hz, H, Ar CH); δC (100MHz; CDCl3) 29.2 (2 x CH3), 36.0 (C), 36.7 (CH2), 52.8 (CH2), 
69.4 (CH2), 113.8 (Ar CH), 116.4 (C), 117.5 (gem. CH2), 121.4 (Ar CH), 131.5 (Ar CH), 132.9 (Ar CH), 
133.2 (alkene CH), 134.4 (C), 157.2 (C), 161.6 (C), 163.7 (C). 
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Dimorpholine azodicarboxamide 81129 
 
Morpholine (50.25 g, 575 mMol) was slowly added to a solution of diethyl azodicarboxylate 74 (50.00 
g, 287 mMol) in diethylether (1 L)   at 0°C; this mixture was then stirred under an atmosphere of 
nitrogen for 4 hours. The reaction mixture was then filtered under suction to yield diazene-1,2-
diylbis(morpholinomethanone) 81 (48.49 g, 66%) as an orange solid which was used without further 
purification.  
M.p. 138-140°C lit. 140-141°C89; HRMS(EI+) C10H16O4N4Na requires 279.1069 [M+Na] found 279.1060 -
3.2246 ppm; νmax (DCM)/cm
-1) 1439 (N=N), 1706 (C=O); δH (400MHz; CDCl3) 3.60-3.62 (m, H, CH), 3.71-
3.77 (m, 2H, 2 x CH), 3.81-3.84 (m, H, CH); δC (100MHz; CDCl3) 42.5 (CH2), 44.1 (CH2), 65.1 (CH2), 65.2 
(CH2), 159.3 (C). The data above is in good agreement with literature data.
89,130  
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General Procedure for Benzisoxazole O-alkylation 
DMDC (54.5 mMol) was added to a solution of phenolic benzisoxazole (21.8 mMol), prop-2-en-1-ol 
(54.5 mMol) and triphenylphosphine (54.5 mMol) in dry THF (360 mL) at 0°C. This mixture was then 
allowed to stir overnight while slowly warming to room temperature. Following that, the mixture was 
cooled to 0°C and filtered through a prepacked ISOLUTE SCX-2 column with two column lengths of 
THF. The filtrate was then dried over magnesium sulfate and concentrated under reduced pressure. 
The crude product was then purified via flash column chromatography using light petroleum:ethyl 
acetate (1:1 v/v) as an eluent to yield the desired O-alkyl benzisoxazole. 
3-(2-(Prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 
 
Orange gel (99%); HRMS(EI+) C16H16O3N requires 270.1130 [M+H] found 270.1122 -2.9617 ppm; νmax 
(ATR)/cm-1) 1687 (C=O); δH (600 MHz, CDCl3) 1.96 (dd, J = 12.90, 6.30 Hz, 2H, CH2), 2.24-2.32 (m, 2H, 
CH2, OCCH2), 2.78 (t, J = 6.30 Hz, 2H, O=CCH2),  4.41 (dd, J = 5.00, 1.30 Hz, 2H, OCH2), 5.05 (dd, J = 
10.60, 1.50 Hz, H, cis-gem CH2), 5.17 (dd, J = 17.20, 1.70 Hz, H, trans-gem. CH2), 5.71-5.85 (m, H, alkene 
CH), 6.85-6.95 (m, 2H, 2 x Ar CH), 7.26-7.31 (m, H, Ar CH), 7.33 (dd, J = 7.50, 1.70 Hz, H, Ar CH); δC (150 
MHz, CDCl3) 22.0 (CH2), 23.0 (CH2), 38.1 (CH2), 69.0 (OCH2), 112.5 (Ar CH), 115.5 (C), 116.7 (gem. CH2), 
117.4 (C), 120.4 (Ar CH), 130.3 (Ar CH), 131.5 (Ar CH), 133.2 (Alkene CH), 157.0 (C), 157.3 (C), 180.8 
(Isoxazole CO), 191 (C=O).   
 
 
 
 
 
 
 
 
 
149 
 
3-(2-(Prop-2-enyloxy)phenyl)-6-methyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 84 
 
Yellow gel (83%); HRMS(EI+) C17H18O3N requires 284.1287 [M+H] found 284.1275 -4.2234 ppm; νmax 
(ATR)/cm-1) 1689 (C=O); δH (400 MHz, CDCl3) 1.12 (d, J=6.40 Hz, 3H, CH3), 2.21 (dd, J=15.60, 5.20 Hz, H, 
CH), 2.41-2.50 (m,  2H, 2 x CH), 2.60 (dd, J=17.20, 9.60, H, CH), 3.07 (dd, J=4.80, 17.20 Hz, H, CH), 4.50 
(dd, J=4.80, 0.80 Hz, 2H, OCH2), 5.14 (dd, J=10.40, 1.60 Hz, H, cis-gem. CH2), 5.24 (dd, J=17.20, 1.60 Hz, 
H, trans-gem. CH2), 5.83-5.92 (m, H, alkene CH), 6.95-7.01 (m, 2H, 2 x Ar CH), 7.36-7.41 (m, 2H, 2 x Ar 
CH); δC (100 MHz, CDCl3) 20.7 (CH3), 30.4 (CH), 30.9 (CH2), 46.7 (CH2), 69.1 (OCH2), 112.4 (Ar CH), 115.4 
(C), 116.9 (gem. CH2), 117.2 (C), 120.5 (Ar CH), 130.4 (Ar CH), 131.6 (Ar CH), 133.2 (Alkene CH), 157.0 
(C), 157.4 (C), 180.5 (Isoxazole CO), 191.0 (C=O). 
3-(2-(But-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 77 
 
Beige solid (83%) M.p. 79-81°C; HRMS(EI+) C17H18O3N requires 284.1287 [M+H] found 284.1277 -
3.5195 ppm; νmax (ATR)/cm
-1) 1685 (C=O); δH (400 MHz, CDCl3)  2.23 (quintet, J=6.40 Hz, 2H, CH2), 2.40 
(quartet, 6.80 Hz, 2H, CH2), 2.54 (t, J=6.40, 2H, CH2), 3.09 (t, J=6.40, 2H, CH2), 4.04 (t, J=6.80 Hz, CH2), 
5.01-5.10 (m, 2H, gem. CH2), 5.73-5.83 (m, H, alkene CH), 6.99 (d, J=8.80 Hz, H, Ar CH), 7.04 (dd, 
J=7.60, 1.20 Hz, 1 H, Ar CH), 7.41-7.48 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 22.3 (CH2), 23.3 (CH2), 
33.6 (CH2), 38.4 (CH2), 67.4 (OCH2), 111.8 (Ar CH), 115.8 (C), 116.8 (Gem. CH2), 117.0 (C), 120.4 (Ar CH), 
130.5 (Ar CH), 131.6 (Ar CH), 134.6 (Alkene CH), 157.3 (C), 157.7 (C), 180.4 (Isoxazole CO), 191.3 (C=O). 
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3-(2-(Pent-4-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 82 
 
Beige solid (74%) M.p. 57-58°C; HRMS(EI+) C18H19O3NNa requires 320.1263 [M+Na] found 320.1253 -
3.1238 ppm; νmax (ATR)/cm
-1) 1691 (C=O); δH (500 MHz, CDCl3) 1.63 – 1.74 (m, 2H, CH2), 1.97-2.07 (m, 
2H, CH2), 2.09-2.17 (m, 2H, CH2), 2.39-2.46 (m, 2H, CCH2), 2.94 (t, J=6.30 Hz, 2H, CH2), 3.94 (t, J=6.40 
Hz, OCH2), 4.82-5.05 (m, 2H, gem. CH2), 5.75 (m, H, alkene CH), 6.93-6.97 (m, 2H, 2 x Ar CH), 7.36-7.39 
(m, 2H, 2 x Ar CH); δC (125 MHz, CDCl3) 22.2 (CH2), 23.1 (CH2), 28.3 (CH2), 30.0 (CH2), 38.2 (CH2), 67.3 
(OCH2), 111.8 (Ar CH), 115.0 (gem. CH2), 115.7 (C), 117.1 (C), 120.1 (Ar CH), 130.3 (Ar CH), 131.5 (Ar 
CH), 137.8 (Alkene CH), 157.4 (C), 157.6 (C), 180.1 (Isoxazole CO), 191.3 (C=O). 
3-(2-(Hex-5-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 83 
 
Brown gel (94%); HRMS(EI+) C19H22O3N requires 312.1560 [M+H] found 312.1598 12.1734 ppm; νmax 
(ATR)/cm-1) 1689 (C=O); δH (400 MHz, CDCl3)  1.37-1.48 (m, 2H, CH2), 1.62 (quintet, J=6.40 Hz, 2H, CH2), 
1.99-2.09 (m, 2H, CH2), 2.47 (t, J=5.60 Hz, 2H, CH2), 3.00-3.02 (m, 2H, CH2), 3.96 (t, J=6.40, 2H, OCH2), 
4.92-5.01 (m, 2H, gem. CH2), 5.72-5.79 (m, H, alkene CH), 6.95-7.00 (m, 2H, 2 x Ar CH), 7.37-7.43 (m, 
2H, 2 x Ar CH); δC (100 MHz, CDCl3) 22.2 (CH2), 23.2 (CH2), 25.2 (CH2), 28.3 (CH2), 33.4 (CH2), 38.2 (CH2), 
68.6 (OCH2), 111.7 (Ar CH), 114.7 (Gem. CH2), 115.7 (C), 116.9 (C), 120.1 (Ar CH), 130.3 (Ar CH), 131.6 
(Ar CH), 138.5 (Alkene CH), 157.4 (C), 157.6 (C), 180.5 (Isoxazole CO), 191.4 (C=O). 
 
 
 
 
151 
 
3-(2,2,2-Trichloro-1-iminoethoxy)prop-1-ene 8690 
 
2,2,2-Trichloroacetonitrile 82 (9.82 g, 68.2 mMol) was added to a solution of 1,8-
diazabicyclo[5.4.0]undec-7-ene (10.5 g, 68.2 mMol)  in dichloromethane (100 ml) and cooled to 0°C. 
To this prop-2-en-1-ol (2.00 g, 2.34 ml, 34.5 mMol) was slowly added; following this the reaction 
mixture was stirred at 0°C for 1 hour. The insoluble material was then filtered off and the reaction 
mixture concentrated under reduced pressure. The crude product was purified by flash 
chromatography using light petroleum:ethyl acetate (95:5 v/v) as eluent to yield 3-(2,2,2-trichloro-1-
iminoethoxy)prop-1-ene 83 as a clear oil (12.6 g, 80%). This compound slowly decomposed over time.  
δH (400MHz; CDCl3) 4.81-4.83 (m, 2H, CH2), 5.32 (dd, J=1.20, 10.40 Hz, H, cis-gem. CH2), 5.84 (dd, 
J=1.20, 17.20 Hz, H, trans-gem. CH2), 5.99-6.10 (m, H, alkene CH), 8.34 (broad s, H, NH); δC (100MHz; 
CDCl3) 69.4 (OCH2), 91.4 (CCl3), 118.5 (gem. CH2), 131.4 (Alkene CH), 162.4 (C=N). The data above is in 
good agreement with literature data.90 
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3-([1,1'-Biphenyl]-2-yl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 87 
 
Tetrakis(triphenylphospine)palladium (0.120 g, 0.103 mMol) and 3-(2-bromophenyl)-6,7-
dihydrobenzo[d]isoxazol-4(5H)-one 4 (0.300 g, 1.03 mMol)  were added to degassed dimethoxyethane 
(DME) (10 mL) and the solution was purged with nitrogen for 10 minutes. Two separated solutions of 
phenylboronic acid (0.180 g, 1.55 mMol) in ethanol (10 mL) and aqueous sodium carbonate (1.04 mL, 
2.06 mMol) were degassed with nitrogen and added to the reaction mixture sequentially. The reaction 
mixture was then heated at reflux for 18 hours; following this the reaction was diluted with water (50 
mL) and the mixture was extracted with ethyl acetate (3 x 50 mL), dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude product was purified using column 
chromatography with light petroleum:ethyl acetate (15:75 v/v) eluent  to yield 3-([1,1'-biphenyl]-2-yl)-
6,7-dihydrobenzo[d]isoxazol-4(5H)-one 84 (0.241 g, 81%) as a yellow solid. 
MS(EI+) C19H16NO2; requires 290.1181 [M+H], found 290.1179 -0.6894 ppm; νmax (ATR)/cm
-1 1684 
(C=O); δH (400MHz; CDCl3) 2.26-2.32 (m, 2H, CH2), 2.55-2.58 (m, 2H, CH2), 3.11 (t, J=6.33 Hz, 2H, CH2), 
7.24 (m, H, Ar CH), 7.34-7.63 (m, 5H, 5 x Ar CH), 7.71 (d, J=7.60 Hz,  H, Ar CH), 8.27-8.27 (m, H, Ar CH). 
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General procedure for preparation of O-alkyl-C-allyl benzisoxazoles alpha to the isoxazole  
O-Alkyl benzisoxazole (1 mMol) was dissolved in anhydrous THF (10 mL) and cooled to -78°C under an 
atmosphere of nitrogen. Following this, lithium bis(trimethylsilyl)amide (1.01 mMol) was slowly added 
to ensure the temperature remained below -70°C. This mixture was kept at -78°C for 1 hour before 
being warmed to 0°C. After an hour at this temperature a solution of 3-bromoprop-1-ene (1.00 mMol) 
and freshly purified potassium iodide (1.00 mmol) in dry THF (10 mL) at 0°C was slowly added and the 
reaction mixture was allowed to warm to room temperature overnight. Saturated ammonium 
chloride solution (10 mL) was then added to the solution and it was allowed to stir for 30 minutes 
under an open atmosphere. The mixture was then diluted with DCM (30 mL) and water (10mL), the 
organic layer was separated and washed with water (10mL) and saturated sodium chloride solution 
(10mL). The organic layer was dried over magnesium sulfate and concentrated under reduced 
pressure. The crude product was purified via flash column chromatography using light petrol:ethyl 
acetate:dichloromethane (5:1:4 v/v/v) as eluent to yield a mixture of C-allylated-O-alkyl 
benzisoxazoles. 
7- Prop-2-enyl-3-(2-(prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 88 
 
Yellow oil (56%); MS(EI+) C19H20NO3; requires 310.1443 [M+H] found 310.1435 -2.5794 ppm; νmax 
(ATR)/cm-1 1688 (C=O); δH (500 MHz, CDCl3) 1.80-1.89 (m, H,CH), 2.05-2.09 (m, H, CH), 2.13-2.22 (m, H, 
CH), 2.33-2.36 (m, H, CH), 2.50-2.54 (m, H, CH), 2.86-3.00 (m, 2H, CH2), 4.35-4.47 (m, 2H, OCH2), 4.91-
5.00 (m, 2H, gem. CH2),  5.06 (dd, H, J=10.60, 1.40 Hz, cis-gem. CH2), 5.16 (dd, H, J=17.10, 1.20 Hz, 
trans-gem. CH2), 5.60-5.71 (m, H, alkene CH), 5.79 (m, H, alkene), 6.82-6.95 (m, 2H, 2 x Ar CH), 7.28-
7.32 (2H, m, 2 x Ar CH); δC (125 MHz, CDCl3) 21.3 (CH2), 26.0 (CH2), 32.2 (CH2), 45.5 (CH) 68.1 (OCH2), 
111.3 (Ar CH), 114.4 (C), 115.9 (gem. CH2), 116.1 (gem. CH2), 116.20 (C), 119.5 (Ar CH), 129.4 (Ar CH), 
130.5 (Ar CH), 132.2 (Alkene CH), 134.8 (Alkene CH), 156 (C), 157 (C), 179 (Isoxazole CO), 191 (C=O). 
Both the high resolution mass and NMR spectra indicated the presence of other multiply allylated 
materials. 
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7- Prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 90 
 
Yellow oil (28%); MS(EI+) C20H22NO3; requires 324.1560 [M+H] found 324.1593 10.1802 ppm; νmax 
(ATR)/cm-1 1688 (C=O); δH (400 MHz, CDCl3) 1.90-1.96 (m, H,CH), 2.08-2.47 (m, 5H, 5 x CH), 2.62-2.69 
(m, 1 H, CH), 2.91-3.10 (m, 2H, CH2), 3.97-4.03 (m, 2H, OCH2), 4.96-5.10 (m, 4H, 2 x gem. CH2), 5.68-
5.79 (m, 2H, 2 x alkene CH), 6.94-7.00 (m, 2H, 2 x Ar CH), 7.36-7.42 (m, 2 x Ar CH); δC (100 MHz, CDCl3) 
22.5 (CH2), 27.2 (CH2), 33.2 (CH2), 33.6 (CH2), 46.7 (CH), 67.4 (OCH2), 111.9 (Ar CH), 115.5 (Gem. CH2), 
116.8 (C), 117.2 (Gem. CH2), 117.3 (C), 120.3 (Ar CH), 130.4 (Ar CH), 131.6 (Ar CH), 134.5 (Alkene CH), 
135.9 (Alkene CH), 157.3 (C), 157.9 (C), 180.0 (Isoxazole CO), 192.4 (C=O). 
Both the high resolution mass and NMR spectra indicated the presence of other multiply allylated 
materials. 
 
7- Prop-2-enyl-3-(2-(pent-4-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 91 
 
Yellow oil (42%);  MS(EI+) C21H23NO3Na; requires 360.1576 [M+Na] found 360.1571 -1.3883 ppm; νmax 
(ATR)/cm-1 1688 (C=O); δH (400 MHz, CDCl3) 1.65-1.75 (m, 2H, CH2), 1.94-2.34 (m, 5H, 5 x CH), 2.42-
2.70 (m, 3H, 3 x CH), 3.00-3.15 (m, 2H, CH2), 3.93-4.01 (m, 2H, OCH2), 4.92-5.22 (m, 4H, 2 x gem. CH2), 
5.68-5.80 (m, 2H, 2 x Alkene CH), 7.00-7.03 (m, 2H, 2 x Ar CH), 7.34-7.45 (m, 2 H, 2 x Ar CH); δC (100 
MHz, CDCl3) 22.5 (CH2), 27.1 (CH2), 28.3 (CH2), 30.1 (CH2), 39.2 (CH2), 46.7 (CH), 67.4 (OCH2), 111.8 (Ar 
CH), 115.1 (C), 117.3 (gem. CH2), 118.6 (gem. CH2), 120.2 (Ar CH), 130.4 (Ar CH), 131.6 (Ar CH), 133.6 
(Alkene CH), 135.9 (C), 137.8 (Alkene CH), 157.4 (2 x C), 179.9 (Isoxazole CO), 192.4 (C=O). 
Both the high resolution mass and NMR spectra indicated the presence of other multiply allylated 
materials. 
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7- Prop-2-enyl-3-(2-(hex-5-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 92 
 
Yellow oil (24%);  MS(EI+) C22H25NO3Na; requires 374.1732 [M+Na] found 374.1728 -1.0690 ppm; νmax 
(ATR)/cm-1 1688 (C=O); δH (400 MHz, CDCl3) 1.36-1.45 (m, 2H, CH2), 1.57-1.68 (m, 2H, CH2), 1.87-2.37 
(m, 5H, 5 x CH), 2.45-2.52 (m, H, CH), 2.68-2.73 (m, H, CH), 3.02-3.13 (m, H, CH2), 3.94-4.02 (m, 2H, 
OCH2), 4.89-5.14 (m, 4H, 2 x gem. CH2), 5.73-5.84 (m, 2H, 2 x alkene CH), 6.90-7.08 (m, 2H, 2 x Ar CH), 
7.38-7.55 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 22.5 (CH2), 24.8 (CH2), 27.1 (CH2), 28.6 (CH2), 33.2 
(CH2), 33.4 (CH2), 46.6 (CH), 67.8 (OCH2), 117.3 (Ar CH), 114.7 (gem. CH2), 115.5 (C), 116.9 (C), 117.2 
(gem. CH2), 120.2 (Ar CH), 130.2 (Ar CH), 131.5 (Ar CH), 135.9 (alkene CH), 138.5 (alkene CH), 157.4 (C), 
157.8 (C), 179.9 (isoxazole CO), 192.4 (C=O). 
Both the high resolution mass and NMR spectra indicated the presence of other multiply allylated 
materials. 
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3-(2-(Prop-2-enyloxy)phenyl)-4-((triisopropylsilyl)oxy)-6,7-dihydrobenzo[d]isoxazole 95 
 
A solution of 3-(2-(prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (1.00 g, 3.72 
mMol) in anhydrous THF (50 mL), was prepared and cooled to -78°C under an atmosphere of nitrogen. 
Following this, lithium bis(trimethylsilyl)amide (4.08 mL, 4.08 mMol) was slowly added, this addition 
was tapered to ensure the temperature remained under -70°C. After an hour at this temperature 
triisopropyl triflate (1.14 g, 3.72 mMol) was added and the reaction mixture was allowed to warm to 
room temperature overnight. Following this saturated ammonium chloride solution (10 mL) was 
added to the solution and it was allowed to stir for 30 minutes under an open atmosphere. The 
mixture was then diluted with DCM (25 mL) and water (25mL), the organic layer was separated and 
washed with water (25mL) and saturated sodium chloride solution (25mL). The organic layer was dried 
over magnesium sulfate and concentrated under reduced pressure. The crude product was then 
purified via flash column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to yield 3-
(2-(prop-2-enyloxy)phenyl)-4-((triisopropylsilyl)oxy)-6,7-dihydrobenzo[d]isoxazole 95 (1.17g, 74%) as a 
brown oil.  Compound slowly decomposes in air. 
HRMS(EI+) C25H36O3NSi requires 426.2464 [M+H] found 426.2460 -0.9384 ppm; νmax (DCM)/cm
-1) 1596 
(Si-O); δH (500 MHz, CDCl3) 0.67 (m, 2H, 6 x CH3, 3 x CH), 2.43 (td, J=8.70, 4.50 Hz, 2H, CH2), 2.76 (t, 
J=8.70 Hz, 2H, CH2), 4.62 (t, J=4.50 Hz, H, alkene CH),  5.05 (dd, J=10.70, 1.30 Hz, H, cis-gem. CH2), 5.21 
(dd, J=17.30, 1.30 Hz, H, trans-gem. CH2), 5.84 (m, H, alkene CH), 6.80 (d, J=8.30 Hz, H, Ar CH), 6.87 (t, 
J=7.40 Hz, H, Ar CH), 7.20-7.26 (m, H, Ar CH), 7.30 (dd, J=7.40, 1.40 Hz, 2H).  
 
 
 
 
 
 
157 
 
Diethyl 3-(2-(prop-2-enyloxy)phenyl)-4-oxo-6,7-dihydrobenzo[d]isoxazole-5,5(4H)-dicarboxylate 98 
 
 A solution of 3-(2-(prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (0.250 g, 0.93 
mMol) in anhydrous THF (20 mL), was prepared and cooled to -78°C under an atmosphere of nitrogen. 
Following this, lithium bis(trimethylsilyl)amide (0.93 mL, 0.93 mMol) was slowly added, this addition 
was tapered to ensure the temperature remained under -70°C. After an hour at this temperature ethyl 
chloroformate (0.101 g, 0.93 mMol) was added and the reaction mixture was allowed to warm to 
room temperature overnight. Following this saturated ammonium chloride solution (10 mL) was 
added to the solution and it was allowed to stir for 30 minutes under an open atmosphere. The 
mixture was then diluted with DCM (20 mL) and water (20 mL), the organic layer was then separated 
and washed with water (20 mL) and saturated sodium chloride solution (20mL). The organic layer was 
dried over magnesium sulfate and concentrated under reduced pressure. The crude product was then 
purified via flash column chromatography using light petroleum:ethyl acetate (1:1 v/v) as eluent to 
yield diethyl 3-(2-(prop-2-enyloxy)phenyl)-4-oxo-6,7-dihydrobenzo[d]isoxazole-5,5(4H)-dicarboxylate 
98 (73 mg, 20%) as a clear oil. 
MS(EI+) C22H23NO7Na requires 436.1372 [M+Na] found 436.1366 -1.3757 ppm; νmax (ATR)/cm
-1 1687 
(C=O); δH (400 MHz, CDCl3) 1.24 (t, J=7.20, 6H, 2 x CH3), 2.84 (t, J=6.00, 2H, CH2), 3.07 (t, J=6.00 Hz, 2H, 
CH2), 4.17-4.30 (m, 4H, 2 x CH2), 4.57 (d, J=5.20 Hz, 2H, OCH2), 5.18 (dd, J=10.40, 1.20 Hz, H, cis-gem. 
CH2), 5.28 (dd, J=17.60, 1.20 Hz, H, trans-gem. CH2), 5.90-5.99 (m, H, alkene CH), 6.96-7.00 (m, 2H, 2 x 
Ar CH), 7.37-7.41 (m, 2H, 2 x Ar CH);δC (100 MHz, CDCl3) 14.0 (2 x CH3), 20.1 (CH2), 29.6 (CH2), 62.6 (2 x 
CH2), 67.1 (C), 69.7 (OCH2), 112.7  (Ar CH), 114.9 (C), 116.6 (C), 117.2 (gem. CH2), 120.6 (Ar CH), 130.8 
(Ar CH), 131.8 (Ar CH), 133.5 (alkene CH), 157.3 (C), 158.2 (C), 167.0 (C), 179 (C), 182.8 (C). 
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2-(4-(((Trifluoromethyl)sulfonyl)oxy)-6,7-dihydrobenzo[d]isoxazol-3-yl)phenyl 
trifluoromethanesulfonate 101 
 
Triflic anhydride (1.47 mL, 8.73 mMol) was added drop wise to a solution of 3-(2-hydroxyphenyl)-6,7-
dihydrobenzo[d]isoxazol-4(5H)-one 61 (1.00g, 4.37 mMol) and pyridine  (0.70 mL, 8.73 mMol) in 
dichloromethane (50 mL) at 0°C. After 18 hours the reaction mixture was quenched with saturated 
ammonium chloride (25 mL) and separated. The organic layer was washed with 1M sodium hydroxide 
solution (2 x 25 mL) and saturated sodium chloride solution (50 mL). The organic layer was then dried 
over sodium sulfate, filtered and concentrated under reduced pressure. The crude product was then 
purified via flash column chromatography using light petroleum:ethyl acetate (1:1 v/v) as eluent to 
yield 2-(4-(((trifluoromethyl)sulfonyl)oxy)-6,7-dihydrobenzo[d]isoxazol-3-yl)phenyl 
trifluoromethanesulfonate 101 as a brown gel (0.93g , 43%). 
MS(EI+) C15H10NO7F6S2 requires 493.9803 [M+H] found 493.9807 1.0122  ppm; νmax (ATR)/cm
-1 1134 
(S=O), 1423 (SO); δH (400 MHz, CDCl3) 2.78-2.83 (m, 2H, CH2), 3.09 (t, J=9.20, 2H, CH2), 5.78 (t, J=4.40 
Hz, H, alkene CH), 7.46-7.81 (m, 4H, 4 x Ar CH); δC (100 MHz, CDCl3) 20.8 (CH2), 23.2 (CH2), 109.6 (C), 
113.1 (Alkene CH), 121.8 (C), 121.9 (Ar CH), 128.7 (Ar CH), 132.2 (Ar CH), 132.4 (Ar CH),139.9 (C), 147.3 
(C), 152.5 (C), 172.3 (C), CF3 quaternary carbon atoms could not be detected in time allocated for this 
experiment; δF (376 Mhz, CDCl3) 88.13 (CF3), 88.35 (CF3). 
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3-(2-(Prop-2-enyloxy)phenyl)-6,7-dihydro-5H-spiro[benzo[d]isoxazole-4,2'-[1,3]dioxolane] 107 
 
3-(2-(Allyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (1.00 g, 3.72 mMol) was added to a 
solution of ethylene glycol (0.46 g, 7.43 mMol) and para-toluenesulfonic acid (0.035 g, 0.186 mMol) in 
dry toluene (40 mL) and heated under Dean-Stark conditions for 18 hours. The reaction mixture was 
allowed to cool to room temperature, after which it was diluted with water (40 mL) and extracted. The 
organic extracts were then washed with water (40 mL) and saturated sodium chloride solution (40 mL) 
before being dried over magnesium sulfate and concentrated under reduced pressure to yield 3-(2-
(prop-2-enyloxy)phenyl)-6,7-dihydro-5H-spiro[benzo[d]isoxazole-4,2'-[1,3]dioxolane] 107 (1.02 g, 88%) 
as a yellow oil.  
MS(EI+) C18H19NO4Na requires 336.1212 [M+H] found 336.1206 -1.7851  ppm; δH (500 MHz, CDCl3) 
1.70-1.78 (m, 2H, CH2), 1.85-1.96 (m, 2H, CH2), 2.64 (t, J=6.30 Hz, 2H, CH2), 3.20 (t, J=6.50 Hz, 2H, 2 x 
eq. CH), 3.61 (t, J=6.50 Hz, 2H, 2 x ax. CH), 4.45 (d, J=4.90 Hz, 2H, OCH2), 5.06 (dd, J=10.60, 1.10 Hz, H, 
cis-gem. CH2), 5.21 (dd, J=17.30, 1.10 Hz, H, trans-gem. CH2), 5.85 (m, H,  alkene CH), 6.86 (m, 2H, 2 x 
Ar CH), 7.20-7.27 (m, 2H, Ar CH); δC (125 MHz, CDCl3) 19.6 (CH2), 21.6 (CH2), 34.1 (CH2), 63.9 (2 x OCH2), 
68.4 (OCH2), 104.8 (C), 111.8 (Ar CH), 114.6 (C), 115.9 (gem. CH2), 118.3 (C), 119.1 (Ar CH), 129.4 (Ar 
CH), 130.4 (Ar CH), 132.3 (alkene CH), 155.6 (Ar C), 156.8 (C), 170.0 (isoxazole CO). 
Both the mass and NMR spectra indicated the presence of starting 3-(2-(Prop-2-enyloxy)phenyl)-6,7-
dihydrobenzo[d]isoxazol-4(5H)-one following multiple purification attempts. 
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3-(2-(Prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 108 
 
Sodium borohyride method 
3-(2-(Prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (0.294g, 1.09 mMol) was 
dissolved in ethanol (20 mL). Sodium borohydride (0.041g, 1.09 mMol) was added and the mixture 
was heated at reflux for 18 hours. The reaction mixture was then quenched with water (10 mL) and 
washed three times with dichloromethane (3 x 10 mL). The combined organic extracts were then 
washed with saturated sodium chloride solution (30 mL), dried over magnesium sulfate, filtered and 
concentrated under reduced pressure to yield 3-(2-(prop-2-enyloxy)phenyl)-4,5,6,7-
tetrahydrobenzo[d]isoxazol-4-ol 108 as a cream solid (0.271g. 92%). 
Lithium aluminium hydride method 
3-(2-(Prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (0.203g, 0.755 mMol) was 
dissolved in dry diethyl ether (10 mL) and cooled to 0°C. Lithium aluminium hydride (0.029g, 0.755 
mMol) was carefully added  and the solution was allowed to warm to room temperature. After six 
hours the reaction mixture was diluted with diethyl ether (20 mL), quenched with water (10%) in THF 
and washed with 1M sodium hydroxide (1M), water (2 x 10mL) and saturated sodium chloride solution 
(10 mL). The organic layer was then dried over magnesium sulfate, filtered and concentrated under 
reduced pressure to yield 3-(2-(prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 108 as 
a cream solid (0.156g. 76%). 
MS(EI+) C160H18NO3 requires 272.1286 [M+H] found 272.1281 -1.8374 ppm; νmax (ATR)/cm
-1 3334 (OH); 
δH (400 MHz, CDCl3) 1.59-1.65 (m, H, CH), 1.78-1.88 (m, 2H, 2 x CH), 2.03-2.13 (m, H, CH), 2.55-2.63 (m, 
H, CH), 2.76-2.81 (m, H, CH), 3.09 (broad s, H, OH), 4.49-4.58 (m, 2H, OCH2), 4.64 (s, H, CH), 5.23 (d, 
J=10.40 Hz, H, cis-gem. CH2), 5.31 (d, J=16.80 Hz, H, trans-gem. CH2), 5.88-5.98 (m, H, alkene CH), 6.94-
7.02 (m, 2H, 2 x Ar CH), 7.34-7.42 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 17.5 (CH2), 22.9 (CH2), 31.1 
(CH2), 61.2 (CH), 70.2 (OCH2), 113.3 (Ar CH), 116.3 (C), 119.0 (C), 119.2 (gem. CH2), 121.8 (Ar CH), 131.3 
(CH), 131.7 (CH), 132.2 (CH), 155.8 (C), 159.1 (C), 169.7 (C). 
 
 
 
161 
 
General procedure for hydrazone formation 
O-Alkyl benzisoxazole (1 mMol), N,N-dimethylhydrazine (10 mMol) and trifluoroacetic acid were 
dissolved in toluene (25 mL) and heated under Dean-Stark conditions for six hours. Following this the 
reaction mixture was allowed to cool to room temperature, upon which it was washed with water (2 x 
25 mL) and brine (25 mL), dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The crude product was purified via column chromatography using light petroleum:ethyl 
acetate (4:6 v/v) as a solvent. 
3-(2-(Prop-2-enyloxy)phenyl)-4-(2,2-dimethylhydrazono)-4,5,6,7-tetrahydrobenzo[d]isoxazole 110 
 
Orange gel (68%); MS(EI+) C18H22N3O2 requires 312.1712 [M+H] found 312.1701 -3.5237 ppm; νmax 
(ATR)/cm-1 1628 (C=N); δH (400 MHz, CDCl3) 2.02-2.05 (m, 2H, CH2), 2.30 (s, 6H, 2 x CH3), 2.65-2.68 (m, 
2H, CH2), 2.89 (t, J=6.00, 2H, CH2), 4.50-4.52 (m, 2H, OCH2), 5.13-5.16 (m, H, gem. CH2), 5.22-5.27 (m, 
H, gem. CH2), 5.88-5.92 (m, H, alkene CH), 6.88 (d, J=8.00, H, Ar CH), 6.96-7.00 (m, H, Ar CH), 7.35-7.40 
(m, 2H, 2 x Ar CH);δC (100 MHz, CDCl3) 22.1 (CH2), 23.3 (CH2), 25.9 (CH2), 47.3 (2 x CH3), 68.5 (OCH2), 
111.3 (Ar CH), 113.7 (C), 116.3 (gem. CH2), 119.3 (C), 120.0 (Ar CH), 130.5 (2 x Ar CH), 133.3 (alkene 
CH), 158.9 (C), 157.1 (C), 157.9 (C), 172.1 (C).  
3-(2-(But-3-en-1-yloxy)phenyl)-4-(2,2-dimethylhydrazono)-4,5,6,7-tetrahydrobenzo[d]isoxazole 111 
 
Orange gel (74%); MS(EI+) C19H23N3O2Na requires 348.1688 [M+Na] found 348.1675 -3.7338 ppm; νmax 
(ATR)/cm-1 1631 (C=N); δH (400 MHz, CDCl3) 2.02-2.06 (m, 2H, CH2), 2.30 (s, 6H, 2 x CH3), 2.37-2.42 (m, 
2H, CH2), 2.66-2.69 (m, 2H, CH2), 2.89 (t, J=6.80 Hz, 2H, CH2), 3.97 (t, J=6.80 Hz, 2H, OCH2), 4.98-5.06 
(m, 2H, gem. CH2). 5.69-5.83 (m, H, alkene CH), 6.87 (d, J=8.40 Hz, H, Ar CH), 6.95-6.99  (m, H, Ar CH), 
7.35-7.43 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 22.2 (CH2), 23.0 (CH2), 33.8 (CH2), 47.3 (2 x CH3), 67.2 
(OCH3), 111.0 (Ar CH), 113.8 (C), 116.7 (gem. CH2), 119.3 (C), 119.8 (Ar CH), 130.3 (Ar CH), 130.5 (Ar 
CH), 134.5 (alkene CH), 154.8 (C), 157.4 (C), 157.9 (C), 171.9 (C). 
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4-(2,2-Dimethylhydrazono)-3-(2-(pent-4-en-1-yloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazole 112 
 
Orange gel (60%); MS(EI+) C20H26N3O2 requires 340.2025 [M+H] found 340.2014 -3.2334 ppm; νmax 
(ATR)/cm-1 1633 (C=N); δH (400 MHz, CDCl3) 1.73 (quintet, J=7.20 Hz, 2H, CH2), 2.01-2.09 (m, 4H, 2 x 
CH2), 2.29 (s, 6H, 2 x CH3), 2.64-2.67 (m, 2H, CH2), 2.88 (t, J=6.40 Hz, 2H, CH2), 3.93 (t, J=6.40, 2H, 
OCH2), 4.91-4.99 (m, 2H, gem. CH2), 5.70-5.83 (m, H, alkene CH), 6.86 (d, J=8.40 Hz, H, Ar CH), 6.93-
6.970 (m, H, Ar CH), 7.34-7.37 (m, 2H, Ar CH);  δC (100 MHz, CDCl3) 24.5 (CH2), 25.3 (CH2), 28.2 (CH2), 
30.8 (CH2), 32.5 (CH2), 49.6 (2 x CH3), 69.5 (OCH2), 113.3 (Ar CH), 116.1 (C), 117.2 (gem. CH2), 121.6 (C), 
122.0 (Ar CH), 132.6 (Ar CH), 132.8 (Ar CH), 140.3 (alkene CH), 157.0 (C), 159.9 (C), 160.3 (C), 174.2 (C). 
4-(2,2-Dimethylhydrazono)-3-(2-(hex-5-en-1-yloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazole 113 
 
Orange gel (69%); MS(EI+) C21H28N3O2 requires 354.2182 [M+H] found 354.2168 -3.9524 ppm; νmax 
(ATR)/cm-1 1631 (C=N); δH (400 MHz, CDCl3) 1.39-1.43 (m, 2H, CH2), 1.63-1.67 (m, 2H, CH2), 2.00-2.05 
(m, 4H, 2 x CH2), 2.30 (s, 6H, 2 x CH3), 2.64-2.67 (m, 2H, CH2), 2.89 (t, J=6.40 Hz, 2H, CH2), 3.93 (t, J=6.40 
Hz, 2H, OCH2), 4.92-5.00 (m, 2H, gem. CH2), 5.70-5.81 (m, H, alkene CH), 6.86 (d, J=8.80 Hz, H, Ar CH), 
6.94-6.98 (m, H, Ar CH), 7.35-7.39 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 22.2 (CH2), 23.0 (CH2), 25.3 
(CH2), 25.9 (CH2), 28.7 (CH2), 33.5 (CH2), 47.3 (2 x CH3), 67.9 (OCH2), 110.9 (Ar CH), 113.8 (C), 114.6 
(gem. CH2), 119.2 (C), 119.6 (Ar CH), 130.2 (Ar CH), 130.5 (Ar CH), 138.6 (alkene CH), 154.7 (C), 157.6 
(C), 158.0 (C), 171.9 (C). 
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General procedure for preparation of O-alkyl-C-prop-2-enyloxy benzisoxazole hydrazones  
O-Alkyl isoxazole hydrazone (1 mMol) was dissolved in anhydrous THF (10 mL) and cooled to -78°C 
under an atmosphere of nitrogen. Following this, freshly prepared LDA (1.01 mMol) was slowly added 
to ensure the temperature remained below -70°C. After fifteen minutes a solution of 3-bromoprop-1-
ene (1 mMol) and freshly purfieid potassium iodide (1 mMol) in anhydrous THF at -78°C was added 
dropwise via cannula. After two hours the reaction was warmed to 0°C and then allowed to warm to 
room temperature over an hour. After saturated ammonium chloride solution (10 mL) was added to 
the solution and it was allowed to stir for 30 minutes under an open atmosphere. The mixture was 
then diluted with DCM (30 mL) and water (10mL), the organic layer was separated and washed with 
water (10mL) and saturated sodium chloride solution (10mL). The organic layer was dried over 
magnesium sulfate and concentrated under reduced pressure. The crude product was purified via 
flash column chromatography using light petrol:ethyl acetate:dichloromethane (5:1:4 v/v/v) as eluent 
to yield the desired C-allyl-O-alkyl benzisoxazole hydrazone. 
5-prop-2-enyl-3-(2-(prop-2-enyloxy)phenyl)-4-(2,2-dimethylhydrazono)-4,5,6,7-
tetrahydrobenzo[d]isoxazole  114 
 
Orange gel (34%); MS(EI+) C21H26N3O2 requires 352.2025 [M+H] found 352.2012 -3.6911 ppm; νmax 
(ATR)/cm-1 1629 (C=N); δH (400 MHz, CDCl3) 1.65-1.74 (m, H, CH), 2.01-2.09 (m, H, CH), 2.22 (s, 6H, 2 x 
CH3), 2.28-2.38 (m, 2H, 2 x CH), 2.65-2.72 (m, H, CH), 2.84-2.91 (m, H, CH), 3.00-3.07 (m, H, CH), 4.41-
4.43 (m, 2H, OCH2), 5.04-5.22 (m, 4H, 2x gem. CH2), 5.70-5.88 (m, 2H, 2 x alkene CH), 6.80 (d, J=8.00 
Hz, H, Ar CH), 6.89-6.93 (m, H, Ar CH), 7.28-7.38 (m, 2H, 2 x Ar CH); δC (100 MHz, CDCl3) 24.0 (CH2), 
26.7 (CH2), 33.2 (CH), 35.0 (CH2), 46.3 (2 x CH3), 67.4 (OCH2), 110.3 (Ar CH), 112.5 (C), 115.1 (gem. CH2), 
116.8 (gem. CH2), 118.3 (C), 119.0 (Ar CH), 129.5 (2 x Ar CH), 132.2 (alkene CH), 133.9 (alkene CH), 
153.8 (C), 156.0 (C), 156.9 (C), 173.0 (C). 
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5-Prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-4-(2,2-dimethylhydrazono)-4,5,6,7-
tetrahydrobenzo[d]isoxazole 115 
 
Orange gel (45%); MS(EI+) C22H28N3O2 requires 366.2182 [M+H] found 366.2167 -4.0959  ppm; νmax 
(ATR)/cm-1 1629 (C=N); δH (400 MHz, CDCl3) 1.73-1.81 (m, H, CH), 2.08-2.14 (m, H, CH), 2.29 (s, 6H, 2 x 
CH3), 2.36-2.49 (m, 4H, 4 x CH), 2.72-2.78 (m, H, CH), 2.93-3.02 (m, H, CH), 3.07-3.14 (m, H, CH), 3.96 
(t, J=6.80 Hz, 2H, OCH2), 4.97-5.05 (m, 2H, gem. CH2), 5.11-5.18 (m, 2H, gem. CH2), 5.70-5.92 (m, 2H, 2 
x alkene CH), 6.86 (d, J=8.40 Hz, H, Ar CH), 6.94-6.98 (m, H, Ar CH), 7.34-7.41 (m, 2H, 2 x Ar CH); δC 
(100 MHz, CDCl3) 25.0 (CH2), 27.7 (CH2), 33.8 (CH2), 34.2 (CH), 36.1 (CH2), 47.3 (2 x CH3), 67.1 (OCH2), 
111.0 (Ar CH), 113.6 (C), 116.7 (gem. CH2), 117.8 (gem. CH2), 119.3 (C), 119.8 (Ar CH), 130.3 (Ar CH), 
130.5 (Ar CH), 134.6 (alkene CH), 134.9 (alkene CH), 154.8 (C), 157.4 (C), 158.0 (C), 173.8 (C).  
5-Prop-2-enyl-4-(2,2-dimethylhydrazono)-3-(2-(pent-4-en-1-yloxy)phenyl)-4,5,6,7-
tetrahydrobenzo[d]isoxazole 116 
 
Orange gel (49%); MS(EI+) C23H30N3O2 requires 380.2338 [M+H] found 380.2329 -2.3670 ppm; νmax 
(ATR)/cm-1 1630 (C=N); δH (400 MHz, CDCl3)  1.70-1.83 (m, 3H, 3 x CH), 2.05-2.12 (m, 3H, 3 x CH), 2.31 
(s, 6H, 2 x CH3), 2.38-2.53 (m, 2H, 2 x CH), 2.74-2.80 (m, H, CH), 2.93-2.99 (m, H, CH), 3.07-3.15 (m, H, 
CH), 3.94 (t, J=6.40 Hz, 2H, OCH2), 4.93-5.03 (m, 2H, gem. CH2), 5.13-5.20 (m, 2H, gem. CH2), 5.72-5.94 
(m, 2H, 2 x alkene CH), 6.88 (d, J=8.40 Hz, H, Ar CH), 6.96-7.04 (m, H, Ar CH), 7.36-7.46 (m, 2H, 2 x Ar 
CH); δC (100 MHz, CDCl3) 23.9 (CH2), 26.6 (CH2), 27.5 (CH2), 29.1 (CH2), 33.2 (CH), 35.0 (CH2), 46.3 (2 x 
CH3), 66.1 (OCH2), 110.0 (Ar CH), 112.6 (C), 113.9 (gem. CH2), 116.8 (gem. CH2), 118.2 (C), 118.7 (Ar 
CH), 129.2 (Ar CH), 129.4 (Ar CH), 133.8 (alkene CH), 137.0 (alkene CH), 153.7 (C), 156.5 (C), 157.0 (C), 
172.8 (C). 
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5-Prop-2-enyl-4-(2,2-dimethylhydrazono)-3-(2-(hex-5-en-1-yloxy)phenyl)-4,5,6,7-
tetrahydrobenzo[d]isoxazole 117 
 
Orange gel (63%); MS(EI+) C24H32N3O2 requires 394.2495 [M+H] found 394.2481 -3.5511 ppm; νmax 
(ATR)/cm-1 1633 (C=N); δH (400 MHz, CDCl3) 1.24-1.32 (m, 2H, 2 x CH), 1.48-1.67 (m, 3H, 3 x CH), 1.87-
2.00 (m, 3H, 3 x CH), 2.16 (s, 6H, 2 x CH3), 2.23-2.33 (m, 2H, 2 x CH), 2.58-2.64 (m, H, CH), 2.80-2.86 (m, 
H, CH), 2.93-2.99 (m, H, CH), 3.80 (t, J=6.40 Hz, 2H, OCH2), 4.79-5.08 (m, 4H, 2 x gem. CH2), 5.56-5.79 
(m, 2H, 2 x alkene CH), 6.73 (d, J=8.00 Hz, H, Ar CH, 6.82 (t, J=7.20 Hz, H, Ar CH), 7.19-7.29 (m, 2H, 2 x 
Ar CH); δC (100 MHz, CDCl3) 23.9 (CH2), 24.3 (CH2), 26.7 (CH2), 27.7 (CH2), 32.5 (CH2), 33.1 (CH), 35.0 
(CH2), 46.2 (2 x CH3), 66.6 (OCH2), 109.8 (Ar CH), 112.6 (C), 113.6 (gem. CH2), 116.7 (gem. CH2), 118.3 
(C), 118.5 (Ar CH), 129.1 (Ar CH), 129.4 (Ar CH), 133.8 (alkene CH), 137.5 (alkene CH), 153.6 (C), 156.6 
(C), 157.0 (C), 172.7 (C). 
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5-Prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 90’ 
 
A solution of 5-prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-4-(2,2-dimethylhydrazono)-4,5,6,7-
tetrahydrobenzo[d]isoxazole 108 (0.369g, 1.01 mMol) and iodomethane (3.58g, 25.2 mMol) in THF (25 
mL) was refluxed for two days. After this 2M hydrochloric acid (10 mL) was added and the solution 
was left to stir for another six hours. Following this the reaction mixture was extracted with 
dichloromethane (3 x 10 mL). The combined organic extracts were washed with water (15 mL) and 
brine (15 mL), dried over magnesium sulfate, filtered and concentrated under reduced pressure. The 
crude product was purified via preparative thin layer chromatography using light petroleum:ethyl 
acetate (1:1 v/v) to yield 5-prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-
4(5H)-one 86 as a yellow oil (24 mg, 7%).  
HRMS(EI+) C20H21O3NNa requires 346.1419 [M+Na] found 346.1410 -2.6001 ppm; νmax (ATR)/cm
-1 1689 
(C=O); δH (400MHz; CDCl3) 1.96-2.04 (m, H, CH), 2.35-2.42 (m, 3H, CH, CH2), 2.45-2.54 (m, 2H, 2 x CH), 
2.58-2.56 (m, H, CH), 2.82-2.92 (m, H, CH), 3.23-3.34 (m, H, CH), 4.04 (t, J-6.80 Hz, 2H, OCH2), 5.00-5.09 
(m, 2H, gem. CH2), 5.13-5.27 (m, 2H, gem. CH2), 5.70-5.96 (m 2H, 2 x alkene CH), 6.98-7.06 (m, 2H, 2 x 
Ar CH), 7.45-7.51 (m, 2H, 2 x Ar CH); δC (100MHz; CDCl3) 27.7 (CH2), 33.6 (CH2), 34.6 (CH), 35.6 (CH2), 
37.6 (CH2), 67.3 (OCH2), 111.8 (Ar CH), 115.3 (C), 116.7 (gem. CH2), 117.0 (Ar C), 118.5 (gem. CH2), 
120.4 (Ar CH), 130.4 (Ar CH ), 131.1 (Ar CH), 134.1 (alkene CH), 134.6 (alkene CH), 157.3 (C), 157.7 (C), 
182.1 (ixoazole CO), 191.3 (C=O).  
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5-Prop-2-enyl-3-(2-(prop-2-enyl)phenyl)-1-(dimethylamino)-6,7-dihydro-H-indazol-4(5H)-one 129 
 
Brown crystal (by-product); MS(EI+) C21H26N3O2 requires 352.2025 [M+H] found 352.2012 -3.6911  
ppm; νmax (ATR)/cm
-1 1666 (C=O); δH (400 MHz, CDCl3)  1.84-1.94 (m, H, CH), 2.10-2.25 (m, 2H, 2 x CH), 
2.36-2.43 (m, H, CH), 2.63-2.69 (m, H, CH), 2.72-2.82 (m, H, CH), 2.90 (s, 6H, 2 x CH3), 2.94-3.06 (m, H, 
CH), 4.52 (m, 2H, OCH2), 5.01-5.08 (m, 2H, gem. CH2), 5.13 (dd, J=10.80, 1.60 Hz, H, cis-gem. CH2), 5.26 
(dd, J=17.20, 1.60 Hz, H, trans-gem. CH2), 5.75-5.97 (m, 2H, 2 x alkene CH), 6.92-6.90 (m, 2H, 2 x Ar 
CH), 7.28-7.33 (m, H, Ar CH), 7.39 (dd, J=7.20, 1.60 Hz, H, Ar CH); δC (100 MHz, CDCl3) 20.3 (CH2), 27.9 
(CH2), 33.7 (CH2), 46.1 (2 x CH3), 47.0 (CH), 69.4 (OCH2), 112.7 (Ar CH), 114.6 (C), 116.4 (gem. CH2), 
116.6 (gem. CH2), 120.6 (Ar CH), 122.7 (C), 129.9 (Ar CH), 131.0 (Ar CH), 133.9 (alkene CH), 136.9 
(alkene CH), 146.1 (C), 147.2 (C), 157.1 (C), 192.9 (C=O).  
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4-Prop-2-enyl-3-(2-(prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 130 
 
A solution of 3-(2-(prop-2-enyloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 70 (0.250 g, 0.930 
mMol) in anhydrous THF (10 mL) was prepared and cooled to 0°C under an atmosphere of nitrogen. 
Following this, prop-2-enyl magnesium bromide (1.02 mL, 1.02 mMol) was slowly added over an hour 
and then left to warm to room temperature over 30 minutes. Saturated ammonium chloride solution 
(2 mL) was then added to the solution and it was allowed to stir for 30 minutes under an open 
atmosphere. The mixture was then diluted with DCM (10 mL) and water (10mL), the organic layer was 
separated and washed with water (10mL) and saturated sodium chloride solution (10mL). The organic 
layer was dried over magnesium sulfate and concentrated under reduced pressure. The crude product 
was purified via flash column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to 
yield 4-prop-2-enyl-3-(2-(prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 130 (0.109g, 
38%) as a yellow oil.  
νmax (ATR)/cm
-1 3529 (OH); MS(EI+) C19H22NO3 requires 312.1560 [M+H] found 312.1593 10.5716  ppm; 
δH (500 MHz, CDCl3) 1.54-1.64 (m, H, CH), 1.79-1.87 (m, H, CH), 1.88-1.98 (m, H, CH), 2.11-2.21 (m, 2H, 
2 x CH), 2.26 (dd, J=13.90, 7.40 Hz, H,  CH), 2.60 (ddd, J=17.50, 11.70, 6.00 Hz, H, CH), 2.82 (m, H, CH), 
3.82 (s, H, OH), 4.55-4.67 (m, 2H, OCH2), 4.77 (dd, J=17.10, 1.10 Hz, H, trans-gem. CH2), 4.88 (dd, 
J=10.20, 1.10 Hz, H, cis-gem. CH2), 5.31 (dd, J=10.40, 0.9 Hz, H, cis-gem. CH2), 5.37 (dd, J=17.20, 0.90 
Hz, H, trans-gem. CH2), 5.40-5.49 (m, H, alkene CH), 5.93-6.01 (m, H, alkene CH), 7.05 (dd, J=8.30 Hz, H, 
Ar CH), 7.10 (t, J=7.50 Hz, H, Ar CH), 7.41 (dd, J=7.50, 1.50 Hz, H, Ar CH), 7.42-7.47 (m, H, Ar CH). δC 
(125 MHz, CDCl3) 18.4 (CH2), 23.1 (CH2), 34.7 (CH2), 45.4 (CH2), 68.5 (COH), 70.8 (OCH2), 113.6 (Ar CH) 
117.2 (C), 118.0 (gem. CH2), 119.9 (gem. CH2), 120.5 (C), 122.2 (Ar CH), 131.3 (Ar CH), 131.6 (Ar CH), 
131.7 (alkene CH), 133.6 (alkene CH), 155.3 (Ar C), 158.1 (C), 170.1 (C). 
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4-Prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 131 
 
A solution of 3-(2-(but-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 77 (0.250 g, 0.880 
mMol) in anhydrous THF (10 mL) was prepared and cooled to 0°C under an atmosphere of nitrogen. 
Following this, prop-2-enyl magnesium bromide (1.66 mL, 1.66 mMol) was slowly added over an hour 
and left to warm to room temperature over 10 minutes. Saturated ammonium chloride solution (2 mL) 
was then added to the solution and it was allowed to stir for 30 minutes under an open atmosphere. 
The mixture was then diluted with DCM (10 mL) and water (10mL), the organic layer was separated 
and washed with water (10mL) and saturated sodium chloride solution (10mL). The organic layer was 
dried over magnesium sulfate and concentrated under reduced pressure. The crude product was 
purified via flash column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to yield 4- 
prop-2-enyl-3-(2-(but-3-en-1-yloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-ol 131 (0.199g, 70%) 
as a yellow oil.  
MS(EI+) C20H23NO2Na requires 348.1576, [M+Na] found 348.1567 -2.5850  ppm; δH (500 MHz, CDCl3) 
1.56-1.65  (m, H, CH), 1.77-1.86 (m, H,  CH), 1.88-1.99 (m, H, CH), 2.14 (dd, J=14.00, 7.30 Hz, 2H, 2 x 
CH), 2.24 (dd, J=14.00, 7.30 Hz, H, CH), 2.39-2.50 (m, 2H, CH2), 2.59 (m, H, CH), 2.86 (m, H, CH), 3.91 (s, 
H, OH), 3.97 (dt, J=9.40, 7.00 Hz, H, OCH2), 4.22 (dt, J=9.40, 7.00 Hz, H, OCH2), 4.77 (dd, J=17.10, 1.30 
Hz, H, trans-gem. CH2), 4.88 (dd, J=9.60, 1.30 Hz, H, cis-gem. CH2), 5.01-5.11 (m, 2H, gem. CH2), 5.45 
(m, H, alkene CH), 5.64-5.77 (m, H, alkene CH), 7.02-7.14 (m, 2H, 2 x Ar CH), 7.39 (dd, J=7.50, 1.60 Hz, 
H, Ar CH), 7.44 (td, J=8.30, 1.60 Hz, H, Ar CH); δC (125 MHz, CDCl3) 18.5 (CH2), 23.1 (CH2), 33.3 (CH2), 
34.7 (CH2), 45.5 (CH2), 68.5 (COH), 69.67 (OCH2), 114.2 (Ar CH), 117.2 (C), 117.8 (gem. CH2), 117.9 
(gem. CH2), 120.7 (C), 122.3 (Ar CH), 131.3 (Ar CH), 131.4 (Ar CH), 133.1 (alkene CH), 133.6 (alkene CH), 
155.6 (C), 158.0 (C), 170.0 (C). 
 
 
 
 
170 
 
General procedure for isoxazole ring cleavage  
Isoxazole (1.00 mMol) was added to a solution of molybdenum hexacarbonyl (1.00 mMol) in 
acetonitrile (8 mL) and water (2 mL). This mixture was then heated to reflux for 1 hour. Following this 
2M hydrochloric acid (1mL) was added and the mixture was stirred for 30 minutes, before being 
filtered through a pad of celite. After the mixture was diluted with DCM (10 mL) and extracted. The 
extracted organic layers were then washed with water (10 mL) and saturated sodium chloride solution 
(10 mL) before being dried over magnesium sulfate and concentrated under reduced pressure. The 
crude product was then purified via flash column chromatography using light peteroleum:ethyl 
acetate (1:1 v/v) as eluent to yield the desired enamino ketone. 
2-((2-(Prop-2-enyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione 135 
 
White crystals (85%) M.p. 168-170; HRMS(EI+) C16H17NO3Na requires 294.1106 [M+Na] found 
294.1099 -2.3801 ppm; νmax (ATR)/cm
-1) 1623 (C=O), 3185 (NH); δH (400 MHz, CDCl3) 1.95 (quintet, 
J=6.00 Hz, 2H, CH2), 2.49 (t, J=6.00 Hz, 4H, 2 x CH2), 4.52-4.54 (m, 2H, OCH2), 5.24 (dd, J=10.80, 1.60 Hz, 
H, cis-gem. CH2), 5.36 (dd, J=17.20, 1.60 Hz, H, trans-gem. CH2), 6.20 (broad s, H, NH), 6.91 (d, J=8.40 
Hz, H, Ar CH), 7.01-7.05 (m, H, Ar CH), 7.15 (dd, J=7.20 Hz, 1.60 Hz, H, Ar CH), 7.37-7.41 (m, H, Ar CH), 
12.01 (broad s, H, NH); δC (100MHz; CDCl3) 18.2 (CH2), 37.9 (2 x CH2), 68.2 (OCH2), 108.7 (C), 111.3 (Ar 
CH), 116.2 (gem. CH2), 119.9 (Ar CH), 126.3 (Ar CH), 127.0 (C), 129.7 (Ar CH), 131.9 (alkene CH), 153.6 
(C), 168.4 (C), 197.3 (broad s, 2 x C=O). 
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2-(Amino(2-(but-3-en-1-yloxy)phenyl)methylene)cyclohexane-1,3-dione  136 
 
Yellow crystals (88%) M.p. 152-153; HRMS(EI+) C17H20NO3Na requires 286.1443 [M+Na] found 
286.1435 -2.7958 ppm;  δH (500 MHz, CDCl3) 1.87-1.98 (m, 2H, CH2), 2.41-2.46 (m, 6H, 3 x CH2), 3.99 (t, 
J=6.60 Hz, 2H, CH2), 5.01-5.15 (m, 2H, gem. CH2), 5.73-5.85 (m, H, alkene CH), 6.31 (broad s, H, NH), 
6.89 (d, J=8.30 Hz, H, Ar CH), 6.97 (t, J=7.40 Hz, H, Ar CH), 7.08 (d, J=7.40 Hz, H, Ar CH), 7.31-7.39 (m, H, 
Ar CH), 12.03 (bs, H, NH); δC (125 MHz, CDCl3) 19.3 (CH2), 33.6 (CH2), 38.9 (CH2), 67.6 (OCH2), 109.5 (C), 
112.0 (Ar CH), 117.1 (gem. CH2), 120.7 (Ar CH), 127.4 (Ar CH), 127.9 (C), 130.7 (Ar CH), 134.4 (alkene 
CH), 154.9 (C), 169.8 (C), 198 (broad s 2 x C=O). 
4-Prop-2-enyl-2-((2-(prop-2-enyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione 139 
 
Yellow crystals (28%) M.p. 87-89; HRMS(EI+) C19H22NO3 requires 312.1600 [M+H] found 312.1589 -
3.5238 ppm; νmax (ATR)/cm
-1) 1630 (C=O); δH (500 MHz, CDCl3) 1.65-1.72 (m, H, CH), 1.95-2.04 (m, H, 
CH), 2.06-2.22 (m, H,  CH), 2.43-2.64 (m, 4H, 4 x CH), 4.49 (d, J=4.10 Hz, 2H, OCH2), 5.01-5.06 (m, 2H, 
gem. CH2), 5.22 (dd, J=10.60, 1.30, H, cis-gem. CH2), 5.33 (dd, J=17.30, 1.30 Hz, trans-gem. CH2), 5.73-
5.81 (m, H, alkene CH), 5.84-6.02 (m, H, alkene CH), 6.25 (bs, H, NH), 6.89 (d, J=8.30 Hz, H, Ar CH), 6.99 
(t, J=7.40 Hz, H, Ar CH), 7.10 (d, J=7.40 Hz, H, Ar CH), 7.31-7.39 (m, H, Ar CH), 12.04 (broad s, H, NH); δC 
(125 MHz, CDCl3) 23.7 (CH2), 34.7 (CH2), 37.4 (CH2), 46.4 (CH), 69.1 (OCH2), 109.2 (C), 112.3 (Ar CH), 
116.5 (gem. CH2), 117.2 (gem. CH2), 120.9 (Ar CH), 127.4 (Ar CH), 128.2 (C), 130.7 (Ar CH), 133.0 
(alkene CH), 136.7 (alkene CH), 154.6 (C), 169.6 (C); the remaining quaternary carbons could not be 
detected under the experimental conditions. 
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4,4-Diprop-2-enyl -2-((2-(prop-2-enyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione 140 
 
Yellow crystals (4%) M.p. 91-93; HRMS(EI+) C22H26NO3 requires 352.1913 [M+H] found 352.1900 -
3.6912 ppm;  νmax (ATR)/cm
-1) 1631 (C=O); δH (400 MHz, CDCl3) 1.79 (t, J=6.80 Hz, 2H, CH2), 2.12-2.17 
(m, 2H, 2 x CH), 2.37-2.45 (m, 4H, 4 x CH), 4.46-4.48 (m, 2H, OCH2), 5.00-5.04 (m, 4H, 2 x gem. CH2), 
5.19 (dd, J=10.80, 1.60 Hz, H, cis-gem. CH2), 5.31 (dd, J=17.20, 1.60 Hz, H, trans-gem. CH2), 5.65-5.75 
(m, 2H, 2 x alkene CH), 5.88-5.97 (m, H, alkene CH), 6.58 (broad s, H, NH),  6.86 (d, J=8.40 Hz, H, Ar CH), 
6.97 (t, J=7.60 Hz, H, Ar CH), 7.05 (dd, J=7.60, 1.60 Hz, H, Ar CH), 7.31-7.36 (m, H, Ar CH), 12.01 (broad 
s, H, NH); δC (100 MHz, CDCl3) 25.6 (CH2), 33.3 (CH2), 39.6 (CH2), 46.2 (C), 68.0 (OCH2), 107.8 (C), 111.2 
(Ar CH), 116.2 (gem. CH2),  116.8 (2 x gem. CH2), 119.8 (Ar CH), 126.4 (Ar CH), 127.3 (C), 129.5 (Ar CH), 
131.9 (alkene CH), 133.5 (2 x alkene CH), 153.4 (C), 169.2 (C), 197.2 (broad s C=O), 199.3 (broad s C=O). 
4,6-Diprop-2-enyl-2-((2-(prop-2-enyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione  141 
 
Yellow crystals (28%); HRMS(EI+) C22H26NO3 requires 352.1913 [M+H] found 352.1906 -1.9876 ppm;  
νmax (ATR)/cm
-1) 1629 (C=O); δH (400 MHz, CDCl3) 1.33-1.43 (m, H, CH), 1.83 (t, J=6.40 Hz, H, CH), 2.00-
2.04 (m, H, CH), 2.12-2.21 (m, 2H, 2 x CH), 2.41-2.69 (m, 4H, 4 x CH), 4.48-4.49 (m, 2H, OCH2), 5.00-
5.07 (m, 4H, 2 x gem. CH2), 5.21-5.34 (m, 2H, gem. CH2), 5.66-5.82 (m, 2H, 2 x alkene CH), 5.88-5.98 
(m, H, alkene CH), 6.12 (broad s, ½H, NH), 6.39 (broad s, ½H, NH), 6.88 (d, J=8.40 Hz, H, Ar CH), 6.98 (t, 
J=7.20 Hz, H, Ar CH), 7.05-7.11 (m, H, Ar CH), 7.26-7.36 (m, H, Ar CH), 12.03 (broad s, H, NH); δC (100 
MHz, CDCl3) 25.6 (CH2), 28.8 (CH2), 33.3 (CH2), 33.8 (CH2), 39.6 (CH2), 45.4 (2 x CH), 68.0 (OCH2), 68.4 
(OCH2), 107.8 (C), 108.2 (C), 111.3 (Ar CH), 112.5 (Ar CH), 115.5 (gem. CH2), 115.9 (gem. CH2), 116.6 
(gem. CH2), 117.0 (gem. CH2), 118.6 (Ar CH), 119.9 (Ar CH), 124.7 (C), 126.1 (Ar CH), 126.4 (Ar CH), 
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127.2 (C), 128.7 (C), 129.1 (Ar CH), 129.7 (Ar CH), 131.5 (Ar CH), 131.9 (Ar CH), 133.0 (CH), 133.2 (CH), 
135.6 (2 x alkene CH), 152.2 (C), 153.4 (C), 158.7 (C), 168.5 (C), 197.8 (broad C=O). 
1H and 13C spectra indicated the presence of a mixture of diastereomers.  
4,4,6-Triprop-2-enyl -2-((2-(prop-2-enyl)phenyl)(amino)methylene)cyclohexane-1,3-dione 142 
 
Brown gel (3%); HRMS(EI+) C25H30NO3 requires 392.2226 [M+H] found 392.2221 -1.2748 ppm;  νmax 
(ATR)/cm-1) 1633 (C=O); δH (400 MHz, CDCl3) 1.63-1.77 (m, 2H CH2), 2.03-2.11 (m, 2H, 2 x CH), 2.27-
2.41 (m, 2H, 2 x CH), 2.56-2.58 (m, 2H, 2 x CH), 2.69-2.72 (m, H, CH), 4.50 (d, J=4.80 Hz, 2H, OCH2), 
4.99-5.09 (m, 6H, 3 x gem. CH2), 5.22 (dd, J=10.80, 2.80 Hz, H, cis-gem.  CH2), 5.33 (dd, J=15.60, 2.80 
Hz, H, trans-gem. CH2), 5.62-5.83 (m, 3H, 3 x alkene CH), 5.88-5.99 (m, H, alkene CH), 6.12 (broad s, H, 
NH), 6.89 (d, J=8.40, H, Ar CH), 6.96-7.01 (m, H, Ar CH), 7.10 (dd, J=7.20, 1.60 Hz, Ar CH), 7.33-7.38 (m, 
H, Ar  CH), 12.10 (broad s, H, NH); δC (100 MHz, CDCl3) 31.3 (CH2), 33.8 (CH2), 40.5 (CH2), 40.8 (CH) 46.8 
(C), 68.0 (OCH2), 111.3 (Ar CH), 116.2 (gem. CH2), 116.5 (gem. CH2), 116.6 (gem. CH2), 117.1 (gem. 
CH2), 119.9 (Ar CH), 126.4 (Ar CH), 127.5 (C), 129.6 (Ar CH), 131.9 (alkene CH), 132.9 (alkene CH), 134.0 
(alkene CH), 135.7 (alkene CH), 153.4 (C), 168.7 (C); the remaining quaternary carbons could not be 
detected under the experimental conditions. 
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General procedure for ring closing metathesis 
Diene (1.00 mMol) was dissolved in dry degassed dichloromethane. This Grubbs 2nd generation 
catalyst (0.10 mMol) was added in one portion and the mixture was stirred at reflux for 18 hours. The 
reaction was then allowed to cool to room temperature and evaporated to dryness under reduced 
pressure. The crude product was then purified via flash column chromatography using light 
petroleum:ethyl acetate:dichloromethane (5:1:4 v/v/v) as eluent (unless otherwise stated) to yield the 
purified macrocyclic compound. 
5,6-Dihydro-3,5-ethanobenzo[2,3][1]oxacyclododecino[4,5-c]isoxazol-4(9H)-one 148 
 
Dark green solid (60%); ; νmax (ATR)/cm
-1) 1683 (C=O);  δH (400 MHz, CDCl3) 3.93-403 (m, 2H, OCH2), 
6.93-6.99 (m, presumed multiple aromatic H), 7.25-7.42 (m, presumed to be multiple aromatic H); the 
remainder of the 1H NMR suggests a complex mixture of diastereomers with peaks that may be 
consistent with the macrocyclic structure proposed. 13C NMR spectra displayed a complex mixture of 
diastereomers with peaks that may be consistent with the macrocyclic structure proposed. 
5,6-Dihydro-3,5-ethanobenzo[2,3][1]oxacyclotridecino[4,5-c]isoxazol-4(9H)-one 149 
 
Beige solid (47%) not of sufficient purity for melting point analysis; HRMS(EI+) C19H20NO3 requires 
310.1443 [M+H] found 310.1431 -3.8692 ppm; νmax (ATR)/cm
-1) 1681 (C=O); δH (400 MHz, CDCl3) 3.87-
4.16 (m, 2CH, OCH2), 6.91-7.01 (m, presumed multiple aromatic H), 7.25-7.41 (m, presumed to be 
multiple aromatic H); the remainder of the 1H NMR suggests a complex mixture of diastereomers with 
peaks that may be consistent with the macrocyclic structure proposed. 13C NMR spectra displayed a 
complex mixture of diastereomers with peaks that may be consistent with the macrocyclic structure 
proposed. 
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(3Z,10E)-11-Amino-5,6,7,8-tetrahydro-6,10-methanobenzo[b][1]oxacyclotridecine-9,16(2H)-dione 
154 
 
Column eluent: ethyl acetate; purple gel (30%); HRMS(EI+) C17H17NO3Na requires 306.1106 [M+Na] 
found 306.1093 -4.2468 ppm;  δH (400 MHz, CDCl3) 1.90-2.06 (m, 2H, CH2), 2.39-2.54 (m, 3H, 3 x CH), 
2.60 (dt, 16.40, 4.80 Hz, H, CH), 2.83-2.92 9 (m, H, CH), 4.21-4.25 (m, H, OCH), 4.60 (dd, J=10.40, 6.40 
Hz, H, OCH), 5.95-6.12 (m, 3H, NH, 2 x alkene CH), 6.93 (d, J=8.40 Hz, H, Ar CH), 7.09 (t, J=7.60 Hz, H, Ar 
CH), 7.32 (dd, J=7.60, 2.00 Hz, H, Ar CH), 7.41-7.46 (m, H, Ar CH); δC (100 MHz, CDCl3) 23.0 (CH2), 29.3 
(broad, CH2), 37.0 (CH2), 47.2 (CH), 62.5 (broad OCH2), 110.7 (C), 113.4 (Ar CH), 121.7 (Ar CH), 124.9 
(alkene CH), 127.7 (C), 128.0 (Ar CH), 131.7 (Ar CH), 137.7 (alkene CH), 154.4 (C), 166.5 (C), 198.5 
(C=O), 199.0 (C=O).  
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General procedure for Benzisoxazole to Benzoxazole rearragement 
Benzisoxazole (4.37 mMol) and caesium carbonate (4.37 mMol) were dissolved in dry THF (30 mL), and 
the reaction mixture was heated under reflux for the stated period of time. 2M hydrochloric acid 
solution (10 mL) and dichloromethane (25 mL) or ethyl acetate (25 mL) were added to the reaction 
mixture after it had cooled to room temperature. The mixture was then separated and the organic 
layer was washed with water (25 mL) and saturated sodium chloride solution (25 mL), dried over 
magnesium sulfate and concentrated under reduced pressure to yield crude benzoxazole which used 
without purification, or purified via column chromatography using light petroleum:ethyl acetate (1:1 
v/v) as a solvent.  
2-(2-Hydroxyphenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one 166 
 
Beige solid (82%), m.p. 125-127°C, HRMS(EI+) C15H16O3N requires 258.1130 [M+H] found 258.1125 -
1.9371 ppm; νmax (DCM)/cm
-1) 1694 (C=O), 3410 (OH); δH (400MHz; CDCl3) 1.08 (s, 6H, 2 x CH3), 2.41 (s, 
2H, OCCH2), 2.83 (s, 2H, O=CCH2) 6.85 (t, J=8.00 Hz H,  Ar CH), 6.97 (t, J=8.00 Hz, H, Ar CH), 7.29 (t, 
J=8.00 Hz H, Ar CH), 7.69 (d, J= 8.00Hz, H, Ar CH) 10.54 (broad s, H, OH); δC (100MHz; CDCl3) 27.6 (2x 
CH3), 34.5 (C) 34.9 (CH2), 51.2 (CH2) 109 (C), 116.4 (Ar CH), 118.5 (Ar CH), 125.3 (Ar CH), 131.9 (C), 
132.1 (Ar CH), 156.5 (C), 160.6 (C,) 161.2 (C), 189.2 (C=O). 
2-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 167 
 
Beige solid (87%), decomposes 202-204°C, HRMS(EI+) C13H12O3N requires 230.0817 [M+H] found 
230.0809 -3.4770 ppm; νmax (DCM)/cm
-1) 1694 (C=O), 3408 (OH); δH (400MHz; CDCl3) 2.20-2.27 (m, 2H, 
CH2), 2.57 (t, J=5.60 Hz, 2H, OCCH2), 3.00 (t, 2H, J=6.00 Hz, O=CCH2), 6.86-6.90 (m, H, Ar CH), 7.10 (dd, 
J=0.80, 8.40Hz, H, Ar CH), 7.30-7.34 (m, H, Ar CH), 7.74 (dd, J=1.60, 8.00Hz, H, Ar CH) 10.58 (broad s, H, 
OH); δC (100MHz; CDCl3) 22.2 (2x CH2), 37.9 (CH2), 110 (C), 117.6 (Ar CH), 119.5 (Ar CH), 126.3 (Ar CH), 
133.2 (Ar CH), 133.7 (Ar C), 157.7 (C), 161.2 (C,) 163.0 (C), 190.7 (C=O). 
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2-(2-Hydroxy-4-nitrophenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 193 
 
Yellow solid (77%) M.p. 184-186°C; HRMS(EI+) C13H11N2O5 requires 275.0668 [M+H] found 275.0659 -
3.2719 ppm; νmax (DCM)/cm
-1 1344 (NO2) 1698 (C=O), 3584 (OH); δH (400MHz; CDCl3) 2.35 (quin, J=6.40 
Hz, 2H,  CH2), 2.69 (t, J=6.40 Hz, 2H, OCCH2), 3.14 (t, J=6.4 Hz, 2H, O=CCH2), 7.19 (d, J=9.20 Hz, H, Ar 
CH), 8.28 (dd, J= 9.20, 2.80 Hz, H,  Ar CH), 8.78 (d, J=2.80 Hz, H, Ar CH), 11.50 (broad s, H, Ar OH); δC 
(100MHz; CDCl3) 21.1 (CH2), 21.2 (CH2), 36.9 (CH2), 109.2 (C), 117.4 (Ar CH), 121.8 (Ar CH), 127.3 (Ar 
CH), 132.7 (C), 139.4 (C), 158.4 (C), 161.3 (C), 162.6 (C), 189.3 (C). 
2-(2-Hydroxyphenyl)-6-methyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one 203 
 
Beige solid (88%), M.p. 154-156°C, HRMS(EI+) C14H14O3N requires 244.0974 [M+H] found 244.0968 -
2.4580 ppm; νmax (ATR)/cm
-1) 1680 (C=O), 3187 (OH); δH (400MHz; CDCl3) 1.20 (d, J=6.40 Hz, 3H, CH3), 
2.32 (dd, J=16.00, 11.20 Hz, H, CH), 2.49-2.70 (m, 3H, 3 x CH), 3.07 (dd, J=17.20, 4.80 Hz H, CH), 6.87 
(dd, J=8.00 Hz, H, Ar CH), 7.00 (d, 8.40 Hz, H, Ar CH), 7.30-7.34 (m, H, Ar CH), 7.69 (dd, J= 1.6, 8.00 Hz, 
H, Ar CH), 10.59 (broad s, H, OH); δC (100MHz; CDCl3) 21.1 (CH3), 29.9 (CH2), 30.6 (CH), 46.4 (CH2) 109.9 
(C), 117.3 (Ar CH), 119.5 (Ar CH), 126.3 (Ar CH), 133.1 (Ar CH), 133.2 (Ar C), 157.4 (C), 161.2 (C,) 162.8 
(C), 190.3 (C=O). 
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2-(3,5-Dichloro-2-hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 204 
 
Brown solid (58%) Decomposes 165-167°C; HRMS(EI+) C13H10NO3
35Cl2 requires 298.0038 [M+H] found 
298.0027 -3.6912 ppm; νmax (DCM)/cm
-1 1698 (C=O), 3691 (OH); δH (400MHz; CDCl3) 2.32-2.35 (m, 2H, 
CH2), 2.66 (t, J=6.40 Hz, 2H, OCCH2), 3.11 (t, J=6.00 Hz, 2H, O=CCH2), 7.46 (d, J=2.40 Hz, H, Ar CH), 7.70 
(d, J= 2.40 Hz, H,  Ar CH), 11.20 (broad s, H, Ar OH); δC (100MHz; CDCl3) 22.1 (CH2), 22.2 (CH2), 37.9 
(CH2), 111.7 (C), 123.4 (C), 124.2 (Ar CH), 124.3 (C), 132.9 (Ar CH), 133.7 (C), 152.2 (C), 159.5 (C), 163.6 
(C), 190.4 (C). 
 
2-(2-Hydroxy-3-methoxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 205 
 
White solid (70%) M.p. 114-115°C; HRMS(EI+) C14H13NO4Na requires 282.0742 [M+Na] found 282.0731 
-3.8997 ppm; νmax (DCM)/cm
-1 1693 (C=O), 3580 (OH); δH (400MHz; CDCl3) 2.30 (quin, J=6.40 Hz, 2H,  
CH2), 2.63 (t, J=6.40 Hz, 2H, OCCH2), 3.06 (t, J=6.4 Hz, 2H, O=CCH2), 3.92 (s, 3H, OCH3), 6.89 (t, J=8.00, 
H,  Ar CH), 6.98 (d, J=8.00, H, Ar CH), 7.41 (d, J=8.00 Hz, H, Ar CH), 10.79 (broad s, H, Ar OH); δC 
(100MHz; CDCl3) 21.1 (CH2), 21.2 (CH2), 36.9 (CH2), 55.4 (OCH3), 109.2 (C), 113.7 (Ar CH), 116.8 (Ar CH), 
118.3 (Ar CH), 132.6 (C), 146.8 (C), 147.6 (C), 160.2 (C), 161.9 (C), 189.6 (C). 
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2-(2-Fluoro-6-hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 206 
 
White solid (75%), m.p. 200-202°C, HRMS(EI+) C13H11O3NF requires 248.07230 [M+H] found 248.0714 -
-3.6280 ppm; νmax (DCM)/cm
-1) 1684 (C=O), 3396 (OH); δH (400MHz; CDCl3) 2.23-2.36 (m, 2H, CH2), 2.67 
(t, J=7.20 Hz, 2H, OCCH2), 3.11 (t, J=6.40 Hz, 2H, O=CCH2), 6.90 (td, J=8.00, 4.80 Hz, H,  Ar CH), 7.18-
7.23 (m, H, Ar CH), 7.29 (dt, J=8.00, 1.20 Hz, Ar CH), 10.54 (broad s, H, OH); δC (100MHz; CDCl3) 21.1 
(CH2), 21.2 (CH2) 36.9 (CH2) 111.3 (d, J=4 Hz C-F, C), 118.1 (d, J=2 Hz C-F, Ar CH) 118.3 (d, J=13 Hz C-F, 
Ar CH), 120.3 (d, J=3 Hz C-F, Ar CH),  145.2 (d J=13 Hz C-F, C), 150.6 (d, J=244 Hz C-F, Ar CF), 159.4 (d, 
J=4 Hz C-F, C), 162.1 (C), 189.5 (C). The remaining quaternary carbon could not be distinguished from 
the noise in the time allocated for this experiment. 
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N-(2-(Ethylthio)-6-oxocyclohex-1-en-1-yl)-2-hydroxybenzamide 186 
 
3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61 (2.18 mMol, 0.500g), thioethane (2.18 
mMol, 0.135g) and caesium carbonate (2.18 mMol, 0.720g) were dissolved in dry THF (10 mL), and the 
reaction mixture was heated under reflux for 4 hours. 2M Hydrochloric acid (10 mL) and 
dichloromethane (10 mL) were added to the reaction mixture after it had cooled to room 
temperature. The mixture was then separated and the organic layer was washed with water (10 mL) 
and saturated sodium chloride solution (10 mL), dried over magnesium sulfate and concentrated 
under reduced pressure to yield N-(2-(ethylthio)-6-oxocyclohex-1-en-1-yl)-2-hydroxybenzamide 175 as 
clear crystals (6%) decomposes 159-161°C. 
HRMS(EI+) C15H17O3NSNa requires 314.0827 [M+Na] found 314.0819 -2.5471 ppm; νmax (ATR)/cm
-1 
1628 (C=O), 3327 (OH); δH (400MHz; CDCl3) 1.31 (t, J=7.20 Hz, 3H,  CH3), 2.14 (quintet, J=6.40 Hz, 2H, 
CH2), 2.55 (t, J=6.40 Hz, 2H, O=CCH2), 2.82 (t, J= 6.40 Hz, 2H, O=CCH2), 2.90 (q, J=7.20 Hz, 2H, SCH2), 
6.84-6.89 (m, H, Ar CH), 6.95 (dd, J=8.40, 1.20 Hz, H,  Ar CH), 7.38-7.40 (m, H, Ar CH), 7.59 (dd, J= 8.00, 
1.60 Hz, H, Ar CH), 8.06 (broad s, H, NH), 11.85 (broad s, H, Ar OH); δC (100MHz; CDCl3) 14.3 (CH3), 22.0 
(CH2), 25.4 (CH2), 29.5 (CH2), 36.3 (CH2), 114.1 (C), 118.5 (Ar CH), 118.9 (Ar CH), 126.3 (1 x Ar CH, 1 x C), 
134.7 (Ar CH), 159.0 (C), 161.7 (C), 168.0 (C), 191.2 (C). 
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2-Hydroxy-N-(2-hydroxy-6-oxocyclohex-1-en-1-yl)benzamide 180 
 
3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61 (2.18 mMol, 0.500g) and caesium 
carbonate (4.36 mMol, 1.42g) were dissolved in ethanol (30 mL), and the reaction mixture was heated 
under reflux for the 4 hours. 1M Hydrochloric acid (20 mL) and dichloromethane (50 mL) was added to 
the reaction mixture after it had cooled to room temperature. The mixture was then separated and 
the organic layer was washed with water (50 mL) and saturated sodium chloride solution (50 mL), 
dried over magnesium sulfate and concentrated under reduced pressure to yield 2-hydroxy-N-(2-
hydroxy-6-oxocyclohex-1-en-1-yl)benzamide 180 as a beige solid (91%). 
M.p. 172-174°C; HRMS(EI+)  C13H13NO4Na requires 270.0742 [M+Na] found 270.0729 -4.8135 ppm; 
νmax (ATR)/cm
-1 3177 (OH); δH (400MHz; CDCl3) 2.06 (quin, J=6.40 Hz, 2H,  CH2), 2.56 (t, J=6.40 Hz, 2H, 
OCCH2), 2.68 (t, J=6.40 Hz, 2H, O=CCH2), 6.98 (t, J=7.60 Hz, Ar CH), 7.05 (d, J=8.40 Hz, H, Ar CH), 7.46-
7.50 (m,  H, Ar CH), 7.67 (d, J=8.40, H,  Ar CH), 9.48 (broad s, H, OH), 10.93 (broad s, H, Ar OH), 12.88 
(broad s, H, NH); δC (100MHz; CDCl3) 20.3 (CH2), 30.2(CH), 35.0 (CH2), 113.4 (C), 113.7 (C), 118.9 (Ar 
CH), 119.8 (Ar CH), 127.1 (Ar CH), 135.2 (Ar CH), 160.8 (C), 165.9 (C), 167.4 (C), 192.9 (C). 
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4-Prop-2-enyl-2-(2-(prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 208 
 
1M Prop-2-enyl magnesium bromide solution in diethyl ether (12.12 mL, 12.12 mMol) was slowly 
added  to a solution of 2-(2-hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one  71 (1.63 g, 6.06 
mMol) in dry THF (100 mL) at -50°C over an hour; after which the reaction mixture was left to warm to 
room temperature over  18 hours. The reaction was then quenched with aqueous hydrochloric acid 
(2M, 20 mL) and diluted with dichloromethane (100 mL). The reaction mixture was then washed with 
water (2 x 100 mL) and aqueous sodium chloride solution (1 x 100 mL) and dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to yield 4-prop-2-enyl-2-(2-
(prop-2-enyloxy)phenyl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 208 (1.18g, 63%) as a yellow oil. 
νmax (ATR)/cm
-1 3423 (OH); δH (400MHz; CDCl3) 1.73-1.90 (m, 3H, 3 x CH), 1.95-2.06 (m, H, CH), 2.26 (s, 
H, OH), 2.53-2.61 (m, 2H, 2 x CH), 2.65-2.77 (m, 2H, 2 x CH), 4.53 (m, 2H, OCH2), 5.06-5.14 (m ,2H, 
gem. CH2), 5.22 (dd, J=10.40, Hz,  cis-gem.CH2), 5.53 (dd, J=17.60, 1.60 Hz, trans-gem. CH2), 5.84-5.93 
(m, H, alkene CH), 5.95-6.01 (m, H, alkene CH), 6.91-6.97 (m, 2H, 2 x Ar CH), 7.28-7.32 (m, H, Ar CH), 
7.84 (dd, J=7.60, 1.60 Hz, H, Ar CH); δC (100MHz; CDCl3) 19.3 (CH2), 22.0 (CH2), 35.4 (CH2), 45.1 (CH2), 
69.3 (COH), 69.4 (OCH2),  113.5 (Ar CH), 117.0 (2 x gem. CH2) 117.7 (C), 118.8 (Ar CH), 130.5 (Ar CH), 
131.2 (Ar CH), 132.9 (alkene CH), 133.9 (alkene CH), 138.5 (C), 148.0 (C), 156.4 (C), 159.0 (C). 
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2-(2-(Prop-2-enyloxy)phenyl)-4-(but-3-en-1-yl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 209 
 
5-Bromo-1-pentene (1.00 g, 0.79 mL, 6.70 mMol) was added to magnesium turnings (0.179 g, 7.40 
mMol) in dry THF (50 mL) and heated to reflux for one hour. This solution was then allowed to cool to 
room temperature before being slowly added to a solution of 3-(2-prop-2-enylphenyl)-6,7-dihydro-5H-
1,2-benzoxazol-4-one 71 (0.90 g, 3.55 mMol) in dry THF (50 mL) at -40°C over an hour. The reaction 
mixture was allowed to warm to room temperature over 18 hours before being quenched with 
hydrochloric acid (2M, 10 mL) and diluted with dichloromethane (50 mL). The reaction mixture was 
then washed with water (2 x 50 mL) and aqueous sodium chloride solution (1 x 50 mL) and dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was purified 
by flash column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to yield 3-(2-
allyloxyphenyl)-4-pent-4-enyl-6,7-dihydro-5H-1,2-benzoxazol-4-ol 209  (0.46g, 41%) as a yellow oil.  
 
δH (500MHz; CDCl3) 1.43-1.48 (m, H, CH), 1.59-1.64 (m, H, CH), 1.76 (m, H, CH), 1.84-1.93 (m, 3H, 3 x 
CH), 1.99-2.11 (m, 4H, 4 x CH), 2.56-2.69 (m, 2H, 2 x CH), 2.93 (broad s, H, OH), 4.58-4.64 (m, 2H, OCH2) 
4.93 (dd, J=10.00, H, cis-gem. CH2), 5.01 (dd, J=18.50, 1.50 Hz, H, trans-gem. CH2), 5.28 (dd, J=10.50, 
1.50 Hz, H, cis-gem. CH2), 5.58 (dd, J=17.50, 1.50 H, trans-gem. CH2), 5.77-5.86 (m, H, alkene CH), 6.02-
6.10 (m, H, alkene CH), 6.95-7.02 (m, 2H, 2 x Ar CH), 7.32-7.40 (m, H, Ar CH), 7.88 (dd, J=8.00, 1.5, H, Ar 
CH); δC (125MHz; CDCl3) 19.4 (CH2), 22.0 (CH2), 23.2 (CH2), 34.2 (CH2), 35.2 (CH2), 37.0 (CH2),  69.4 
(COH), 69.8 (OCH2), 113.5 (Ar CH), 114.4 (gem. CH2), 117.0 (gem. CH2), 117.6 (C), 120.9 (Ar CH), 130.4 
(Ar CH), 131.2 (Ar CH), 132.8 (alkene CH), 138.9 (alkene CH), 139.0 (C), 147.7 (C), 156.4 (C), 158.7 (C). 
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4- Prop-2-enyl-2-(2-hydroxyphenyl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 212 
 
 
Grubbs II catalyst (0.273 g, 0.32 mMol) was added to a solution of 4-allyl-3-(2-allyloxyphenyl)-6,7-
dihydro-5H-1,2-benzoxazol-4-ol 158 (0.50g, 1.60 mMol) in anhydrous toluene (80 mL). The reaction 
mixture was then heated to 90°C for 18 hours. Following this the residue was allowed to cool to room 
temperature before being concentrated under reduced pressure. The mixture was then purified by 
flash column chromatography using isohexane:ethyl acetate (1:1 v/v) as eluent to yield 4-prop-2-enyl-
3-(2-hydroxyphenyl)-6,7-dihydro-5H-1,2-benzoxazol-4-ol 201 (0.12 g, 26%) as a dark green oil.  
 
LCMS rt: 1.72 minutes; MS(ESI+) C16H18NO3 requires 272.13 [M+H] found 272.15 73.49 ppm; δH 
(400MHz; CDCl3) The aliphatic region of the spectra displays a complex mixture; 5.16-5.22 (m, 2H, 
gem. CH2), 5.84-5.95 (m, H, alkene H), 6.88-6.96 (m, H, Ar CH), 7.04 (d, J=7.60 Hz, H, Ar CH) 7.30-7.35 
(m, H, Ar CH), 7.78 (dd, J=8.00, 2.00 Hz, H, Ar CH), 11.13 (broad s, H, OH). 
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2-(2-Hydroxyphenyl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 210 
 
2-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 167 (0.500g, 2.18 mMol) was dissolved in 
ethanol (20 mL). Sodium borohydride (0.082g, 2.18 mMol) was added and the mixture was heated at 
reflux for 18 hours. The reaction mixture was then quenched with water (15 mL) and washed three 
times with dichloromethane (3 x 15 mL). The combined organic extracts were then washed with 
saturated sodium chloride solution (30 mL), dried over magnesium sulfate, filtered and concentrated 
under reduced pressure to yield 2-(2-Hydroxyphenyl)-4,5,6,7-tetrahydrobenzo[d]oxazol-4-ol 108 as a 
cream solid (0.453g. 90%). 
 
M.p. 142-143°C; HRMS(EI+) C13H13O3NNa requires 254.0793 [M+Na] found 254.0788 -1.9679 ppm;  
νmax (ATR)/cm
-1 3264 (OH); δH (400MHz; CDCl3) 1.90-2.20 (m, 3H, 3 x CH), 2.30 (broad s, H, OH), 2.65-
2.72 (m, H, CH), 2.77-2.84 (m, H, CH), 4.88 (t, J=4.00 Hz, 2H, OCH2), 6.93-6.97 (m, H, Ar CH), 7.07 (dd, 
J=8.40, 1.20 Hz, H, Ar CH), 7.33-7.34 (m, H, Ar CH), 7.80 (dd, J=7.60, 1.20 Hz, H, Ar CH), 11.13 (broad s, 
H, OH); δC (100MHz; CDCl3) 18.7 (CH2), 21.7 (CH2), 31.7 (CH2), 63.1 (CH), 111.3 (C), 117.1 (Ar CH), 119.4 
(Ar CH), 125.7 (Ar CH), 132.0 (Ar CH), 135.1 (C), 147.8 (C), 156.9 (C), 160.2 (C), 
 
 
 
 
 
 
 
 
 
 
 
 
186 
 
2-(2-(Pyrimidin-2-yloxy)phenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 216 
 
2-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]oxazol-4(5H)-one 167 (2.18 mMol, 0.500g), 2-
chloropyrimidine (6.54 mMol, 0.750g), copper powder (2.18 mMol, 0.140g) and caesium carbonate 
(2.18 mMol, 0.720g) were dissolved in dry DMF (25 mL), and the reaction mixture was heated under 
reflux for 18 hours. Dichloromethane (50 mL) was added to the reaction mixture after it had cooled to 
room temperature. The mixture was then separated and the organic layer was washed with water (2 x 
25mL) and saturated sodium chloride solution (25 mL), dried over magnesium sulfate and 
concentrated under reduced pressure. The crude residue was purified via flash column 
chromatography (light petroleum:ethyl acetate, (1:1 v/v) to yield 2-(2-(pyrimidin-2-yloxy)phenyl)-6,7-
dihydrobenzo[d]oxazol-4(5H)-one 216 as intense yellow solid (47%).  
M.p. 178-180°C; HRMS(EI+) C17H13O3N3Na requires 330.0855 [M+Na] found 330.0846 -2.7265 ppm;  
νmax (DCM)/cm
-1 1692 (C=O); δH (400MHz; CDCl3) 2.17 (quintet, J=6.40 Hz, 2H, CH2), 2.55 (t, J=6.40 Hz, 
2H, O=CCH2), 2.80 (t, J= 6.40 Hz, 2H, O=CCH2), 7.04 (t, J=4.80 Hz, H, Ar CH), 7.31 (dd, J=8.40, 1.20 Hz, H, 
Ar CH), 7.38-7.42 (m, H,  Ar CH), 7.56-7.60 (m, H, Ar CH), 8.30 (dd, J=8.00, 1.60 Hz, H, Ar CH), 8.55 (d, 
J=4.80 H, Ar CH), 11.85 (broad s, H, Ar OH); δC (100MHz; CDCl3) 22.1 (CH2), 22.2 (CH2), 37.9 (CH2), 116.1 
(Ar CH), 120.0  (C), 124.0 (Ar CH), 126.2 (Ar CH), 130.5 (Ar CH), 132.5 (Ar CH, C), 134.8 (C), 159.3 (C), 
159.7 (C), 164.0 (2 x Ar CH), 165.6 (C), 191.4 (C). 
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General procedure for phenol mono-triflation 
Triflic anhydride (1.47 mL, 4.37 mMol) was added dropwise to a solution of the phenol (4.37 mMol) 
and pyridine  (0.70 mL, 4.37 mMol) in dichloromethane (50 mL) at 0°C. After 4 hours the reaction 
mixture was quenched with saturated ammonium chloride (25 mL) and separated. The organic layer 
was washed with 1M sodium hydroxide solution (2 x 25 mL) and saturated sodium chloride solution 
(50 mL). The organic layer was then dried over sodium sulfate, filtered and concentrated under 
reduced pressure. The crude product was purified via flash column chromatography using 
isohexane:ethyl acetate (1:1 v/v) as eluent to yield the desired phenol. 
2-(4-Oxo-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-yl)phenyl trifluoromethanesulfonate 220 
 
Brown gel (79%); MS(EI+) C14H10NO5F3SNa requires 384.0130 [M+Na] found 384.0121 -2.3437  ppm; 
νmax (ATR)/cm
-1 1136 (S=O), 1691 (C=O); δH (400 MHz, CDCl3) 2.27 (quintet, J=6.40 Hz, 2H, CH2), 2.56 (t, 
J=6.40 Hz, 2H, CH2), 3.10 (t, J=6.40 Hz, 2H, CH2),  7.45 (dd, J= 8.40, 0.80 Hz, H, Ar CH), 7.48-7.52 (m, H, 
Ar CH), 7.60—7.62 (m, H, Ar CH), 7.70 (dd, J=7.60, 2.00 Hz, H, Ar CH); δC (100 MHz, CDCl3) 22.1 (CH2), 
23.22 (CH2), 38.1 (CH2), 114.8 (C), 118.5 (quartet, J=319 Hz, CF3), 121.8 (Ar CH), 121.9 (C), 128.3 (Ar 
CH), 132.0 (Ar CH), 132.1 (Ar CH), 147.3 (C), 155.2 (C), 181.7 (isoxazole C), 191.5 (C=O); δF (376 Mhz, 
CDCl3) 88.03 (CF3). 
2-(4-Oxo-4,5,6,7-tetrahydrobenzo[d]oxazol-2-yl)phenyl trifluoromethanesulfonate 221 
 
White crystals (63%), M.p. 114-116°C; MS(EI+) C14H10NO5F3SNa requires 384.0130 [M+Na] found 
384.0115 1.5625  ppm; νmax (ATR)/cm
-1 1140 (S=O), 1688 (C=O); δH (400 MHz, CDCl3) 2.31 (quintet, 
J=6.00 Hz, 2H, CH2), 2.66 (t, J=6.00 Hz, 2H, CH2), 3.09 (t, J=6.00 Hz, 2H, CH2), 7.41 (d, J=8.00 Hz, H, Ar 
CH), 7.50-7.54 (m, H, Ar CH), 7.57-7.62 (m, H, Ar CH), 8.33 (dd, J=8.00, 2.00 Hz, H, Ar CH); δC (100 MHz, 
CDCl3) 22.2 (2 x CH2), 38.0 (CH2), 118.6 (q, J=319 Hz, CF3), 120.4 (C), 122.9 (Ar CH), 128.9 (Ar CH), 131.3 
(Ar CH), 132.7 (Ar CH), 135.1 (C), 146.5 (C), 157.6 (C), 164.8 (C), 191.5 (C=O); δF (376 Mhz, CDCl3) 88.65 
(CF3). 
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2-(4-Oxo-4,5,6,7-tetrahydrobenzo[d]oxazol-2-yl)-1,4-phenylene bis(trifluoromethanesulfonate) 222 
 
Clear oil (5%); δH (400MHz; CDCl3) 2.32 (quintet, J=6.00 Hz, 2H, CH2), 2.68 (t, J=6.00 Hz, 2H, CH2), 3.09 
(t, J=6.00 Hz, 2H, CH2), 7.35 (d, J=9.20 Hz, H, Ar CH), 7.53 (dd, J=9.20, 2.80 Hz, H, Ar CH), 8.38 (d, J=2.80 
Hz, H, Ar CH); δC (100MHz; CDCl3) 22.2 (2 x CH2), 37.9 (CH2), 117.0 (C), 121.8 (C), 124.3 (Ar CH), 130.9 
(Ar CH), 132.5 (Ar CH), 134.9 (C), 135.3 (C), 144.7 (C), 156.5 (C), 165.0 (C), 191.2 (C=O). The remaining 
quaternary carbon could not be distinguished from the noise in the time allocated for this experiment. 
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Appendix i – Crystal Structures 
 
All crystal structure datra described herin was collected and solved by Dr Mark Elsegood of 
Loughborough University. Full data sets aviable on request to M.R.J.Elsegood@lboro.ac.uk or 
R.C.F.Jones@lboro.ac.uk. 
X-Ray crystal structure of 3-(2-Hydroxyphenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 61 
 
 
Table 1.  Crystal data and structure refinement for 61. 
Identification code  RCFJ39 
Chemical formula  C13H11NO3 
Formula weight  229.23 
Temperature  150(2) K 
Radiation, wavelength  MoKa, 0.71073 Å 
 
ii 
 
Crystal system, space group  orthorhombic, Pca21 
Unit cell parameters a = 15.024(3) Å a = 90° 
 b = 21.464(4) Å b = 90° 
 c = 13.309(3) Å g = 90° 
Cell volume 4291.8(15) Å3 
Z 16 
Calculated density  1.419 g/cm3 
Absorption coefficient m 0.102 mm1 
F(000) 1920 
Crystal colour and size colourless, 0.87  0.25  0.10 mm3 
Reflections for cell refinement 4726 (q range 2.25 to 25.31°) 
Data collection method Bruker APEX 2 CCD diffractometer 
 w rotation with narrow frames 
q range for data collection 0.95 to 26.54° 
Index ranges h 18 to 18, k 26 to 26, l 16 to 16 
Completeness to q = 26.54° 99.4 %  
Intensity decay 0% 
Reflections collected 36812 
Independent reflections 8811 (Rint = 0.0638) 
Reflections with F2>2s 5081 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.917 and 0.999 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0580, 2.9563 
Data / restraints / parameters 8811 / 1 / 625 
Final R indices [F2>2s] R1 = 0.0564, wR2 = 0.1288 
R indices (all data) R1 = 0.1218, wR2 = 0.1684 
Goodness-of-fit on F2 1.008 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.403 and 0.290 e Å3 
  
 
iii 
 
X-Ray crystal structure of 3-(2-(but-3-en-1-yloxy)phenyl)-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 77 
 
 
 
 
 
 
 
 
 
 
iv 
 
RCFJ 44 
C17H17NO3 Dx = 1.291 Mg m
-3
 
Mr = 283.31 Mo K radiation,  = 0.71073 Å 
Orthorhombic, Pbca Cell parameters from 11913 reflections 
a = 15.8407 (11) Å  = 2.5–28.3° 
b = 13.7859 (9) Å  = 0.09 mm-1 
c = 26.6923 (18) Å T = 150 K 
V = 5829.0 (7)  Å
3
 Tablet, colourless 
Z = 16 0.75 × 0.66 × 0.10 mm 
F(000) = 2400  
 
 
Data collection 
Bruker APEX 2 CCD diffractometer 6149 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.045 
 rotation with narrow frames scans max = 30.6°, min = 1.5° 
Absorption correction: multi-scan  
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = -2222 
Tmin = 0.936, Tmax = 0.991 k = -1919 
65102 measured reflections l = -3737 
8885 independent reflections  
 
 
 
 
 
 
 
 
v 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F
2
 > 2(F2)] = 0.047 Hydrogen site location: mixed 
wR(F
2
) = 0.129 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.01 w = 1/[2(Fo
2
) + (0.0587P)
2
 + 1.7931P]     
where P = (Fo
2
 + 2Fc
2
)/3 
8885 reflections (/)max < 0.001 
514 parameters max = 0.49 e Å
-3
 
21 restraints min = -0.20 e Å
-3
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material  
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
 
 
vi 
 
X-Ray crystal structure of 5-allyl-3-(2-(allyloxy)phenyl)-1-(dimethylamino)-6,7-dihydro-H-indazol-
4(5H)-one 129 
 
 
 
 
 
 
vii 
 
RCJF 56 
C2H25N3O2 Z = 2 
Mr = 351.44 F(000) = 376 
Triclinic, P¯1 Dx = 1.201 Mg m
-3
 
a = 9.812 (4) Å Mo K radiation,  = 0.71073 Å 
b = 10.456 (4) Å Cell parameters from 1987 reflections 
c = 10.951 (4) Å  = 2.4–23.8° 
 = 101.805 (5)°  = 0.08 mm-1 
 = 112.996 (5)° T = 150 K 
 = 99.966 (5)° Tablet, colourless 
V = 971.6 (7)  Å
3
 0.61 × 0.32 × 0.09 mm
3 
 
Data collection 
Bruker APEX 2 CCD diffractometer 2577 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.046 
 rotation with narrow frames scans max = 26.5°, min = 2.1° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = -1212 
Tmin = 0.954, Tmax = 0.993 k = -1313 
11195 measured reflections l = -1313 
3991 independent reflections  
 
 
 
 
 
 
 
 
viii 
 
Refinement 
Refinement on F
2
 Hydrogen site location: mixed 
Least-squares matrix: full H atoms treated by a mixture of independent 
and constrained refinement 
R[F
2
 > 2(F2)] = 0.055 w = 1/[2(Fo
2
) + (0.0626P)
2
 + 0.3996P]   
where P = (Fo
2
 + 2Fc
2
)/3 
wR(F
2
) = 0.152 (/)max < 0.001 
S = 1.03 max = 0.51 e Å
-3
 
3991 reflections min = -0.38 e Å
-3
 
306 parameters Extinction correction: SHELXL, 
Fc
*
=kFc[1+0.001xFc
23/sin(2)]-1/4 
17 restraints Extinction coefficient: 0.013 (3) 
Primary atom site location: structure-invariant 
direct methods 
 
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
ix 
 
X-Ray crystal structure of 2-((2-(allyloxy)phenyl)(amino)methylene)cyclohexane-1,3-dione 135 
 
 
 
 
 
 
 
 
 
 
 
x 
 
RCFJ 42 
Crystal data 
C16H17NO3 F(000) = 576 
Mr = 271.30 Dx = 1.321 Mg m
-3
 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 10.7250 (17) Å Cell parameters from 3054 reflections 
b = 8.1582 (13) Å  = 2.6–30.4° 
c = 15.601 (3) Å  = 0.09 mm-1 
 = 91.636 (3)° T = 150 K 
V = 1364.5 (4)  Å
3
 Tablet, yellow 
Z = 4 0.45 × 0.29 × 0.07 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 4137 independent reflections 
Radiation source: fine-focus sealed tube 3017 reflections with I > 2(I) 
graphite Rint = 0.035 
 rotation with narrow frames scans max = 30.5°, min = 1.9° 
Absorption correction: multi-scan  
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = -1515 
Tmin = 0.960, Tmax = 0.994 k = -1111 
15472 measured reflections l = -2221 
 
 
 
 
 
 
 
 
 
xi 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: all non-H atoms 
found by direct methods 
R[F
2
 > 2(F2)] = 0.045 Hydrogen site location: difference Fourier map 
wR(F
2
) = 0.125 All H-atom parameters refined 
S = 1.04 w = 1/[2(Fo
2
) + (0.0672P)
2
 + 0.1144P]     
where P = (Fo
2
 + 2Fc
2
)/3 
4137 reflections (/)max < 0.001 
249 parameters max = 0.41 e Å
-3
 
0 restraints min = -0.20 e Å
-3
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
 
 
xii 
 
X-Ray crystal structure of 2-(2-hydroxyphenyl)-6,6-dimethyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one  
166 
 
 
 
 
 
 
 
 
 
xiii 
 
RCFJ46 
Crystal data 
C15H15NO3 Dx = 1.305 Mg m
-3
 
Mr = 257.28 Mo K radiation,  = 0.71073 Å 
Orthorhombic, Pna21 Cell parameters from 4807 reflections 
a = 12.9420 (14) Å  = 2.4–23.7° 
b = 9.330 (1) Å  = 0.09 mm-1 
c = 21.682 (2) Å T = 150 K 
V = 2618.1 (5)  Å
3
 Plate, colourless 
Z = 8 0.48 × 0.40 × 0.04 mm 
F(000) = 1088  
 
Data collection 
Bruker APEX-II CCD diffractometer Rint = 0.037 
Radiation source: fine-focus sealed tube max = 26.4°, min = 1.9° 
 and  scans h = -1616 
20349 measured reflections k = -1111 
5338 independent reflections l = -2727 
4424 reflections with I > 2(I)  
 
 
 
 
 
 
 
 
 
 
xiv 
 
Refinement 
Refinement on F
2
 Secondary atom site location: all non-H atoms 
found by direct methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F
2
 > 2(F2)] = 0.035 All H-atom parameters refined 
wR(F
2
) = 0.084 w = 1/[2(Fo
2
) + (0.0467P)
2
 + 0.0138P]     
where P = (Fo
2
 + 2Fc
2
)/3 
S = 1.04 (/)max < 0.001 
5338 reflections max = 0.19 e Å
-3
 
463 parameters min = -0.17 e Å
-3
 
1 restraint Absolute structure:  Flack x determined using 
1909 quotients [(I+)-(I-)]/[(I+)+(I-)]   (Parsons 
and Flack (2004), Acta Cryst. A60, s61). 
Primary atom site location: structure-invariant 
direct methods 
Flack parameter: 0.8 (5) 
 
 
 
Computing details 
Data collection: Bruker APEX2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
xv 
 
X-Ray crystal structure of 2-hydroxy-N-(2-hydroxy-6-oxocyclohex-1-en-1-yl)benzamide 180 
 
 
 
 
 
 
 
 
 
xvi 
 
RCFJ43 
Crystal data 
C13H13NO4 F(000) = 520 
Mr = 247.24 Dx = 1.446 Mg m
-3
 
Monoclinic, P21/n Mo K radiation,  = 0.71073 Å 
a = 5.5001 (6) Å Cell parameters from 6269 reflections 
b = 15.2463 (18) Å  = 2.7–30.6° 
c = 13.6680 (16) Å  = 0.11 mm-1 
 = 97.7388 (18)° T = 150 K 
V = 1135.7 (2)  Å
3
 Block, colourless 
Z = 4 1.02 × 0.79 × 0.38 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 2970 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.026 
 rotation with narrow frames scans max = 30.6°, min = 2.0° 
Absorption correction: multi-scan  
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = -77 
Tmin = 0.898, Tmax = 0.960 k = -2121 
12997 measured reflections l = -1919 
3446 independent reflections  
 
 
 
 
 
 
 
 
 
xvii 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F
2
 > 2(F2)] = 0.045 Hydrogen site location: mixed 
wR(F
2
) = 0.131 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.05 w = 1/[2(Fo
2
) + (0.080P)
2
 + 0.2403P]     
where P = (Fo
2
 + 2Fc
2
)/3 
3446 reflections (/)max < 0.001 
201 parameters max = 0.42 e Å
-3
 
35 restraints min = -0.22 e Å
-3
 
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare 
material for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
 
xviii 
 
X-Ray crystal structure of N-(2-(ethylthio)-6-oxocyclohex-1-en-1-yl)-2-hydroxybenzamide 186 
 
 
 
 
 
 
 
 
 
xix 
 
RCFJ45 
Crystal data 
C15H17NO3S F(000) = 616 
Mr = 291.35 Dx = 1.329 Mg m
-3
 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 9.7309 (7) Å Cell parameters from 6233 reflections 
b = 7.3003 (5) Å  = 2.9–30.4° 
c = 20.4979 (14) Å  = 0.23 mm-1 
 = 91.268 (1)° T = 150 K 
V = 1455.78 (18)  Å
3
 Block, colourless 
Z = 4 0.61 × 0.23 × 0.16 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 3740 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.024 
 rotation with narrow frames scans max = 30.6°, min = 2.0° 
Absorption correction: multi-scan  
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = -1313 
Tmin = 0.873, Tmax = 0.964 k = -1010 
16546 measured reflections l = -2929 
4425 independent reflections  
 
 
 
 
 
 
 
 
xx 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: all non-H atoms 
found by direct methods 
R[F
2
 > 2(F2)] = 0.042 Hydrogen site location: difference Fourier map 
wR(F
2
) = 0.121 All H-atom parameters refined 
S = 1.06 w = 1/[2(Fo
2
) + (0.078P)
2
 + 0.188P]     
where P = (Fo
2
 + 2Fc
2
)/3 
4425 reflections (/)max = 0.001 
249 parameters max = 0.75 e Å
-3
 
0 restraints min = -0.24 e Å
-3
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
 
 
 
xxi 
 
X-Ray crystal structure of 3-(2-hydroxyphenyl)-5,5-dimethyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one 
194 
 
 
 
 
 
 
 
 
xxii 
 
RCFJ55 
Crystal data 
C15H15NO3 Dx = 1.370 Mg m
-3
 
Mr = 257.28 Mo K radiation,  = 0.71073 Å 
Orthorhombic, Pbca Cell parameters from 4851 reflections 
a = 11.1585 (12) Å  = 2.8–30.3° 
b = 11.4154 (12) Å  = 0.10 mm-1 
c = 19.588 (2) Å T = 150 K 
V = 2495.1 (5)  Å
3
 Tablet, colourless 
Z = 8 0.58 × 0.54 × 0.16 mm
3 
F(000) = 1088  
 
Data collection 
Bruker APEX 2 CCD diffractometer 3005 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.032 
 rotation with narrow frames scans max = 30.4°, min = 2.1° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = -1512 
Tmin = 0.946, Tmax = 0.985 k = -1616 
18546 measured reflections l = -2727 
3766 independent reflections  
 
 
 
 
 
 
 
 
 
xxiii 
 
Refinement 
 Refinement on F2 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F
2
 > 2(F2)] = 0.043 All H-atom parameters refined 
wR(F
2
) = 0.127  w = 1/[2(Fo
2
) + (0.0729P)
2
 + 0.574P]   
where P = (Fo
2
 + 2Fc
2
)/3 
S = 1.03 (/)max < 0.001 
3766 reflections max = 0.42 e Å
-3
 
232 parameters min = -0.20 e Å
-3
 
6 restraints  
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken  into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic)   treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
 
 
 
 
xxiv 
 
X-Ray crystal structure of 2-(4-oxo-4,5,6,7-tetrahydrobenzo[d]oxazol-2-yl)phenyl 
trifluoromethanesulfonate 221 
 
 
 
 
 
 
 
 
xxv 
 
RCFJ52 
Crystal data 
C14H10F3NO5S F(000) = 1472 
Mr = 361.29 Dx = 1.612 Mg m
-3
 
Monoclinic, C2/c Mo K radiation,  = 0.71073 Å 
a = 21.725 (4) Å Cell parameters from 3754 reflections 
b = 11.1783 (19) Å  = 2.5–28.3° 
c = 12.802 (2) Å  = 0.28 mm-1 
 = 106.781 (3)° T = 150 K 
V = 2976.6 (9)  Å
3
 Plate, colourless 
Z = 8 0.61 × 0.53 × 0.07 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 3202 reflections with I > 2(I) 
Radiation source: fine-focus sealed tube Rint = 0.037 
 rotation with narrow frames scans max = 29.6°, min = 2.0° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = -3030 
Tmin = 0.849, Tmax = 0.981 k = -1515 
16267 measured reflections l = -1717 
4181 independent reflections  
 
 
 
 
 
 
 
 
 
xxvi 
 
Refinement 
Refinement on F
2
 Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F
2
 > 2(F2)] = 0.041 Hydrogen site location: difference Fourier map 
wR(F
2
) = 0.106 All H-atom parameters refined 
S = 1.06 w = 1/[2(Fo
2
) + (0.0449P)
2
 + 2.0142P]   
where P = (Fo
2
 + 2Fc
2
)/3 
4181 reflections (/)max < 0.001 
257 parameters max = 0.34 e Å
-3
 
0 restraints min = -0.48 e Å
-3
 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when 
they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
 
